
<html lang="en"     class="pb-page"  data-request-id="c6ff27dc-ae05-4ffe-8187-5fd5a9047542"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm400650w;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2013.56.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Dihydrothiazolopyridone Derivatives as a Novel Family of Positive Allosteric Modulators of the Metabotropic Glutamate 5 (mGlu5) Receptor" /></meta><meta name="dc.Creator" content="José Manuel  Bartolomé-Nebreda" /></meta><meta name="dc.Creator" content="Susana  Conde-Ceide" /></meta><meta name="dc.Creator" content="Francisca  Delgado" /></meta><meta name="dc.Creator" content="Laura  Iturrino" /></meta><meta name="dc.Creator" content="Joaquín  Pastor" /></meta><meta name="dc.Creator" content="Miguel Ángel  Pena" /></meta><meta name="dc.Creator" content="Andrés A.  Trabanco" /></meta><meta name="dc.Creator" content="Gary  Tresadern" /></meta><meta name="dc.Creator" content="Carola M.  Wassvik" /></meta><meta name="dc.Creator" content="Shaun R.  Stauffer" /></meta><meta name="dc.Creator" content="Satyawan  Jadhav" /></meta><meta name="dc.Creator" content="Kiran  Gogi" /></meta><meta name="dc.Creator" content="Paige N.  Vinson" /></meta><meta name="dc.Creator" content="Meredith J.  Noetzel" /></meta><meta name="dc.Creator" content="Emily  Days" /></meta><meta name="dc.Creator" content="C. David  Weaver" /></meta><meta name="dc.Creator" content="Craig W.  Lindsley" /></meta><meta name="dc.Creator" content="Colleen M.  Niswender" /></meta><meta name="dc.Creator" content="Carrie K.  Jones" /></meta><meta name="dc.Creator" content="P. Jeffrey  Conn" /></meta><meta name="dc.Creator" content="Frederik  Rombouts" /></meta><meta name="dc.Creator" content="Hilde  Lavreysen" /></meta><meta name="dc.Creator" content="Gregor J.  Macdonald" /></meta><meta name="dc.Creator" content="Claire  Mackie" /></meta><meta name="dc.Creator" content="Thomas  Steckler" /></meta><meta name="dc.Description" content="Starting from a singleton chromanone high throughput screening (HTS) hit, we describe a focused medicinal chemistry optimization effort leading to the identification of a novel series of phenoxymet..." /></meta><meta name="Description" content="Starting from a singleton chromanone high throughput screening (HTS) hit, we describe a focused medicinal chemistry optimization effort leading to the identification of a novel series of phenoxymet..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 4, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400650w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400650w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400650w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400650w" /></link>
        
    
    

<title>Dihydrothiazolopyridone Derivatives as a Novel Family of Positive Allosteric Modulators of the Metabotropic Glutamate 5 (mGlu5) Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400650w" /></meta><meta property="og:title" content="Dihydrothiazolopyridone Derivatives as a Novel Family of Positive Allosteric Modulators of the Metabotropic Glutamate 5 (mGlu5) Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0019.jpeg" /></meta><meta property="og:description" content="Starting from a singleton chromanone high throughput screening (HTS) hit, we describe a focused medicinal chemistry optimization effort leading to the identification of a novel series of phenoxymethyl-dihydrothiazolopyridone derivatives as selective positive allosteric modulators (PAMs) of the metabotropic glutamate 5 (mGlu5) receptor. These dihydrothiazolopyridones potentiate receptor responses in recombinant systems. In vitro and in vivo drug metabolism and pharmacokinetic (DMPK) evaluation allowed us to select compound 16a for its assessment in a preclinical animal screen of possible antipsychotic activity. 16a was able to reverse amphetamine-induced hyperlocomotion in rats in a dose-dependent manner without showing any significant motor impairment or overt neurological side effects at comparable doses. Evolution of our medicinal chemistry program, structure activity, and properties relationships (SAR and SPR) analysis as well as a detailed profile for optimized mGlu5 receptor PAM 16a are described." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400650w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400650w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400650w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400650w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400650w&amp;href=/doi/10.1021/jm400650w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 7243-7259</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400966v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400715h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Dihydrothiazolopyridone Derivatives as a Novel Family of Positive Allosteric Modulators of the Metabotropic Glutamate 5 (mGlu<sub>5</sub>) Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+Manuel++Bartolom%C3%A9-Nebreda">José Manuel Bartolomé-Nebreda</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susana++Conde-Ceide">Susana Conde-Ceide</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisca++Delgado">Francisca Delgado</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Iturrino">Laura Iturrino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joaqu%C3%ADn++Pastor">Joaquín Pastor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miguel+%C3%81ngel++Pena">Miguel Ángel Pena</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andr%C3%A9s+A.++Trabanco">Andrés A. Trabanco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Tresadern">Gary Tresadern</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carola+M.++Wassvik">Carola M. Wassvik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaun+R.++Stauffer">Shaun R. Stauffer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Satyawan++Jadhav">Satyawan Jadhav</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kiran++Gogi">Kiran Gogi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paige+N.++Vinson">Paige N. Vinson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meredith+J.++Noetzel">Meredith J. Noetzel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emily++Days">Emily Days</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>△</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C.+David++Weaver">C. David Weaver</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>△</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Craig+W.++Lindsley">Craig W. Lindsley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Colleen+M.++Niswender">Colleen M. Niswender</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carrie+K.++Jones">Carrie K. Jones</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=P.+Jeffrey++Conn">P. Jeffrey Conn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederik++Rombouts">Frederik Rombouts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hilde++Lavreysen">Hilde Lavreysen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>●</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregor+J.++Macdonald">Gregor J. Macdonald</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Mackie">Claire Mackie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>▲</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Steckler">Thomas Steckler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>●</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Neuroscience Medicinal Chemistry, <sup>¶</sup>CREATe Analytical Sciences, and <sup>‡</sup>CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>§</sup>Department of Pharmacology and <sup>∥</sup>Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">⊥</span> <span class="aff-text">Vanderbilt Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span></div><div class="aff-info" id="aff4"><span class="aff-text"><sup>#</sup>Department of Chemistry and <sup>△</sup>Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span></div><div class="aff-info" id="aff5"><span class="aff-text"><sup>○</sup>Neuroscience Medicinal Chemistry, <sup>●</sup>Neuroscience Biology, and <sup>▲</sup>CREATe Discovery ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div><div class="corresp-info"><strong>*</strong>Phone: +34 925 245778. Fax: +34 925 245771. E-mail: <a href="/cdn-cgi/l/email-protection#69030b081b1d06050629001d1a47030703470a0604"><span class="__cf_email__" data-cfemail="177d75766563787b78577e6364397d797d3974787a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400650w&amp;href=/doi/10.1021%2Fjm400650w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 7243–7259</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 15, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 May 2013</li><li><span class="item_label"><b>Published</b> online</span>4 September 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 September 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400650w" title="DOI URL">https://doi.org/10.1021/jm400650w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7243%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJos%25C3%25A9%2BManuel%2BBartolom%25C3%25A9-Nebreda%252C%2BSusana%2BConde-Ceide%252C%2BFrancisca%2BDelgado%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D18%26contentID%3Djm400650w%26title%3DDihydrothiazolopyridone%2BDerivatives%2Bas%2Ba%2BNovel%2BFamily%2Bof%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BMetabotropic%2BGlutamate%2B5%2B%2528mGlu5%2529%2BReceptor%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7259%26publicationDate%3DSeptember%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400650w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1714</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400650w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Dihydrothiazolopyridone Derivatives as a Novel Family of Positive Allosteric Modulators of the Metabotropic Glutamate 5 (mGlu5) Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Manuel Bartolomé-Nebreda&quot;},{&quot;first_name&quot;:&quot;Susana&quot;,&quot;last_name&quot;:&quot;Conde-Ceide&quot;},{&quot;first_name&quot;:&quot;Francisca&quot;,&quot;last_name&quot;:&quot;Delgado&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Iturrino&quot;},{&quot;first_name&quot;:&quot;Joaquín&quot;,&quot;last_name&quot;:&quot;Pastor&quot;},{&quot;first_name&quot;:&quot;Miguel&quot;,&quot;last_name&quot;:&quot;Ángel Pena&quot;},{&quot;first_name&quot;:&quot;Andrés&quot;,&quot;last_name&quot;:&quot;A. Trabanco&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Tresadern&quot;},{&quot;first_name&quot;:&quot;Carola&quot;,&quot;last_name&quot;:&quot;M. Wassvik&quot;},{&quot;first_name&quot;:&quot;Shaun&quot;,&quot;last_name&quot;:&quot;R. Stauffer&quot;},{&quot;first_name&quot;:&quot;Satyawan&quot;,&quot;last_name&quot;:&quot;Jadhav&quot;},{&quot;first_name&quot;:&quot;Kiran&quot;,&quot;last_name&quot;:&quot;Gogi&quot;},{&quot;first_name&quot;:&quot;Paige&quot;,&quot;last_name&quot;:&quot;N. Vinson&quot;},{&quot;first_name&quot;:&quot;Meredith&quot;,&quot;last_name&quot;:&quot;J. Noetzel&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;Days&quot;},{&quot;first_name&quot;:&quot;C.&quot;,&quot;last_name&quot;:&quot;David Weaver&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;W. Lindsley&quot;},{&quot;first_name&quot;:&quot;Colleen&quot;,&quot;last_name&quot;:&quot;M. Niswender&quot;},{&quot;first_name&quot;:&quot;Carrie&quot;,&quot;last_name&quot;:&quot;K. Jones&quot;},{&quot;first_name&quot;:&quot;P.&quot;,&quot;last_name&quot;:&quot;Jeffrey Conn&quot;},{&quot;first_name&quot;:&quot;Frederik&quot;,&quot;last_name&quot;:&quot;Rombouts&quot;},{&quot;first_name&quot;:&quot;Hilde&quot;,&quot;last_name&quot;:&quot;Lavreysen&quot;},{&quot;first_name&quot;:&quot;Gregor&quot;,&quot;last_name&quot;:&quot;J. Macdonald&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Mackie&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Steckler&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;7243-7259&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400650w&quot;},&quot;abstract&quot;:&quot;Starting from a singleton chromanone high throughput screening (HTS) hit, we describe a focused medicinal chemistry optimization effort leading to the identification of a novel series of phenoxymethyl-dihydrothiazolopyridone derivatives as selective positive allosteric modulators (PAMs) of the metabotropic glutamate 5 (mGlu5) receptor. These dihydrothiazolopyridones potentiate receptor responses in recombinant systems. In vitro and in vivo drug metabolism and pharmacokinetic (DMPK) evaluation allowed us to select compound 16a for its assessment in a preclinical animal screen of possible antipsychotic activity. 16a was able to reverse amphetamine-induced hyperlocomotion in rats in a dose-dependent manner without showing any significant motor impairment or overt neurological side effects at comparable doses. Evolution of our medicinal chemistry program, structure activity, and properties relationships (SAR and SPR) analysis as well as a detailed profile for optimized mGlu5 receptor PAM 16a are described.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400650w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400650w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400650w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400650w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400650w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400650w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400650w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400650w&amp;href=/doi/10.1021/jm400650w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400650w" /></input><a href="/doi/pdf/10.1021/jm400650w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400650w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400650w%26sid%3Dliteratum%253Aachs%26pmid%3D23947773%26genre%3Darticle%26aulast%3DBartolom%25C3%25A9-Nebreda%26date%3D2013%26atitle%3DDihydrothiazolopyridone%2BDerivatives%2Bas%2Ba%2BNovel%2BFamily%2Bof%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BMetabotropic%2BGlutamate%2B5%2B%2528mGlu5%2529%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D18%26spage%3D7243%26epage%3D7259%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jmcmar.2013.56.issue-18/production/jmcmar.2013.56.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Starting from a singleton chromanone high throughput screening (HTS) hit, we describe a focused medicinal chemistry optimization effort leading to the identification of a novel series of phenoxymethyl-dihydrothiazolopyridone derivatives as selective positive allosteric modulators (PAMs) of the metabotropic glutamate 5 (mGlu<sub>5</sub>) receptor. These dihydrothiazolopyridones potentiate receptor responses in recombinant systems. In vitro and in vivo drug metabolism and pharmacokinetic (DMPK) evaluation allowed us to select compound <b>16a</b> for its assessment in a preclinical animal screen of possible antipsychotic activity. <b>16a</b> was able to reverse amphetamine-induced hyperlocomotion in rats in a dose-dependent manner without showing any significant motor impairment or overt neurological side effects at comparable doses. Evolution of our medicinal chemistry program, structure activity, and properties relationships (SAR and SPR) analysis as well as a detailed profile for optimized mGlu<sub>5</sub> receptor PAM <b>16a</b> are described.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Schizophrenia is a mental disorder that affects approximately 1% of the world population.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This severely limiting illness is characterized by a combination of so-called positive (e.g., hallucinations and delusions), negative (e.g., anhedonia and poverty of speech), and cognitive symptoms.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Currently available therapies, “typical” and “atypical” antipsychotics, rely on dopamine 2 (D<sub>2</sub>) receptor antagonism to exert their action, and, despite being highly efficacious in addressing positive symptoms, they are of limited value for the treatment of the other core symptoms of the disease. Furthermore, their clinical use is associated with a plethora of severe side-effects (e.g., Parkinson-like extrapyramidal symptoms (EPS), prolactin release, weight gain, or cardiac risk), and as such, patient compliance is extremely poor. As a result, during the past 10–15 years, several alternative mechanisms of action that do not involve direct interaction with dopaminergic receptors have been proposed and investigated.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> The ultimate hope is that different biological pathways may lead to effective antipsychotic medications with both increased efficacy versus all three core symptom domains and improved tolerability due to the lack of direct D<sub>2</sub> receptor blockade.</div><div class="NLM_p">One of the proposed pathophysiological causes that may lead to schizophrenia is a compromised function of <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptors. This NMDA receptor hypofunction triggers a cascade of events, i.e., reduced activation of inhibitory γ-aminobutyric acidergic (GABAergic) interneurons in thalamus and cortex with a consequent disinhibition of excitatory glutamatergic pathways.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> On the basis of these observations, it has been proposed that compounds that enhance NMDA receptor function may have beneficial effects in schizophrenia. Unfortunately, direct agonists of the NMDA receptor tend to be neurotoxic; hence, alternative strategies to increase NMDA receptor function have been suggested. A desired increase in NMDA receptor function may be obtained through an indirect modulation of NMDA receptors via metabotropic glutamate (mGlu) receptors, especially mGlu<sub>5</sub> receptors.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The mGlu<sub>5</sub> receptor belongs to the Group I mGlu receptor subfamily, together with the mGlu<sub>1</sub> receptor.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> They activate phospholipase C (PLC) via coupling to G<sub>q</sub> proteins and are ubiquitously expressed on postsynaptic excitatory terminals in limbic brain regions that are involved in motivational, emotional, and cognitive processes.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> At GABA-ergic interneurons, mGlu<sub>5</sub> and NMDA receptors are coexpressed<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and are not only coupled via intracellular signaling pathways but also physically through scaffolding proteins.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In summary, mGlu<sub>5</sub> receptor-mediated activation of NMDA receptor functioning has recently emerged as a promising non-dopamine based approach for potential therapeutic intervention of schizophrenia.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Taking into account the challenges associated with the development of orthosteric agonists for mGlu receptors (e.g., poor druglike properties, elusive selectivity, or potential tolerance development), current strategies have mainly focused on the identification of positive allosteric modulators (PAMs).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This approach has already proven useful, and in vivoactivity in different preclinical schizophrenia and cognition models has been reported for early prototypical mGlu<sub>5</sub> PAMs such as 3-cyano-<i>N</i>-(1,3-diphenyl-1<i>H</i>-pyrazol-5-yl)benzamide (CDPPB, <b>1</b>)<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> or <i>S</i>-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-methanone (ADX47273, <b>2</b>)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and more recently for novel structurally distinct chemical series including <i>N</i>-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide (VU0360172, <b>3</b>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><i>N</i>-(1-methylethyl)-5-(pyridin-4-ylethynyl)pyridine-2-carboxamide (LSN2463359, <b>4</b>),<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> 4-butoxy-<i>N</i>-(2,4-difluor-ophenyl)benzamide (VU0357121, <b>5</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> 2-(4-(2-(benzyloxy)acetyl)piperazin-1-yl)benzonitrile (VU0364289, <b>6</b>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (1-(4-(2-chloro-4-fluorophenyl)piperazin-1-yl)-2-(pyridin-4-ylmethoxy)eth-anone (CPPZ, <b>7</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and (7<i>S</i>)-3-<i>tert</i>-butyl-7-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-<i>a</i>]pyridine (LSN2814617, <b>8</b>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> These novel PAM classes represent a significant evolution from the first generation as they offer improved drug-likeliness (e.g., improved solubility, unbound fraction in brain or oral bioavailability and in vivo efficacy). Although the preclinical biological data clearly suggest the potential of mGlu<sub>5</sub> receptor PAMs as a novel class of antipsychotic agents, the identification of a compound suitable for clinical proof-of-concept studies still remains a challenge and will be crucial to clarify the potential role of mGlu<sub>5</sub> receptor PAMs as improved antipsychotics.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. mGlu<sub>5</sub> receptor PAMs with reported efficacy in preclinical models of schizophrenia and cognition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Given the promise offered by mGlu<sub>5</sub> receptor PAMs as a potential novel treatment for schizophrenia, we performed an HTS campaign looking for for starting points for a medicinal chemistry program. The in vitro mGlu<sub>5</sub> PAM calcium mobilization assay provides two measures of compound activity: pEC<sub>50</sub>, which is defined as the negative logarithm of the concentration at which half-maximal potentiation of glutamate is reached, and the maximal increase in observed glutamate response, the % Glu Max. Screening of the Janssen corporate library in a cell line expressing the human mGlu<sub>5</sub> receptor with this functional calcium mobilization assay resulted in the identification of the subsequently reported chromanone <b>9</b>,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> as a promising hit. Compound <b>9</b> possessed potent in vitro mGlu<sub>5</sub> PAM activity (EC<sub>50</sub> = 128 nM, Glu Max = 82%). As a first step, and since molecule <b>9</b> contains labile substructures such as the ester group, we verified that the products of the ester hydrolysis, benzoic acid and 6-hydroxy-chromanone, were not responsible for the mGlu<sub>5</sub> PAM activity of the HTS sample of <b>9</b>. Both compounds were found to be inactive under the same assay conditions (EC<sub>50</sub> > 10 μM), while quality control of the sample <b>9</b> was good (LCMS purity > 95%), providing confidence in the HTS in vitro data. Furthermore, <b>9</b> showed satisfactory selectivity<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> versus other representative members of the mGlu family (mGlu<sub>1,2,8</sub> EC<sub>50</sub> > 10 μM). Unfortunately, and as anticipated from the presence of the carboxylic ester functionality, <b>9</b> was found to be completely hydrolyzed in rat plasma, which precluded any further work for its in vivo pharmacological characterization. Nevertheless, compound <b>9</b> was considered as a good starting point for optimization due to its low molecular weight, moderate lipophilicity (clogP = 3.3), high ligand efficiency<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (LE = 0.34), and promising selectivity.</div><div class="NLM_p">As seen in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, our strategy for the exploration of the chromanone <b>9</b> followed two parallel approaches, first fixing the chromanone scaffold while performing an extensive search for replacements for the labile ester group (<b>A</b>) and, in addition, seeking to replace and optimize the chromanone bicycle as it also contains a ketone moiety, a potential metabolic hot spot and biologically reactive group (<b>B</b>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Parallel simultaneous evolution from HTS hit <b>9</b> to optimized series <b>15</b> and <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Approach <b>A</b> involved the synthesis and evaluation of several libraries of diverse potential ester surrogates including, among others, alkyls, amides, amines, heterocycles, and ethers as alternate spacers between the chromanone core and the distal phenyl ring.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Among this set of linkers, only previously published benzyloxy and phenoxymethyl derivatives <b>10</b> and <b>11</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> retained significant mGlu<sub>5</sub> receptor PAM activity (EC<sub>50</sub> = 950 nM, 76% Glu Max and EC<sub>50</sub> = 2.14 μM, 94% Glu Max respectively) and promising selectivity versus the other mGlu receptor subtypes (mGlu<sub>1–4,6–8</sub> EC<sub>50</sub> > 10 μM). Similar moieties have recently been reported for other mGlu<sub>5</sub> PAM chemotypes.<a onclick="showRef(event, 'ref19 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref23">(19, 23)</a></div><div class="NLM_p">For the second prong of our strategy, chromanone replacements were sought using different approaches. It is now becoming clear in the literature that some of the most potent in vitro mGlu<sub>5</sub> receptor PAMs have a common phenylacetylene moiety.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> For comparative purposes, we synthesized the corresponding phenylacetylene chromanone analogue <b>12</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> which was also found to be an mGlu<sub>5</sub> receptor PAM (EC<sub>50</sub> = 682 nM, Glu Max 84%) although with an approximately 5-fold decrease in activity compared to the initial HTS hit <b>9</b>. Following this result, we decided to keep the acetylenic spacer constant and combine it with different bicyclic systems with the underlying rationale that this could increase the ability to sample and identify chromanone alternatives. To prioritize among the multiple existing possibilities, our design principle focused on bicyclic scaffolds possessing hydrogen bond acceptors that could mimic those present in the chromanone core. This strategy proved fruitful as among the initial set of compounds synthesized, dihydrobenzothiazolone derivative <b>13</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> emerged as a highly potent (∼21 fold potency increase vs <b>12</b>), efficacious and selective mGlu<sub>5</sub> receptor PAM (EC<sub>50</sub> = 33 nM, 71% Glu Max, mGlu<sub>1–4,6–8</sub> > 10 μM). Despite its high potency and promising metabolic stability in human liver microsomes (55% remaining after 15 min incubation), <b>13</b> was found to be highly unstable in rat liver microsomes (2% remaining after 15 min incubation), likely due to the presence of the exposed keto-group. Furthermore, <b>13</b> was poorly soluble in aqueous buffer (30 μM, pH 7.4), and it could not be formulated in our standard carrier for in vivo testing [<0.25 mg/mL in 20% hydroxypropyl-β-cyclodextrin (HP-β-CD) formulation in water]. Therefore, we focused efforts on the identification of metabolically stable analogues of <b>13</b> bearing a carbonyl function less prone to metabolism. For this purpose, we considered the conversion of the dihydrobenzothiazolone of <b>13</b> into a dihydrothiazolopyridone scaffold. Despite an approximate 4-fold decrease in potency with respect to <b>13</b>, compound <b>14a</b> showed comparable mGlu<sub>5</sub> potency (EC<sub>50</sub> = 123 nM, 79% Glu Max) to HTS hit <b>9</b>. In addition, <b>14a</b> was selective versus the other mGlu receptors at the screening concentration of 10 μM. Importantly, <b>14a</b> showed a remarkably reduced turnover in both human and rat liver microsomes (85% and 63% respectively remaining after 15 min incubation at 1 μM concentration). Furthermore, the amide functionality present in the dihydrothiazolopyridone core of <b>14a</b> represents an attractive chemical handle amenable for further derivatization for structure–activity relationship (SAR) expansion purposes. A preliminary evaluation of tertiary amides showed that the introduction of alkyl substituents could lead to a comparable activity in the case of the methyl derivative <b>14b</b> (EC<sub>50</sub> = 193 nM, 57% Glu Max) or the methoxyethyl substituted example <b>14c</b> (EC<sub>50</sub> = 119 nM, 47% Glu Max) although with a drop of Glu Max in both examples.</div><div class="NLM_p">At this point, having accomplished our initial goal of identifying separate replacements for the ester and keto functions, we decided to combine both approaches and target the synthesis of the corresponding series of benzyloxy- and phenoxymethyl-dihydrothiazolopyridone combinations <b>15</b> and <b>16</b>, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and Activities of Substituted Benzyloxy- and Phenoxymethyl-dihydrothiazolopyridones <b>15</b> and <b>16</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0016.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0017.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0018.gif" alt="" id="GRAPHIC-d5585e917-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values were calculated from three independent experiments using a four-parameter logistic nonlinear regression model taking into account the heterogeneity between experiments and concentration–response curves for each compound.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">HLM and RLM data refer to % of compound metabolized after incubation of tested compound with human and rat microsomes respectively, for 15 min at 1 μM concentration.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Calculated with Biobyte software.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Not tested.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Data obtained from a single experiment not replicated.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Compound <b>13</b> was readily prepared in two steps (39% overall yield), via Sandmeyer reaction and subsequent Sonogashira cross-coupling, from 2-amino-benzothiazolone <b>17</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Isoamyl nitrite, CuBr<sub>2</sub>, CH<sub>3</sub>CN, 80 °C, 1 h, 75%; (b) phenyl acetylene, [1,1′-<i>bis</i>(diphenylphospino)ferrocene]dichloro-palladium(II), CuI, Et<sub>3</sub>N, 1,4-dioxane, reflux, 2 h, 52%.</p></p></figure><div class="NLM_p">The synthesis of the targeted compounds <b>14a</b>–<b>c</b> is shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Starting from commercially available Boc-protected 2,4-dioxopiperidine <b>19</b>, bromination and condensation with thiourea in the presence of sodium hydrogen carbonate followed by Boc deprotection afforded key intermediate <b>20</b> (17% overall yield), which was transformed into the dihydrothiazolopyridone <b>14a</b> with moderate yield (55%) following an analogous procedure to the one described for the synthesis of compound <b>13</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Finally, reaction of <b>14a</b> with the corresponding alkyl halides in the presence of cesium carbonate as base, yielded derivatives <b>14b</b>,<b>c</b> (19 and 20% yield, respectively).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) NBS, CCl<sub>4</sub>, 10–15 °C, 2 h; (ii) thiourea, NaHCO<sub>3</sub>, EtOH, 80 °C, 2.5 h; (iii) HCl, 1,4-dioxane, rt, 30 min, 100%; (b) isoamyl nitrite, CuBr<sub>2</sub>, CH<sub>3</sub>CN, rt, 1.5 h, 55%; (c) phenyl acetylene, [1,1′-bis(diphenylphosphino)ferrocene]dichloro-palladium(II), CuI, Et<sub>3</sub>N, 1,4-dioxane, reflux, 30%; (d) <b>14b</b>, MeI or <b>14c</b>, MeOCH<sub>2</sub>CH<sub>2</sub>Br, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C, 16 h, 19% for <b>14b</b> and 20% for <b>14c</b>.</p></p></figure><div class="NLM_p">The synthetic methods used for the preparation of the final compounds <b>15b</b>,<b>c</b> and <b>16a</b>–<b>q</b> are outlined in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a>–<a class="ref internalNav" href="#sch9" aria-label="9">9</a>. Preparation of most dihydrothiazolopyridones <b>15</b>–<b>16</b> followed a cyclization step performed with a piperidine-2,4-dione, which was commercially available or was prepared using a synthetic sequence shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Thus, commercially available β-amino esters <b>22a</b>–<b>e</b> were reacted with ethyl malonyl chloride to afford the amides <b>23a</b>–<b>e</b> in moderate to good yields (22–70%). Intramolecular cyclization reaction of <b>23a</b>–<b>e</b>, promoted by sodium ethoxide, yielded the corresponding 3-carbethoxypiperidine-2,4-dione derivatives <b>24a</b>–<b>e</b>. Acid mediated decarboxylation of <b>24a</b>–<b>e</b> followed by regioselective bromination afforded the key intermediates <b>25a</b>–<b>e</b> in good yields. These intermediates were found to be highly unstable and had to be used immediately after synthesis.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ethyl malonyl chloride, Et<sub>3</sub>N or DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 22–70%; (b) NaOEt, EtOH, 85 °C, 16 h, 55–91%; (c) <b>24a</b>-<b>c</b>, CH<sub>3</sub>CO<sub>2</sub>H, H<sub>2</sub>O, 90 °C, 16 h, 53–73%; or <b>24d,e</b>, CH<sub>3</sub>CN, H<sub>2</sub>O, 90 °C, 2 h; (d) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min, 73–76%.</p></p></figure><div class="NLM_p">The benzyloxy-dihydrothiazolopiperidones <b>15b,c</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Nucleophilic substitution of the bromothiazolopyridone <b>21</b> with benzyl alcohol yielded the target intermediate <b>15a</b>, which was subsequently <i>N</i>-alkylated with methyl iodide affording compound <b>15b</b> in 30% yield (equation (I), Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Attempts to perform a copper catalyzed <i>N</i>-arylation reaction on <b>15a</b> (CuI, K<sub>3</sub>PO<sub>4</sub>, DMF, microwave irradiation) were unsuccessful as compound <b>15c</b> was found to be unstable under these reaction conditions, and the synthesis of compound <b>15c</b> was carried out as shown in the equation (II) of Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Thus, intermolecular cyclization of <b>25d</b> with thiourea followed by Sandmeyer reaction led with low yield to the intermediate <i>N</i>-aryl bromothiazole derivative <b>26</b>, which was treated with benzyl alcohol in the presence of sodium hydride to yield (63%) the target compound <b>15c</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnOH, NaH, THF, 120 °C, 15 min, microwave, 54%; (b) MeI, NaH, THF, 120 °C, 15 min, microwave, 54%; (c) (i) thiourea, NaHCO<sub>3</sub>, EtOH, 80 °C, 1 h; (ii) isoamyl nitrite, CuBr<sub>2</sub>, CH<sub>3</sub>CN, rt, 45 min, 16%; (d) BnOH, NaH, THF, 120 °C, 15 min, microwave, 63%.</p></p></figure><div class="NLM_p">In the case of the phenoxymethyl-dihydrothiazolopyridones <b>16</b>, five main synthesis routes (Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a>–<a class="ref internalNav" href="#sch9" aria-label="9">9</a>) were used to access the final compounds <b>16a</b>–<b>q</b>. Starting from the bromothiazole derivative <b>21</b>, palladium catalyzed carbonylation followed by alkylation with methyl iodide and reduction of the intermediate ester <b>28</b> led to the alcohol <b>29</b> which after Mitsunobu reaction with phenol afforded <b>16a</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CO, [1,1′-bis(diphenylphospino)ferrocene]dichloro-palladium(II), MeOH, Et<sub>3</sub>N, 50 °C, 16 h, 21%; (b) MeI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 60 h, 42%; (c) NaBH<sub>4</sub>, MeOH, 0 °C, 30 min, 99%; (d) PhOH, di-<i>tert</i>-butyl azodicarboxylate, PPh<sub>3</sub>, THF, 120 °C, 20 min, microwave, 20%.</p></p></figure><div class="NLM_p">Key intermediate <b>31</b> was obtained in 26% yield from intermediate <b>27</b>, in a similar way (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). <i>N</i>-Alkylation of <b>31</b> with several primary alkyl halides <b>32</b> afforded the corresponding <i>N</i>-alkyl derivatives <b>16b</b>,<b>d</b>,<b>g</b> in moderate yields (13–49%) (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaBH<sub>4</sub>, MeOH, 0 °C, 30 min, 40%; (b) PhOH, di-<i>tert</i>-butyl azodicarboxylate, PPh<sub>3</sub>, THF, 120 °C, 20 min, microwave, 64%; (c) <b>32</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h, 13–49%.</p></p></figure><div class="NLM_p">Alternatively, several compounds (<b>16c</b>,<b>e</b>,<b>f</b>,<b>h</b>,<b>i</b>,<b>k</b>) were prepared by intermolecular cyclization between the thioamides <b>33a</b>,<b>b</b> and the corresponding 3-bromopiperidine-2,4-dione <b>25a</b>–<b>e</b> (10–25%) (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). Similarly, derivatives <b>16j</b>,<b>l</b> were accessed by nucleophilic substitution on the chloromethyl thiazol <b>36</b>, obtained via reaction of <b>25d</b> with ethyl thiooxamate followed by ester reduction and subsequent treatment with thionyl chloride, with the corresponding phenols as shown in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>.</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>25a</b>–<b>c</b>, NaHCO<sub>3</sub>, EtOH, 70 °C, 15 min, 10–25% or <b>25d</b>,<b>e</b>, NaHCO<sub>3</sub>, DMF, 100 °C, 30 min, 10–23%.</p></p></figure><figure id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ethyl thiooxamate, NaHCO<sub>3</sub>, EtOH, 80 °C, 2 h, 15%; (b) (i) NaBH<sub>4</sub>, MeOH, 0 °C, 2 h; (ii) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 27%; (c) Ar-OH, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 24 h, 8–20%.</p></p></figure><div class="NLM_p">Finally, intermediate <b>31</b> was also used to prepare the <i>N</i>-pyridyl derivatives <b>16m</b>-<b>q</b> by copper catalyzed coupling with the corresponding halopyridines <b>36</b> as shown in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>, in low to moderate yields (15–64%).</div><figure id="sch9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>16m</b>-<b>o</b>,<b>q</b>, <b>33</b>, CuI, K<sub>2</sub>CO<sub>3</sub>, <i>N</i>,<i>N</i>′-dimethylethylenediamine, toluene, 120 °C, 16 h, 15–64% or <b>16p</b>, 2-bromo-4-fluoropyridine, CuI, K<sub>3</sub>PO<sub>4</sub>, <i>N</i>,<i>N</i>′-dimethylethylenediamine, toluene, 140 °C, 16 h, 64%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the case of benzyloxy-dihydrothiazolopyridone derivatives <b>15</b>, our SAR investigation started with the synthesis of the methyl and 4-fluorophenyl substituted analogues <b>15b</b> (prepared by analogy to <b>14b</b>) and <b>15c</b> (selected because fluorine containing aromatic rings are common motifs as distal aromatic moieties for different mGlu<sub>5</sub> PAM chemotypes).<a onclick="showRef(event, 'ref9 ref16'); return false;" href="javascript:void(0);" class="ref ref9 ref16">(9, 16)</a> As seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the introduction of the 4-fluorophenyl and the methyl substituents resulted in compounds of similar potency. Furthermore, <b>15c</b> showed good metabolic stability in human and rat fortified microsomes. Unfortunately, in the course of the aqueous solubility assessment of derivatives <b>15</b>, these were found to be unstable in acidic media (20% HP-β-CD in water, pH = 4) leading to the corresponding 2-hydroxy-dihydrothiazolopyridone fragments. In light of this finding, we decided to stop the exploration of the benzyloxy-dihydrothiazolopyridone series <b>15</b>. Instead we focused efforts on the phenoxymethyl subseries <b>16</b>, which proved to be stable under the same acidic aqueous solubility conditions. As a first step, the alkyl substituent on the amide moiety was explored. Akin to the benzyloxy series, introduction of a methyl group in <b>16a</b> resulted in a significant reduction (∼6 fold) in mGlu<sub>5</sub> PAM potency compared to the corresponding acetylene analogue <b>14b</b>, or reference compounds <b>1</b> and <b>2</b>, but still retained high efficacy. Replacement of the methyl group in <b>16a</b> by other alkyl chains with increased size and diverse polarity either had a limited effect or was detrimental to activity. Thus, comparable activity was observed for the more lipophilic <b>16b</b> (R<sup>1</sup> = ethyl) and <b>16c</b> (R<sup>1</sup> = isopropyl), although a modest reduction in efficacy was also noted for the bulkier <b>16c</b>. In the case of the methoxyethyl substituted <b>16d</b> and in analogy with the acetylene containing series <b>14</b>, the potency was again in the same range as for <b>16a</b>. The introduction of a cyclopropyl group with pseudo aromatic character in <b>16e</b> resulted as well in a similar potency when compared to <b>16a</b> and its isopropyl congener <b>16c</b>. Noteworthy, the introduction of a methylene spacer between the cyclopropyl group and the dihydrothiazolopyridone core (<b>16f</b>) delivered a remarkable increase in potency (∼6 fold vs. <b>16a</b> and <b>16e</b>). Finally, ring expansion to the more polar tetrahidropyrane ring (<b>16g</b>) had almost negligible effect on both potency and efficacy compared to <b>16a</b>. As observed with the benzyloxy series, better results were obtained with fluorophenyl tethered amides such as <b>16h</b> or <b>16i</b> with in vitro potencies below 100 nM (∼2–3 fold more potent than reference compounds <b>1</b> and <b>2</b>) and good efficacies. Taking <b>16h</b> as a starting point, the introduction of fluorine substitution in the western aromatic ring was found to be preferred at position 3, with <b>16k</b> showing comparable potency and minimally reduced efficacy to <b>16h</b>. A ∼7–10-fold decrease in potency was observed for the 2- and 4-substituted analogues <b>16j</b>,<b>l</b>. In light of the promising in vitro results obtained with the aryl derivatives <b>16h</b>–<b>l</b>, our SAR exploration concluded with the investigation of the effects of replacing the fluorophenyl amide substituents by more polar and weakly basic pyridine rings. From the data in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, it can be concluded that the 2-substituted pyridine analogue <b>16m</b> was preferred over the 3 and 4 regioisomers (<b>16n</b> and <b>16o</b>). On the other hand, although 3-fluorine substitution (<b>16q</b>) did not induce any increase on mGlu<sub>5</sub> potency, a significant improvement was accomplished by the introduction of the fluorine atom in the 5-position of the 2-substituted pyridine ring, with <b>16p</b> showing similar potency to <b>16m</b> and increased efficacy (94% vs. 79%).</div><div class="NLM_p">In light of their good mGlu<sub>5</sub> PAM activity and efficacy compounds <b>16a</b>, <b>16b</b>, <b>16f</b>, <b>16h</b>, and <b>16p</b> were selected as representative examples for further characterization. Metabolic stability evaluation showed significant species differences, with lower turnovers in human vs. rat liver microsomes in all cases. Thus, despite low (<b>16a</b>, <b>16h</b>, and <b>16p</b>, > 75% remaining) to moderate-high (<b>16b</b> and <b>16f</b>, 75–25% remaining) turnover in HLM for the five compounds, metabolic instability in RLM ranged from moderate (<b>16p</b>, ∼30% remaining) to very high (<b>16b</b> and <b>16f</b>, ∼100% metabolized). As high metabolic instability in rodents would hamper further pharmacological evaluation, only compounds <b>16a</b>, <b>16h</b>, and <b>16p</b> were selected for additional DMPK evaluation to confirm their potential utility for proof-of-concept in vivo studies for this series. Thus, <b>16a</b> and <b>16b</b> were evaluated in noncrossover in vivo pharmacokinetic (PK) studies in rats. Because of its poor solubility in aqueous buffer (<4 μM, pH 7.4) and in 20% HP-β-CD in water formulation (<0.20 mg/mL), <b>16h</b> could only be dosed orally as a suspension (5 mg/mL) and was found to be undetectable in the brain after 2.0 h of administration and hence discarded for in vivo pharmacological evaluation. As a consequence of these findings, and because the improvement in kinetic solubility for <b>16p</b> was minimal (10 μM, pH 7.4 and <1 mg/mL in 20% HP-β-CD in water) compared to <b>16h</b>, <b>16p</b> was discarded for further investigation. PK studies (1 mg/kg iv, 10 mg/kg p.o.) with the more soluble <b>16a</b> (97 μM, aqueous buffer pH 7.4 and 4 mg/mL in 20% HP-β-CD in water), revealed a relatively high CL<sub>p</sub> of 50 mL/min/kg and a short half-life (<i>T</i><sub>1/2</sub>) of 0.18 h. Examination of drug concentrations in portal vein, plasma, and brain at different time points (0.5, 1.0, 2.0, 4.0, and 7.0 h) showed a moderate first-pass clearance (<i>E</i><sub>hep</sub> 0.47) with a relatively low volume of distribution (<i>V</i><sub>ss</sub> = 0.70 L/kg) and moderate systemic exposure (plasma<sub>AUC</sub> = 2.9 μM-h). The relative CNS exposure of <b>16a</b> was moderate as well (brain<sub>AUC</sub> = 2.4 μM·h) with a good distribution to the brain (brain<sub>AUC</sub>/plasma<sub>AUC</sub> = 0.90). Additionally, a relatively high unbound fraction in brain (rat <i>f</i><sub>u</sub> brain = 18%) contributed favorably to achieve good absolute brain levels (<i>C</i><sub>max</sub> = 522 nM, <i>T</i><sub>max</sub> = 0.5 h), which were considered adequate to warrant further pharmacological evaluation.</div><div class="NLM_p">Subsequent in vitro examination of <b>16a</b> in a low expressing rat receptor mGlu<sub>5</sub> cell line<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> resulted in a slightly reduced potency (∼2 fold) and efficacy (EC<sub>50</sub> = 3408 nM, 62% Glu Max) compared with the human receptor expressing cell line. <b>16a</b> was found to be selective in an mGlu selectivity panel (mGlu<sub>1–4,6–8</sub> EC<sub>50</sub> > 10 μM)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and also when tested at 10 μM concentration in a panel of 66 off-target class receptors, ion channels and transporters.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Finally, positive allosteric modulator activity was further investigated by fold-shift experiments to determine the degree of cooperativity with glutamate of the compound. Thus, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, progressive fold-shift experiments in our cell line expressing the rat mGlu<sub>5</sub> receptor revealed how the concentration response curve of (CRC) glutamate shifted to the left with increasing concentration of <b>16a</b> (55 nM to 30 μM) with no significant effect change of the maximal response. A 5.4-fold leftward shift in the glutamate EC<sub>50</sub> was observed in the presence of 30 μM <b>16a</b>, and a predicted allosteric modulator affinity of approximately 10 μM (10069 nM) was calculated using the operational model of allosterism described by Gregory et al. (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> These results corroborate a positive allosteric interaction between glutamate and <b>16a</b> and were confirmed in a cell line expressing the human mGlu<sub>5</sub> receptor,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> where 10 μM <b>16a</b> produced a 4.4-fold leftward shift in the glutamate CRC.</div><figure id="fig3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glutamate CRC in the presence of increasing concentrations of <b>16a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Encouraged by its overall profile, <b>16a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) was evaluated in a screen of potential antipsychotic efficacy, the reversal of amphetamine-induced hyperlocomotion in rats.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><figure id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Profile summary of <b>16a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As seen in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, when dosed orally in a 20% HP-β-CD in water formulation, <b>16a</b> showed robust dose-dependent effects in reversal of hyperlocomotion with a lowest active oral dose of 10 mg/kg. The maximal effect (61%) was seen at the highest tested dose of 100 mg/kg, corresponding with an estimated average terminal unbound brain concentration of ∼3.2 μM,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> which is well in line with the rat in vitro mGlu<sub>5</sub> PAM EC<sub>50</sub> of <b>16a</b> and that, according with the progressive fold-shift experiments (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), would correlate with a left-ward shift in the glutamate CRC in the range of ∼1.5–2.9 fold.</div><figure id="fig5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Dose-dependent effect of <b>16a</b> on the reversal of amphetamine-induced hyperlocomotion in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The preliminary in vivo characterization of <b>16a</b> concluded with the evaluation of balance and motor coordination and potential neurological side effects by means of rotarod and Irwin modified neurological battery tests respectively in rats. As it can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, when dosed orally at 30, 56.6, and 100 mg/kg (20% HP-β-CD in water), <b>16a</b> had no statistically significant effect on general motor output as measured by performance on the rotarod (120 s cutoff) test in rats.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Furthermore, <b>16a</b> had no effect on any autonomic or somatomotor nervous system functions as measured using the modified Irwin neurological test battery in rats when tested at a single oral dose of 100 mg/kg (20% HP-β-CD in water).,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> These results highlight how <b>16a</b> neither impacts motor behavior nor shows any overt neurological side effects in rats up to a dose of 100 mg/kg p.o., a dose that has been previously shown to produce maximal efficacy in the inhibition of the amphetamine-induced hyperlocomotion.</div><figure id="fig6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of <b>16a</b> on rotarod performance in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, starting from a singleton phenyl ester chromanone HTS hit, two parallel approaches allowed the identification of the benzyloxy and phenoxymethyl moieties and the dihydrothiazolopyridone core as optimal replacements for the ester and the chromanone core respectively. While the benzyloxy-dihydrothiazolopyridone subseries was found susceptible to hydrolysis, the phenoxymethyl-dihydrothiazolopyridones <b>16</b> proved to be a promising mGlu<sub>5</sub> PAM series. Preliminary focused SAR exploration of amide substituents revealed aromatic groups as preferred substituents for achieving high in vitro mGlu<sub>5</sub> potentiation although their poor DMPK characteristics precluded further in vivo evaluation. On the other hand, the <i>N</i>-methyl analogue <b>16a</b> presented a more balanced profile in terms of in vitro potency, selectivity and DMPK profile, which made it an attractive candidate for in vivo characterization in a model of antipsychotic activity. <b>16a</b> showed robust, dose-dependent effects in the reversal of amphetamine induced hyperlocomotion, with a lowest active dose of 10 mg/kg p.o. and maximal efficacy at a dose of 100 mg/kg p.o. without showing any significant motor impairment or overt neurological side effects up to a dose of 100 mg/kg p.o. These results underscore the potential of <b>16a</b> as an interesting tool compound suitable to unravel the in vivo pharmacology of mGlu<sub>5</sub> positive allosteric modulation. Further investigation and evolution of this novel series of mGlu<sub>5</sub> PAMs are underway and will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">Unless otherwise noted, all reagents and solvents were obtained from commercial suppliers and used without further purification. Thin layer chromatography (TLC) was carried out on silica gel 60 F254 plates (Merck). Flash column chromatography was performed on silica gel, particle size 60 Å, mesh of 230–400 (Merck) under standard techniques. Microwave assisted reactions were performed in a single-mode reactor, Biotage Initiator Sixty microwave reactor (Biotage), or in a multimode reactor, MicroSYNTH Labstation (Milestone, Inc.). Nuclear magnetic resonance (NMR) spectra were recorded with a Bruker DPX-300 a Bruker DPX-400 or a Bruker AV-500 spectrometer (Bruker AG) with standard pulse sequences, operating at 300, 400, and 500 MHz, respectively, using CDCl<sub>3</sub> and DMSO-d<sub>6</sub> as solvents. Chemical shifts (δ) are reported in parts per million (ppm) downfield from tetramethylsilane (δ = 0). Coupling constants are reported in Hertz. Splitting patterns are defined by s (singlet), d (doublet), dd (double doublet), t (triplet), q (quartet), quin (quintet), sex (sextet), sep (septet), or m (multiplet). Liquid chromatography combined with mass spectrometry (LCMS) was performed on either a HP 1100 high-performance liquid chromatography (HPLC) system (Agilent Technologies) or Advanced Chromatography Technologies system composed of a quaternary or binary pump with degasser, an autosampler, a column oven, a diode array detector (DAD), and a column as specified in the respective methods below. Flow from the column was split to a MS spectrometer. The MS detector was configured with either an electrospray ionization source or an electrospray combined with atmospheric pressure chemical ionization (ESCI) dual ionization source. Nitrogen was used as the nebulizer gas. Data acquisition was performed with MassLynx- Openlynx software or with Chemstation-Agilent data browser software. More detailed information about the different LCMS methods employed can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Liquid chromatography combined with high resolution mass spectrometry (LC-HRMS) was performed using a Micromass (Waters) Q-Tof API-US calibrated and verified with sodium iodide. The samples were diluted with a 50:50 0.1% formic acid (in Milli-Q)/acetonitrile solution, directly infused using leucine-enkephalin ([M + H]<sup>+</sup> = 556.2771) as a lockmass. Scan range was from 100 to 1000 Da, with a scan time of 1 s. For a number of compounds, melting points (Mp<sup><i>a</i></sup>) were determined with a WRS-2A melting point apparatus (Shanghai Precision and Scientific Instrument Co. Ltd.). Melting points were measured with a linear heating up rate of 0.2–5.0 °C/min (maximum temperature 300 °C), and the reported values are melt ranges. For another number of compounds, melting points (Mp<sup><i>b</i></sup>) were determined in open capillary tubes on a FP62 or on a FP81HT-FP90 apparatus (Mettler). Melting points were measured with a temperature gradient of 10 °C/min (maximum temperature 300 °C), and the melting point was read from a digital display. Melting point values are peak values and were obtained with experimental uncertainties that are commonly associated with this analytical method.</div><div class="NLM_p">Purities of all new compounds were determined by analytical reversed-phase high-performance liquid chromatography (RP-HPLC) using the area percentage method on the UV trace recorded at a wavelength of 254 nm, and compounds were found to have ≥95% purity unless otherwise specified.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> 2-Bromo-5,6-dihydro-4<i>H</i>-benzothiazol-7-one (<b>18</b>)</h4><div class="NLM_p last">A mixture of <b>17</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (19 g, 112 mmol), CuBr<sub>2</sub> (27 g, 120 mmol), and 3-methyl-1-nitrosooxy-butane (18 g, 153 mmol) in CH<sub>3</sub>CN (250 mL) was stirred at 80 °C for 1 h. The mixture was then cooled to rt and poured into a 10% solution of HCl. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> and the organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo to yield 19.6 g (75%) of <b>18</b> that was used in the next step without any further purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 2.47–2.60 (m, 2 H), 3.07–3.15 (m, 1 H), 3.18–3.29 (m, 1 H), 4.64 (t, <i>J</i> = 3.9 Hz, 1 H).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> 2-Amino-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one hydrochloride salt (<b>20</b>)</h4><div class="NLM_p last">To a solution of <b>19</b> (40 g, 187.58 mmol) in CCl<sub>4</sub> (500 mL) was added NBS (33.38 g, 187.58 mmol) portionwise keeping the reaction temperature in the range of 10–15 °C. The mixture was further stirred at 10–15 °C for 2 h. The mixture was allowed to warm to rt, and the solvent was evaporated in vacuo. The residue thus obtained was dissolved in EtOAc and washed with H<sub>2</sub>O. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered and the solvent was evaporated. The residue thus obtained was dissolved in EtOH (400 mL), and then thiourea (6.5 g, 85.6 mmol) and NaHCO<sub>3</sub> (7.2 g, 85.6 mmol) were added. The resulting mixture was stirred at 80 °C for 2.5 h and then cooled to rt, and the solids were filtered off. The filtrate was evaporated in vacuo to give a residue that was crystallized in EtOH. The yellow crystals thus obtained were dissolved in a 4 M solution of HCl in 1,4-dioxane (100 mL), and the resulting mixture was stirred at rt for 30 min. The solvent was evaporated in vacuo to yield 10 g (88% pure) of <b>20</b> as a yellow powder which was used in the next step without any further purification. LCMS: <i>m</i>/<i>z</i> 170 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.38 min.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> 2-Bromo-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>21</b>)</h4><div class="NLM_p last">A mixture of <b>20</b> (8 g, 39.8 mmol), CuBr<sub>2</sub> (10.43 g, 46.68 mmol), and 3-methyl-1-nitrosooxy-butane (6.8 g, 58.35 mmol) in CH<sub>3</sub>CN (100 mL) was stirred at rt for 1.5 h. The solvent was evaporated in vacuo. The residue thus obtained was dissolved in EtOAc and washed with H<sub>2</sub>O. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo to yield 5 g (55%) of <b>21</b> that was used in the next step without any further purification. LCMS: <i>m</i>/<i>z</i> 233 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.70 min.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> <i>N</i>-(2-Ethoxycarbonyl-ethyl)-<i>N</i>-isopropyl-malonamic Acid Ethyl Ester (<b>23a</b>)</h4><div class="NLM_p last">To a solution of <b>22a</b> (13.5 g, 69 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) was added Et<sub>3</sub>N (26 g, 255 mmol). Then ethyl malonyl chloride (14 g, 93 mmol) was added to the mixture at 0 °C, and the mixture was stirred at rt for 5 h. Then H<sub>2</sub>O was added and the organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered and the solvent was evaporated in vacuo<i>.</i> The crude product was purified by flash column chromatography (silica gel, EtOAc in petroleum ether, 10/90 to 33/66). The desired fractions were collected and the solvents evaporated in vacuo to yield 5.1 g (87% pure) of <b>23a</b> as an oil. LCMS: <i>m</i>/<i>z</i> 274 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.25 min.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> <i>N</i>-Cyclopropyl-<i>N</i>-(2-ethoxycarbonyl-ethyl)-malonamic Acid Ethyl Ester (<b>23b</b>)</h4><div class="NLM_p last">Starting from <b>22b</b> (40.3 g, 256 mmol) and following the procedure described for <b>23a</b>, <b>23b</b> was obtained as an oil (40 g, 60% pure). LCMS: <i>m</i>/<i>z</i> 272 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.91 min.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> <i>N</i>-Cyclopropylmethyl-<i>N</i>-(2-ethoxycarbonyl-ethyl)-malonamic Acid Ethyl Ester (<b>23c</b>)</h4><div class="NLM_p last">Starting from <b>22c</b> (31.3 g, 183 mmol) and following the procedure described for <b>23a</b>, <b>23c</b> was obtained as an oil (33 g, 93% pure). LCMS: <i>m</i>/<i>z</i> 286 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.23 min.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>N</i>-(2-Ethoxycarbonyl-ethyl)-<i>N</i>-(4-fluoro-phenyl)-malonamic Acid Ethyl Ester (<b>23d</b>)</h4><div class="NLM_p last">Starting from <b>22d</b> (10 g, 47.3 mmol) and following the procedure described for <b>23a</b> but using diisopropylethylamine as base, <b>23d</b> was obtained as an orange oil (11 g, 73% pure). LCMS: <i>m</i>/<i>z</i> 326 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.41 min.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> <i>N</i>-(2-Ethoxycarbonyl-ethyl)-<i>N</i>-(2,4-difluoro-phenyl)-malonamic Acid Ethyl Ester (<b>23e</b>)</h4><div class="NLM_p last">Starting from <b>22e</b> (29 g, 127 mmol) and following the procedure described for <b>23a</b>, <b>23e</b> was obtained as an orange oil (35 g, 69% pure). LCMS: <i>m</i>/<i>z</i> 344 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.21 min.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 1-Isopropyl-2,4-dioxo-piperidine-3-carboxylic Acid Ethyl Ester (<b>24a</b>)</h4><div class="NLM_p last">Sodium (0.86 g, 37.3 mmol) was added to EtOH (50 mL) at 0 °C. The mixture was stirred at rt for 1 h. Then <b>23a</b> (5.1 g, 18.6 mmol) was added and the mixture was stirred at 85 °C for 16 h. The mixture was poured into ice H<sub>2</sub>O. The aqueous phase was neutralized by addition of a 2 N HCl solution and extracted with EtOAc. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo to yield 3 g (91%) of <b>24a</b> which was used in the next step without any further purification. LCMS: <i>m</i>/<i>z</i> 228 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.95 min.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-Cyclopropyl-2,4-dioxo-piperidine-3-carboxylic Acid Ethyl Ester (<b>24b</b>)</h4><div class="NLM_p last">Starting from <b>23b</b> (40 g, 147 mmol) and following the procedure described for <b>24a</b>, <b>24b</b> was obtained as an oil (20 g, 61%). LCMS: <i>m</i>/<i>z</i> 226 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.91 min.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-Cyclopropylmethyl-2,4-dioxo-piperidine-3-carboxylic Acid Ethyl Ester (<b>24c</b>)</h4><div class="NLM_p last">Starting from <b>23c</b> (20 g, 70.1 mmol) and following the procedure described for <b>24a</b>, <b>24c</b> was obtained as an oil (10 g, 60%). LCMS: <i>m</i>/<i>z</i> 240 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.21 min.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-(4-Fluoro-phenyl)-2,4-dioxo-piperidine-3-carboxylic Acid Ethyl Ester (<b>24d</b>)</h4><div class="NLM_p last">A mixture of <b>23d</b> (6.27 g, 19.27 mmol) in a 21% solution of sodium ethoxide in EtOH (14.39 mL, 38.55 mmol) was stirred at 85 °C for 16 h. The solvent was evaporated in vacuo and the residue was partitioned between EtOAc and H<sub>2</sub>O. The aqueous layer was separated, acidified by 1N HCl solution addition and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and the solvent evaporated in vacuo to yield 5 g (66% pure) of <b>24d</b> which was used in the next step without any further purification. LCMS: <i>m</i>/<i>z</i> 280 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.73 min.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 1-(2,4-Difluoro-phenyl)-2,4-dioxo-piperidine-3-carboxylic acid ethyl ester (<b>24e</b>)</h4><div class="NLM_p last">Starting from <b>23e</b> (4.8 g, 13.98 mmol) and following the procedure described for <b>24d</b>, <b>24e</b> was obtained as an oil (4.16 g, 55% pure). LCMS: <i>m</i>/<i>z</i> 298 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.65 min.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-Bromo-1-isopropyl-piperidine-2,4-dione (<b>25a</b>)</h4><div class="NLM_p last">A solution of <b>24a</b> (3 g, 13.2 mmol) in a mixture of acetic acid (10 mL) and H<sub>2</sub>O (90 mL) was stirred at 90 °C for 14 h. The mixture was cooled and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel; EtOAc in petroleum ether 10/90 to 33/66). The desired fractions were collected and the solvents evaporated in vacuo. The residue thus obtained was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and NBS (1.1 g, 6.44 mmol) was added. The mixture was stirred at rt for 4 h. Then H<sub>2</sub>O was added and the mixture was extracted with EtOAc. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvents were evaporated in vacuo to yield 0.6 g (53% pure) of <b>26a</b> which was used in the next step without any further purification. LCMS: <i>m</i>/<i>z</i> 234 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.35 min.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 3-Bromo-1-cyclopropyl-piperidine-2,4-dione (<b>25b</b>)</h4><div class="NLM_p last">Starting from <b>24b</b> (20 g, 89 mmol) and following the procedure described for <b>25a</b>, <b>25b</b> was obtained as an oil (11 g, 73% pure). LCMS: <i>m</i>/<i>z</i> 232 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.29 min.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-Bromo-1-cyclopropylmethyl-piperidine-2,4-dione (<b>25c</b>)</h4><div class="NLM_p last">Starting from <b>24c</b> (10 g, 41.8 mmol) and following the procedure described for <b>25a</b>, <b>25c</b> was obtained as an oil (4 g, 66% pure). LCMS: <i>m</i>/<i>z</i> 246 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.053 min.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-Bromo-1-(4-fluoro-phenyl)-piperidine-2,4-dione (<b>25d</b>)</h4><div class="NLM_p last">Starting from <b>24d</b> (7.5 g, 26.86 mmol) and following the procedure described for <b>25a</b>, <b>25d</b> was obtained as an oil (7.7 g, 76% pure). LCMS: <i>m</i>/<i>z</i> 285 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.42 min.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3-Bromo-1-(2,4-difluoro-phenyl)-piperidine-2,4-dione (<b>25e</b>)</h4><div class="NLM_p last">Starting from <b>24e</b> (18 g, 60 mmol) and following the procedure described for <b>25a</b>, <b>25e</b> was obtained as an oil (11 g, 38% pure). LCMS: <i>m</i>/<i>z</i> 304 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.34 min.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-Bromo-5-(4-fluoro-phenyl)-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>26</b>)</h4><div class="NLM_p last">A mixture of <b>25d</b> (4.14 g, 14.48 mmol), thiourea (1.1 g, 14.48 mmol) and NaHCO<sub>3</sub> (1.22 g, 14.48 mmol) in EtOH (60 mL) was stirred at 80 °C for 1 h. The mixture was then cooled to rt and the solids were filtered off. The filtrate was evaporated in vacuo. The residue thus obtained was dissolved in CH<sub>3</sub>CN (80 mL) and then CuBr<sub>2</sub> (3.05 g, 13.67 mmol) and 3-methyl-1-nitrosooxy-butane (2.3 mL, 17.09 mmol) were added. The mixture was stirred at rt for 45 min and then the solvent was evaporated in vacuo. The residue thus obtained was partitioned between EtOAc and H<sub>2</sub>O. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and the solvent evaporated in vacuo<i>.</i> The crude product was purified by flash column chromatography (silica gel, EtOAc in heptane, 0/100 to 30/70). The desired fractions were collected and the solvents evaporated in vacuo to yield 1.2 g (16%) of <b>26</b> as a white solid. LCMS: <i>m</i>/<i>z</i> 327 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.51 min.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-Oxo-4,5,6,7-tetrahydro-thiazolo[5,4-<i>c</i>]pyridine-2-carboxylic acid methyl ester (<b>27</b>)</h4><div class="NLM_p last">A mixture of Et<sub>3</sub>N (17.2 g, 171 mmol) and [1,1′-bis(diphenylphosphino)ferrocene]dichloro-palladium(II) (2 g, 2.7 mmol) in THF (300 mL) was added to a solution of <b>21</b> (7.5 g, 23.6 mmol) in MeOH (300 mL). Then the mixture was stirred at 50 °C overnight under CO atmosphere (2.5 MPa). The mixture was cooled and filtered, and the solvents were evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, MeOH in CH<sub>2</sub>Cl<sub>2</sub>, 1/99). The desired fractions were collected and evaporated in vacuo to yield 4.5 g (21%) of <b>27</b> that crystallized from EtOAc as a yellow solid. Mp<sup><i>a</i></sup> 217.6–220.0 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 3.20 (t, <i>J</i> = 7.1 Hz, 2 H), 3.62–3.79 (m, 2 H), 4.02 (s, 3 H), 5.84 (br. s., 1 H). LCMS: <i>m</i>/<i>z</i> 213 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.94 min.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-Methyl-4-oxo-4,5,6,7-tetrahydro-thiazolo[5,4-<i>c</i>]pyridine-2-carboxylic acid methyl ester (<b>28</b>)</h4><div class="NLM_p last">Iodomethane (4.4 mL, 70.7 mmol) was added to a suspension of <b>27</b> (10 g, 47.1 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (23 g, 70.68 mmol) in DMF (118 mL) under nitrogen. The mixture was stirred at rt for 60 h and then diluted with H<sub>2</sub>O and extracted with EtOAc. The organic layer was separated, dried (MgSO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 50/50). The desired fractions were collected, and the solvents were evaporated in vacuo to yield 4.46 g (42%) of <b>28</b> as a pale brown oily solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 3.13 (s, 3 H), 3.23 (t, <i>J</i> = 7.2 Hz, 2 H), 3.71 (t, <i>J</i> = 7.2 Hz, 2 H), 4.03 (s, 3 H). LCMS: <i>m</i>/<i>z</i> 227 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.60 min.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-Hydroxymethyl-5-methyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>29</b>)</h4><div class="NLM_p last">Sodium borohydride (0.15 g, 4.0 mmol) was added to a stirred solution of <b>28</b> (0.65 g, 2.87 mmol) in a mixture of THF (8.8 mL) and MeOH (8.8 mL). The mixture was stirred at 0 °C for 30 min in a sealed tube under nitrogen and then diluted with H<sub>2</sub>O and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered and the solvents were evaporated in vacuo. The aqueous phase was acidified with 3 N HCl and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and filtered, and the solvents were evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, MeOH in EtOAc, 0/100 to 20/80). The desired fractions were collected and the solvents were evaporated in vacuo to yield 0.59 g (99%) of <b>29</b> as a dark oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 2.81 (t, <i>J</i> = 6.1 Hz, 1H), 3.10 (t, <i>J</i> = 7.2 Hz, 2 H), 3.10 (s, 3 H), 3.66 (t, <i>J</i> = 7.2 Hz, 2 H), 4.93 (d, <i>J</i> = 6.2 Hz, 2 H). LCMS: <i>m</i>/<i>z</i> 199 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.28 min.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-Hydroxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>30</b>)</h4><div class="NLM_p last">Starting from <b>27</b> (10 g, 47 mmol) and following the procedure described for <b>29</b>, <b>30</b> was obtained as an oil (3.5 g, 40%). Mp<sup><i>a</i></sup> 212.1–230.9 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.92 (t, <i>J</i> = 7.0 Hz, 2 H), 3.47 (td, <i>J</i> = 7.0, 2.5 Hz, 2 H), 4.72 (s, 2 H), 6.24 (br. s., 1 H), 7.79 (br. s., 1 H). LCMS: <i>m</i>/<i>z</i> 185 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.63 min.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-Phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>31</b>)</h4><div class="NLM_p last">Di-<i>tert</i>-butyl azodicarboxylate (3.0 g, 13.03 mmol) was added to a stirred solution of <b>30</b> (2 g, 10.86 mmol), phenol (1.23 g, 13.03 mmol), and PPh<sub>3</sub> (3.42 g, 13.03 mmol) in THF (31 mL) under nitrogen. The mixture was stirred at 120 °C for 40 min under microwave irradiation. The solvent was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 100/0). The desired fractions were collected and evaporated in vacuo to yield 1.82 g (69% pure) of <b>31</b> as a white solid. LCMS: <i>m</i>/<i>z</i> 261 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.50 min.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Phenoxy-thioacetamide (<b>33a</b>)</h4><div class="NLM_p last">To a solution of phenoxyacetonitrile (38 g, 285 mmol) in DMF (380 mL), thioacetamide (42.8 g, 450 mmol) and a solution of 4 M HCl in 1.4-dioxane (380 mL) were added. The mixture was stirred at 100 °C for 16 h and then cooled to rt and poured into a saturated solution of NaHCO<sub>3</sub>. The solid formed was filtered off, washed with H<sub>2</sub>O, and dried in vacuo to yield 45 g (94%) of <b>33a</b> as a beige solid which was used in the next step without any further purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 4.88 (s, 2 H), 6.89–6.97 (m, 2 H), 7.04 (t, <i>J</i> = 7.4 Hz, 1 H), 7.29–7.36 (m, 2 H), 7.74 (br. s, 1 H), 7.97 (br. s, 1 H). LCMS: <i>m</i>/<i>z</i> 166 [M – H]<sup>−</sup>, <i>t</i><sub>R</sub> = 1.18 min.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(3-Fluoro-phenoxy)-thioacetamide (<b>33b</b>)</h4><div class="NLM_p last">Starting from (3-fluoro-phenoxy)-acetonitrile (3.39 g, 22.41 mmol) and thioacetamide (4.21 g, 56.02 mmol) and following the procedure described for <b>33a</b>, <b>33b</b> was obtained as a white solid (3.58 g, 86%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 4.78 (s, 2 H), 6.70–6.91 (m, 3 H), 7.25–7.42 (m, 1 H), 9.69 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 184 [M – H]<sup>−</sup>, <i>t</i><sub>R</sub> = 1.19 min.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 5-(4-Fluoro-phenyl)-4-oxo-4,5,6,7-tetrahydro-thiazolo[5,4-<i>c</i>]pyridine-2-carboxylic acid ethyl ester (<b>34</b>)</h4><div class="NLM_p last">A mixture of <b>25d</b> (11.8 g, 41.3 mmol), ethyl thiooxamate (5.5 g, 41.3 mmol), and NaHCO<sub>3</sub> (8.7 g, 103.5 mmol) in EtOH (400 mL) was stirred at 80 °C for 2 h. The mixture was cooled and filtered, and the filtrate was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in petroleum ether, 10/90 to 33/66). The desired fractions were collected and evaporated in vacuo to yield 2 g (68% pure) of <b>34</b>. LCMS: <i>m</i>/<i>z</i> 321 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.05 min.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Chloromethyl-5-(4-fluoro-phenyl)-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>35</b>)</h4><div class="NLM_p last">Sodium borohydride (0.7 g, 18.7 mmol) was added to a solution of <b>34</b> (2 g, 6.3 mmol) in MeOH (50 mL) at 0 °C. The mixture was stirred at rt for 2 h, H<sub>2</sub>O was added, and the mixture was extracted with EtOAc. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in petroleum ether, 20/80 to 66/33). The desired fractions were collected, and the solvents were evaporated in vacuo. The residue thus obtained was added to a mixture of thionyl chloride (10 mL) and CH<sub>2</sub>Cl<sub>2</sub> (10 mL). The mixture was stirred at rt for 2 h. The solvents were then evaporated in vacuo to yield 1 g (87% pure) of <b>35</b> as a solid which was used in the next step without any further purification. LCMS: <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.03 min.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Phenylethynyl-5,6-dihydro-4<i>H</i>-benzothiazol-7-one (<b>13</b>)</h4><div class="NLM_p last">To a solution of <b>18</b> (2.3 g, 9.86 mmol), phenylacetylene (2.01 g, 19.7 mmol), CuI (0.2 g, 1.05 mmol) and Et<sub>3</sub>N (2.98 g, 29.58 mmol) in 1,4-dioxane (50 mL) at rt was added [1,1′-bis(diphenylphosphino)ferrocene]dichloro-palladium(II) (0.2 g, 0.25 mmol). The mixture was stirred at reflux for 2 h under nitrogen. The solvent was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in petroleum ether, 66/33). The desired fractions were collected, and the solvent was evaporated in vacuo to yield 1.2 g (52%) of <b>13</b> as a solid. Mp<sup><i>a</i></sup> 117.1–119.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 2.28 (quin, <i>J</i> = 6.4 Hz, 2 H), 2.70 (t, <i>J</i> = 6.3 Hz, 2 H), 3.13 (t, <i>J</i> = 6.1 Hz, 2 H), 7.39 - 7.53 (m, 3 H), 7.60–7.70 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 254 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.49 min.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-Phenylethynyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>14a</b>)</h4><div class="NLM_p last">To a solution of <b>21</b> (2.33 g, 10 mmol), phenylacetylene (2.0 g, 20 mmol) and Et<sub>3</sub>N (4.5 g, 45 mmol) in 1,4-dioxane (50 mL) at rt under nitrogen were added [1,1′-bis(diphenylphosphino)ferrocene]dichloro-palladium(II) (0.73 g, 1 mmol) and CuI (0.75 g, 4 mmol). The mixture was stirred at 80 °C for 2 h and then cooled to rt, and the solvent was evaporated in vacuo. The resulting residue was dissolved in EtOAc and washed with H<sub>2</sub>O. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in petroleum ether, 10/90 to 50/50). The desired fractions were collected, and the solvent was evaporated in vacuo to yield 0.7 g (30%) of <b>14a</b> as a brown solid. Mp<sup><i>a</i></sup> 232.1–235.1 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.00 (t, <i>J</i> = 7.0 Hz, 2 H), 3.50 (td, <i>J</i> = 7.0, 2.5 Hz, 2 H), 7.44–7.57 (m, 3 H), 7.63–7.72 (m, 2 H), 8.07 (br. s, 1 H). LCMS: <i>m</i>/<i>z</i> 255 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.00 min.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-Methyl-2-phenylethynyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>14b</b>)</h4><div class="NLM_p last">A mixture of <b>14a</b> (0.25 g, 0.98 mmol), methyl iodide (0.84 g, 5.9 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.9 g, 5.9 mmol) in CH<sub>3</sub>CN (50 mL) was stirred at 80 °C for 16 h. The mixture was then cooled to rt and concentrated in vacuo. The crude product was purified by reverse phase HPLC (0.1% TFA in CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O). The desired fractions were collected, washed with a saturated solution of NaHCO<sub>3</sub> and extracted with EtOAc. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo to yield 50 mg (19%) of <b>14b</b>. Mp<sup><i>a</i></sup> 146.1–147.2 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.97 (s, 3 H), 3.09 (t, <i>J</i> = 7.2 Hz, 2 H), 3.67 (t, <i>J</i> = 7.2 Hz, 2 H), 7.43–7.58 (m, 3 H), 7.67 (d, <i>J</i> = 6.8 Hz, 2 H). LCMS: <i>m</i>/<i>z</i> 269 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.29 min.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-(2-Methoxy-ethyl)-2-phenylethynyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>14c</b>)</h4><div class="NLM_p last">Starting from <b>14a</b> (0.7 g, 2.9 mmol) and 2-bromoethyl methyl ether and following the procedure described for <b>14b</b>, <b>14c</b> was obtained as a yellow solid (150 mg, 20%). Mp<sup><i>a</i></sup> 144.5–148.2 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 3.06 (t, <i>J</i> = 7.0 Hz, 2 H), 3.30 (s, 3 H), 3.49–3.59 (m, 2 H), 3.59–3.68 (m, 2 H), 3.74 (t, <i>J</i> = 7.0 Hz, 2 H), 7.26–7.43 (m, 3 H), 7.45–7.62 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 313 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 6.01 min.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-Benzyloxy-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>15a</b>)</h4><div class="NLM_p last">Benzyl alcohol (0.145 mL, 1.42 mmol) was added dropwise to a suspension of NaH (0.067 g, 1.67 mmol, 60% in mineral oils) in THF (6 mL) under nitrogen. The mixture was stirred at rt for 15 min and then <b>21</b> (0.3 g, 1.29 mmol) was added. The mixture was stirred at 120 °C for 15 min under microwave irradiation in a sealed tube. The solvent was removed with a nitrogen flow to yield 0.340 g (70% pure) of <b>15a</b>. LCMS: <i>m</i>/<i>z</i> 261 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.15 min.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-Benzyloxy-5-methyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>15b</b>)</h4><div class="NLM_p last"><b>15a</b> (0.34 g, 1.29 mmol) was added dropwise to a suspension of NaH (0.067 g, 1.67 mmol, 60% in mineral oils) in THF (2 mL) under nitrogen. The mixture was stirred for 15 min then methyl iodide (0.12 mL, 1.68 mmol). The mixture was stirred at 120 °C for 15 min under microwave irradiation in a sealed tube. The mixture was diluted with EtOAc and washed with a saturated solution of NH<sub>4</sub>Cl. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 10/90). The desired fractions were collected and the solvents evaporated in vacuo. The solid obtained was triturated with heptane/Et<sub>2</sub>O to yield 0.190 g (54%) of <b>15b</b>. Mp<sup><i>b</i></sup> 106.4 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 2.96 (t, <i>J</i> = 7.2 Hz, 2 H), 3.05 (s, 3 H), 3.60 (t, <i>J</i> = 7.2 Hz, 2 H), 5.45 (s, 2 H), 7.34–7.50 (m, 5 H). LCMS: <i>m</i>/<i>z</i> 275 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.68 min.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-Benzyloxy-5-(4-fluoro-phenyl)-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>15c</b>)</h4><div class="NLM_p last">Benzyl alcohol (0.38 mL, 3.67 mmol) was added dropwise to a suspension of NaH (0.183 g, 4.58 mmol, 60% in mineral oils) in THF (12 mL) under nitrogen. The mixture was stirred at rt for 15 min and then <b>26</b> (1 g, 3.06 mmol) was added. The mixture was stirred at 120 °C for 25 min under microwave irradiation in a sealed tube. The mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and H<sub>2</sub>O. The organic layer was separated, dried (MgSO<sub>4</sub>), and filtered, and the solvent was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub> in heptane, 0/0/100 to 10/10/80). The desired fractions were collected and evaporated in vacuo to yield 0.68 g (63%) of <b>15c</b> as a white solid. Mp<sup><i>b</i></sup> 130.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 3.08 (t, <i>J</i> = 6.9 Hz, 2 H), 4.01 (t, <i>J</i> = 6.9 Hz, 2 H), 5.49 (s, 2 H), 7.08 (t, <i>J</i> = 8.7 Hz, 2 H), 7.29 (dd, <i>J</i> = 9.0, 4.9 Hz, 2 H), 7.34–7.54 (m, 5 H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ ppm 26.56 (s, 1 C) 49.57 (s, 1 C) 73.78 (s, 1 C) 115.68 (d, <i>J</i> = 22.00 Hz, 2 C) 119.25 (s, 1 C) 127.02 (d, <i>J</i> = 8.25 Hz, 2 C) 128.32 (s, 2 C) 128.64 (s, 2 C) 128.78 (s, 1 C) 134.65 (s, 1 C) 138.24 (d, <i>J</i> = 3.67 Hz, 1 C) 155.14 (s, 1 C) 160.62 (d, <i>J</i> = 245.61 Hz, 1 C) 160.68 (s, 1 C) 177.92 (s, 1 C). LCMS: <i>m</i>/<i>z</i> 355 [M+H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.44 min. HRMS (ES<sup>+</sup>, M + H) calcd. for C<sub>19</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>SF: 355.0917, found 355.0914.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 5-Methyl-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16a</b>)</h4><div class="NLM_p last">Di-<i>tert</i>-butyl azodicarboxylate (1.55 g, 5.90 mmol) was added to a stirred solution of <b>29</b> (0.90 g, 4.54 mmol), phenol (0.534 g, 5.68 mmol) and PPh<sub>3</sub> (1.55 g, 5.90 mmol) in THF (15 mL) under nitrogen. The mixture was stirred at 120 °C for 20 min under microwave irradiation. The solvent was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 50/50). The desired fractions were collected and evaporated in vacuo, and the residue was triturated with diisopropyl ether to yield 0.253 g (20%) of <b>16a</b> as a white solid. Mp<sup><i>a</i></sup> 141.5–142.4 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 3.10 (s, 3 H), 3.14 (t, <i>J</i> = 7.2 Hz, 2 H), 3.67 (t, <i>J</i> = 7.1 Hz, 2 H), 5.33 (s, 2 H), 6.96–7.05 (m, 3 H), 7.28–7.35 (m, 2 H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ ppm 25.64 (s, 1 C) 34.14 (s, 1 C) 48.56 (s, 1 C) 67.30 (s, 1 C) 114.85 (s, 2 C) 121.89 (s, 1 C) 127.04 (s, 1 C) 129.56 (s, 2 C) 157.41–157.65 (m, 1 C) 157.69–157.96 (m, 1 C) 160.76–161.07 (m, 1 C) 171.74 (s, 1 C). LCMS: <i>m</i>/<i>z</i> 275 [M + H]<sup>+</sup>̧ <i>t</i><sub>R</sub> = 1.76 min. HRMS (ES<sup>+</sup>, M + H) calcd. for C<sub>14</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S: 275.0854, found 275.0853.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-Ethyl-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16b</b>)</h4><div class="NLM_p last">Iodoethane (0.069 mL, 0.86 mmol) was added to a suspension of <b>31</b> (150 mg, 0.058 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (281 mg, 0.86 mmol) in anhydrous DMF (2.5 mL). The mixture was stirred at rt for 16 h under nitrogen then at 100 °C for 1 h. The mixture was diluted with H<sub>2</sub>O and extracted with EtOAc. The organic layer was separated, washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvents were evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 50/50). The desired fractions were collected and the solvents evaporated in vacuo. The impure product was triturated with diisopropyl ether and purified by reverse phase HPLC (gradient elution: 80% 0.1% NH<sub>4</sub>CO<sub>3</sub>H/NH<sub>4</sub>OH pH 9 solution in H<sub>2</sub>O, 20% CH<sub>3</sub>CN to 0% 0.1% NH<sub>4</sub>CO<sub>3</sub>H/NH<sub>4</sub>OH pH 9 solution in H<sub>2</sub>O, 100% CH<sub>3</sub>CN). The desired fractions were collected and evaporated in vacuo to yield 62 mg (37%) of <b>16b</b> as a yellow solid. Mp<sup><i>b</i></sup> 116.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 3.12 (t, <i>J</i> = 7.1 Hz, 2 H), 3.57 (q, <i>J</i> = 7.2 Hz, 2 H), 3.67 (t, <i>J</i> = 7.2 Hz, 2 H), 5.33 (s, 2 H), 6.95 - 7.07 (m, 3 H), 7.28 - 7.36 (m, 2 H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ ppm 12.79 (s, 1 C) 25.90 (s, 1 C) 41.35 (s, 1 C) 45.97 (s, 1 C) 67.30 (s, 1 C) 114.87 (s, 2 C) 121.92 (s, 1 C) 127.46 (s, 1 C) 129.61 (s, 2 C) 157.54 (s, 1 C) 157.82 (s, 1 C) 160.31 (s, 1 C) 171.75 (s, 1 C). LCMS: <i>m</i>/<i>z</i> 289 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.00 min. HRMS (ES<sup>+</sup>, M + H) calcd. for C<sub>15</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S: 289.1011, found 289.1013.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-Isopropyl-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16c</b>)</h4><div class="NLM_p last">A mixture of <b>25a</b> (0.23 g, 1.29 mmol) and <b>33a</b> (0.24 g, 1.4 mmol) in EtOH (10 mL) was stirred at rt for 15 min before NaHCO<sub>3</sub> (0.4 g, 3.9 mmol) was added. Then the mixture was stirred at 70 °C for 15 min, diluted with EtOAc, and washed with H<sub>2</sub>O. The organic layer was separated, washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvents were evaporated in vacuo. The crude product was purified by reverse phase HPLC (gradient elution: 0.1% TFA in CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O). The desired fractions were collected and washed with a saturated solution of NaHCO<sub>3</sub> and extracted with EtOAc (2 × 100 mL). The organic layer was separated, washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and the solvents evaporated in vacuo to yield 81 mg (21%) of <b>16c</b> as a white solid. Mp<sup><i>a</i></sup> 104.1–106.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.13 (d, <i>J</i> = 6.8 Hz, 6 H), 3.00 (t, <i>J</i> = 7.0 Hz, 2 H), 3.49 (t, <i>J</i> = 7.0 Hz, 2 H), 4.87 (spt, <i>J</i> = 6.8 Hz, 1 H), 5.26 (s, 2 H), 6.86–7.01 (m, 3 H), 7.21–7.31 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 303 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.42 min.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-(2-Methoxy-ethyl)-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16d</b>)</h4><div class="NLM_p last">Starting from <b>31</b> (150 mg, 0.58 mmol) and 2-bromoethyl methyl ether and following the procedure described for <b>16b</b>, <b>16d</b> was obtained as a yellow solid (90 mg, 49%). Mp<sup><i>b</i></sup> 82.6 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 3.10 (t, <i>J</i> = 7.1 Hz, 2 H), 3.36 (s, 3 H), 3.60 (t, <i>J</i> = 5.2 Hz, 2 H), 3.69 (t, <i>J</i> = 5.2 Hz, 2 H), 3.78 (t, <i>J</i> = 7.2 Hz, 2 H), 5.33 (s, 2 H), 6.97–7.04 (m, 3 H), 7.28–7.35 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 319 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.90 min.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-Cyclopropyl-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16e</b>)</h4><div class="NLM_p last">Starting from <b>25b</b> (0.28 g, 1.2 mmol) and <b>33a</b> (0.23 g, 1.4 mmol) and following the procedure described for <b>16c</b>, <b>16e</b> was obtained as a white solid (72 mg, 20%). Mp<sup><i>a</i></sup> 252.1–255.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.62 - 0.69 (m, 2 H), 0.80 - 0.88 (m, 2 H), 2.65 (tt, <i>J</i> = 7.2, 3.7 Hz, 1 H), 2.99 (t, <i>J</i> = 7.0 Hz, 2 H), 3.63 (t, <i>J</i> = 7.0 Hz, 2 H), 5.25 (s, 2 H), 6.89–6.99 (m, 3 H), 7.21–7.29 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 301 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.86 min.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 5-Cyclopropylmethyl-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-c]pyridin-4-one (<b>16f</b>)</h4><div class="NLM_p last">Starting from <b>25c</b> (250 mg, 1.01 mmol) and <b>33a</b> (0.2 g, 1.22 mmol) and following the procedure described for <b>16c</b>, <b>16f</b> was obtained as a white solid (78 mg, 25%). Mp<sup><i>a</i></sup> 292.6–302.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.23 (q, <i>J</i> = 4.9 Hz, 2 H), 0.40 - 0.56 (m, 2 H), 0.87 - 1.06 (m, 1 H), 3.08 (t, <i>J</i> = 7.2 Hz, 2 H), 3.35 (d, <i>J</i> = 7.0 Hz, 2 H), 3.72 (t, <i>J</i> = 7.2 Hz, 2 H), 5.28 (s, 2 H), 6.86 - 7.02 (m, 3 H), 7.21 - 7.33 (m, 2 H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ ppm 3.49 (s, 2 C) 9.53 (s, 1 C) 25.89 (s, 1 C) 46.52 (s, 1 C) 50.68 (s, 1 C) 67.32 (s, 1 C) 114.89 (s, 2 C) 121.93 (s, 1 C) 127.46 (s, 1 C) 129.62 (s, 2 C) 157.55 (s, 1 C) 157.85 (s, 1 C) 160.56 (s, 1 C) 171.80 (s, 1 C). LCMS: <i>m</i>/<i>z</i> 303 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.32 min. HRMS (ES<sup>+</sup>, M + H) calcd. for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S: 315.1167, found 315.1169.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-Phenoxymethyl-5-(tetrahydro-pyran-4-ylmethyl)-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16g</b>)</h4><div class="NLM_p last">Starting from <b>31</b> (150 mg, 0.58 mmol) and 4-(bromomethyl)tetrahydropyran and following the procedure described for <b>16a</b>, <b>16g</b> was obtained as a white solid (27 mg, 13%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.34–1.48 (m, 2 H), 1.59–1.68 (m, 2 H), 1.90–2.04 (m, 1 H), 3.11 (t, <i>J</i> = 7.0 Hz, 2 H), 3.32–3.42 (m, 2 H), 3.40 (d, <i>J</i> = 7.4 Hz, 2 H), 3.69 (t, <i>J</i> = 7.0 Hz, 2 H), 3.94–4.03 (m, 2 H), 5.33 (s, 2 H), 6.97–7.05 (m, 3 H), 7.28–7.35 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 359 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.10 min.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 5-(4-Fluoro-phenyl)-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16h</b>)</h4><div class="NLM_p last">A mixture of <b>25d</b> (0.41 g, 1.45 mmol) and <b>33a</b> (0.22 g, 1.3 mmol) in DMF (5 mL) was stirred at rt for 15 min before NaHCO<sub>3</sub> (0.19 g, 2.3 mmol) was added. Then the mixture was stirred at 100 °C for 30 min, diluted with EtOAc and washed with H<sub>2</sub>O. The organic layer was separated, dried (MgSO<sub>4</sub>), and filtered, and the solvents were evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 2/98). The desired fractions were collected, and the solvents were evaporated in vacuo<sup> </sup>to yield 0.084 g (16%) of <b>16h</b> as a white solid. Mp<sup><i>b</i></sup> 163.3 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 3.26 (t, <i>J</i> = 6.9 Hz, 2 H), 4.08 (t, <i>J</i> = 6.9 Hz, 2 H), 5.36 (s, 2 H), 6.98–7.06 (m, 3 H), 7.07–7.13 (m, 2 H), 7.28–7.36 (m, 4 H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ ppm 26.32 (s, 1 C) 50.16 (s, 1 C) 67.37 (s, 1 C) 114.87 (s, 2 C) 115.82 (d, <i>J</i> = 22.91 Hz, 2 C) 122.01 (s, 1 C) 127.15 (d, <i>J</i> = 8.25 Hz, 2 C) 127.38 (s, 1 C) 129.64 (s, 2 C) 137.93 (d, <i>J</i> = 3.67 Hz, 1 C) 157.50 (s, 1 C) 158.79 (s, 1 C) 160.79 (d, <i>J</i> = 246.52 Hz, 1 C) 160.36 (s, 1 C) 172.95 (s, 1 C). LCMS: <i>m</i>/<i>z</i> 355 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 6.57 min. HRMS (ES<sup>+</sup>, M + H) calcd. for C<sub>19</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>SF: 355.0917, found 355.0916.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 5-(2,4-Difluoro-phenyl)-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16i</b>)</h4><div class="NLM_p last">Starting from <b>25e</b> (300 mg, 0.99 mmol) and <b>33a</b> (148 m<sub>g</sub>, 0.89 mmol) and following the procedure described for <b>16h</b>, <b>16i</b> was obtained as a yellow solid (37 mg, 10%). Mp<sup><i>a</i></sup> 268.9–284.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 3.28 (t, <i>J</i> = 6.9 Hz, 2 H), 4.01 (t, <i>J</i> = 6.8 Hz, 2 H), 5.37 (s, 2 H), 6.89–6.99 (m, 2 H), 6.99–7.07 (m, 3 H), 7.29–7.39 (m, 3 H). LCMS: <i>m</i>/<i>z</i> 373 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.63 min.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(2-Fluoro-phenoxymethyl)-5-(4-fluoro-phenyl)-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16j</b>)</h4><div class="NLM_p last">A mixture of <b>35</b> (0.3 g, 1.01 mmol), 2-fluorophenol (0.15 g, 1.3 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.4 g, 3 mmol) in DMF (40 mL) was stirred at rt for 1 h. The mixture was filtered and the solvent evaporated in vacuo. The crude product was purified by reverse phase HPLC (gradient elution: 0.1% TFA in CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O). The desired fractions were collected and washed with a saturated solution of NaHCO<sub>3</sub> and extracted with EtOAc (2 × 100 mL). The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and the solvent evaporated in vacuo to yield 31 mg (8%) of <b>16j</b> as a solid. Mp<sup><i>a</i></sup> > 280 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 3.25 (t, <i>J</i> = 6.9 Hz, 2 H), 4.07 (t, <i>J</i> = 6.8 Hz, 2 H), 5.41 (s, 2 H), 6.92–7.19 (m, 6 H), 7.19–7.42 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 373 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.58 min.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-(3-Fluoro-phenoxymethyl)-5-(4-fluoro-phenyl)-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16k</b>)</h4><div class="NLM_p last">Starting from <b>25d</b> (0.39 g, 1.38 mmol) and <b>33b</b> (230 mg, 1.24 mmol) and following the procedure described for <b>16h</b>, <b>16k</b> was obtained as a white solid (120 mg, 23%). Mp<sup><i>b</i></sup> 152.8 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 3.27 (t, <i>J</i> = 6.9 Hz, 2 H), 4.09 (t, <i>J</i> = 6.9 Hz, 2 H), 5.35 (s, 2 H), 6.69–6.84 (m, 2 H), 7.07–7.16 (m, 2 H), 7.23–7.35 (m, 4 H). LCMS: <i>m</i>/<i>z</i> 372 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.88 min.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-(4-Fluoro-phenoxymethyl)-5-(4-fluoro-phenyl)-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16l</b>)</h4><div class="NLM_p last">Starting from <b>35</b> (0.3 g, 1.01 mmol) and 4-fluorophenol (0.15 g, 1.3 mmol) and following the procedure described for <b>16j</b>, <b>16l</b> was obtained as a solid (74 mg, 20%). Mp<sup><i>a</i></sup> > 280 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 3.25 (t, <i>J</i> = 6.7 Hz, 2 H), 4.07 (t, <i>J</i> = 6.8 Hz, 2 H), 5.31 (s, 2 H), 6.85–7.05 (m, 4 H), 7.09 (br. t, <i>J</i> = 8.4, 8.4 Hz, 2 H), 7.26–7.35 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 373 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.62 min.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-Phenoxymethyl-5-pyridin-2-yl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16m</b>)</h4><div class="NLM_p last">K<sub>2</sub>CO<sub>3</sub> (111 mg, 0.81 mmol) was added to a stirred suspension of <b>31</b> (150 mg, 0.4 mmol), 2-iodopyridine (0.043 mL, 0.4 mmol), CuI (0.015 g, 0.081 mmol) and <i>N</i>,<i>N</i>′-dimethylethylenediamine (0.026 mL, 0.24 mmol) in toluene (3 mL) in a sealed tube and under nitrogen. The mixture was stirred at 120 °C for 16 h, filtered through a Celite pad, and washed with EtOAc and the filtrate was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 100/0). The desired fractions were collected and the solvents were evaporated in vacuo. The solid was triturated with diisopropyl ether to yield 57 mg (57%) of <b>16m</b> as a white solid. Mp<sup><i>b</i></sup> 143.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 3.23 (t, <i>J</i> = 6.8 Hz, 2 H), 4.47 (t, <i>J</i> = 6.8 Hz, 2 H), 5.37 (s, 2 H), 7.00–7.06 (m, 3 H), 7.07–7.13 (m, 1 H), 7.29–7.37 (m, 2 H), 7.71 (ddd, <i>J</i> = 8.6, 7.1, 1.8 Hz, 1 H), 7.89 (d, <i>J</i> = 8.3 Hz, 1 H), 8.44 (br. s, 1 H). LCMS: <i>m</i>/<i>z</i> 338 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.42 min.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-Phenoxymethyl-5-pyridin-3-yl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16n</b>)</h4><div class="NLM_p last">Starting from <b>31</b> (150 mg, 0.58 mmol) and 3-bromopyridine and following the procedure described for <b>16m</b>, <b>16n</b> was obtained as a white solid (29 mg, 15%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 3.30 (t, <i>J</i> = 6.8 Hz, 2 H), 4.17 (t, <i>J</i> = 6.8 Hz, 2 H), 5.37 (s, 2 H), 6.96–7.09 (m, 3 H), 7.29–7.41 (m, 3 H), 7.71–7.80 (m, 1 H), 8.50 (dd, <i>J</i> = 4.7, 1.3 Hz, 1 H), 8.65 (d, <i>J</i> = 2.3 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 338 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.00 min.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-Phenoxymethyl-5-pyridin-4-yl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16o</b>)</h4><div class="NLM_p last">Starting from <b>31</b> (150 mg, 0.58 mmol) and 4-iodopyridine and following the procedure described for <b>16m</b>, <b>16o</b> was obtained as a white solid (5 mg, 2.5%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 3.29 (t, <i>J</i> = 6.8 Hz, 2 H), 4.19 (t, <i>J</i> = 6.8 Hz, 2 H), 5.37 (s, 2 H), 6.90–7.12 (m, 3 H), 7.29 - 7.41 (m, 4 H), 8.62 (d, <i>J</i> = 6.4 Hz, 2 H). LCMS: <i>m</i>/<i>z</i> 338 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.09 min.</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 5-(5-Fluoro-pyridin-2-yl)-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16p</b>)</h4><div class="NLM_p last">K<sub>3</sub>PO<sub>4</sub> (1.6 g, 7.49 mmol) was added to a stirred suspension of <b>31</b> (650 mg, 2.5 mmol), 2-bromo-5-fluoropyridine (879 mg, 4.99 mmol), CuI (475 mg, 2.5 mmol) and <i>N</i>,<i>N</i>′-dimethylethylenediamine (0.81 mL, 7.49 mmol) in toluene (12 mL) in a sealed tube and under nitrogen. The mixture was stirred at 140 °C for 16 h and then filtered through a Celite pad. The filtrate was evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 30/70). The desired fractions were collected and the solvents evaporated in vacuo. The solid was triturated with diisopropyl ether to yield 570 mg (64%) of <b>16p</b> as a white solid. Mp<sup><i>a</i></sup> 131.7–132.8 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 3.23 (t, <i>J</i> = 6.8 Hz, 2 H), 4.42 (t, <i>J</i> = 6.9 Hz, 2 H), 5.37 (s, 2 H), 6.86–7.12 (m, 3 H), 7.29–7.38 (m, 2 H), 7.39 - 7.50 (m, 1 H), 7.89 (dd, <i>J</i> = 9.2, 4.0 Hz, 1 H), 8.27 (d, <i>J</i> = 3.2 Hz, 1 H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ ppm 26.15 (s, 1 C) 46.39 (s, 1 C) 67.41 (s, 1 C) 114.83 (s, 2 C) 120.72 (d, <i>J</i> = 4.24 Hz, 1 C) 122.02 (s, 2 C) 124.21 (d, <i>J</i> = 19.78 Hz, 1 C) 127.41 (s, 1 C) 129.65 (s, 2 C) 134.92 (d, <i>J</i> = 25.43 Hz, 1 C) 149.26 (d, <i>J</i> = 2.12 Hz, 1 C) 158.76 (d, <i>J</i> = 259.96 Hz, 1 C) 157.89 (s, 1 C) 160.67 (s, 1 C) 173.65 (s, 1 C). LCMS: <i>m</i>/<i>z</i> 356 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.99 min. HRMS (ES<sup>+</sup>, M + H) calcd. for C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>SF: 356.0869, found 356.0870.</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 5-(3-Fluoro-pyridin-2-yl)-2-phenoxymethyl-6,7-dihydro-5<i>H</i>-thiazolo[5,4-<i>c</i>]pyridin-4-one (<b>16q</b>)</h4><div class="NLM_p last">Starting from <b>31</b> (150 mg, 0.58 mmol) and 2-chloro-3-fluoropyridine and following the procedure described for <b>16m</b>, <b>16q</b> was obtained as a white solid (22 mg, 15%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 3.29 (t, <i>J</i> = 6.8 Hz, 2 H), 4.25 (t, <i>J</i> = 6.8 Hz, 2 H), 5.38 (s, 2 H), 6.98–7.06 (m, 3 H), 7.23–7.29 (m, 1 H), 7.30 - 7.40 (m, 2 H), 7.51 (ddd, <i>J</i> = 9.7, 8.1, 1.6 Hz, 1 H), 8.31 (dt, <i>J</i> = 4.8, 1.2 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 356 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.37 min.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Biology</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Cell Culture</h4><div class="NLM_p last">Human embryonic kidney (HEK) 293 cells were stably transfected with human mGluR<sub>5a</sub> cDNA in expression vector pcDNA4/TO. hmGlu<sub>5</sub> receptor-expressing HEK293 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% heat inactivated dialyzed fetal bovine serum and antibiotics (88 IU/mL penicillin G and 88 μg/mL streptomycin sulfate). Cells were detached with PBS w/o Ca<sup>2+</sup>/Mg<sup>2+</sup> containing 0.04% EDTA and 0.005% trypsin. The cells were grown in 175 cm<sup>2</sup> culture flasks at 37 °C in a 5% CO<sub>2</sub> environment and hold under permanent selection with 200 μg/mL zeocin and 5 μg/mL blasticidin. Cells were cultured at 40 000 cells/cm<sup>2</sup> or 20 000 cells/cm<sup>2</sup> for respectively 3 or 4 days of growth in a F175 flask.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Calcium Mobilization Assay</h4><div class="NLM_p last">Cells were seeded at 40 000 cells/well in PDL-coated MW384, and a day later, medium was removed before addition of a fluo-4-AM solution (HBSS, 2.5 mM probenecid and ∼2 μM fluo-4-AM, pH 7.4). Measurements were performed 90 min later (while incubation at 37 °C and 5% CO<sub>2</sub>) using the FDSS. Two additions were made: first, compound alone was added at 6 s to detect any agonist activity. Next, a suboptimal concentration (nominally 20% of the maximum response, EC<sub>20</sub>) of glutamate was added at 157 s to detect any potentiation of the glutamate response. For each interval, Ca<sup>2+</sup> fluorescence of the Ca<sup>2+</sup>-bound dye was monitored every second, at an excitation wavelength of 480 nm and emission at 540 nm. The ratio of peak versus basal fluorescent signals was used for data analysis.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Data Analysis</h4><div class="NLM_p last">Data were normalized to the control agonist response and sigmoid concentration–response curves plotting these percentages versus the log concentration of the test compound were analyzed using a 4 parameter logistic nonlinear regression model programmed in R (R Development Core Team, 2010. R: A language and environment for statistical computing. R Foundation for Statistical Computing,Vienna, Austria. ISBN 3–900051–07–0, URL <a href="http://www.R-project.org/" class="extLink">http://www.R-project.org/</a>.). The model was determined by the maximal effect of each compound (<i>E</i><sub>max</sub>), its EC<sub>50</sub> and the response in the absence of compound. The fourth parameter determining the slope was fixed to 1. In addition, the heterogeneity between experiments and concentration–response curves for each compound was taken into account by the inclusion of a random effect in both ‘E<sub>0</sub>’ (response in the absence of compound) and <i>E</i><sub>max</sub> of the model</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> In Vivo Pharmacology</h4><div id="sec5_2_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> (a) Animal Husbandry</h5><div class="NLM_p last">Animals were housed in the animal care facility certified by the American Association for the Accreditation of Laboratory Animal Care (AAALAC) under a 12-h light/dark cycle (lights on: 7 a.m.; lights off: 7 p.m.) and had free access to food and water. The animals used in these experiments were food-deprived the evening before experimentation for oral administration of test compound. The experimental protocols performed during the light cycle were approved by the Institutional Animals Care and Use Committee of Vanderbilt University and conformed to the guidelines established by the National Research Council Guide for the Care and Use of Laboratory Animals.</div></div><div id="sec5_2_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> (b) Preparation of Test Article</h5><div class="NLM_p last"><b>16a</b> was formulated in volumes specific to the number of animals dosed each day. The solutions were formulated so that animals were injected with a maximal dosing volume of 10 mL/kg. The appropriate amount according to the dosage was mixed into a 20% 2-(hydroxypropyl)-β-cyclodextrin in sterile water (HP-β-CD; Sigma, Cat. No. C0926-10G) solution. Each mixture was ultrahomogenized on ice for 2–3 min using a hand-held tissue homogenizer. Next, the pH of all solutions was checked using 0–14 EMD pH strips and adjusted to a pH of 6–7 if necessary with 1N NaOH. The mixtures were then vortexed, and stored in a sonication bath at 40 °C until time of injection. <i>d</i>-Amphetamine hemisulfate (AMP) was obtained from Sigma (Cat. No. A5880-1G; St. Louis, MO). Salt-correction was used to determine the correct amount of the <i>d</i>-amphetamine hemisulfate form in mg to add to sterile water in order to yield a 1 mg/mL solution; injected with a maximal dosing volume of 10 mL/kg.</div></div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Reversal of Amphetamine-Induced Hyperlocomotion</h4><div class="NLM_p last">Studies were conducted using Smart Open Field activity chambers (27 × 27 × 20 cm) (Kinder Scientific, Poway, CA) equipped with 16 horizontal (<i>x</i>- and <i>y</i>-axes) infrared photobeams. Changes in locomotor activity were measured as the number of photobeam breaks over time and were recorded with a Pentium I computer equipped with rat activity monitoring system software (Motor Monitor, Kinder Scientific, Poway, CA). Male Harlan Sprague–Dawley rats (Harlan Laboratories, Indianapolis, IN) weighing 250–375 g were used. Animals were habituated in the locomotor activity test chambers for 30 min. Animals were next pretreated for an additional 30 min with either vehicle or a dose of <b>16a</b> p.o., followed by a subcutaneous injection of 1 mg/kg amphetamine or vehicle and monitored for an additional 60 min. <i>Treatment groups.</i> Dose group 1: VAMP = 20% β-CD (<b>16a</b> vehicle), p.o. +1 mg/kg AMP, sc (<i>n</i> = 8). Dose group 2: 3AMP = 3 mg/kg <b>16a</b>, p.o. +1 mg/kg AMP, sc (<i>n</i> = 6). Dose group 3: 10AMP = 10 mg/kg <b>16a</b>, po +1 mg/kg AMP, sc (<i>n</i> = 7). Dose group 4: 30AMP = 30 mg/kg <b>16a</b>, p.o. +1 mg/kg AMP, sc (<i>n</i> = 8). Dose group 5: 56.6AMP = 56.6 mg/kg <b>16a</b>, p.o. + 1 mg/kg AMP, sc (<i>n</i> = 8). Dose group 6: 100AMP = 100 mg/kg <b>16a</b>, p.o. +1 mg/kg AMP, sc (<i>n</i> = 8). Dose group 7: 100 V = 100 mg/kg <b>16a</b>, p.o. + sterile water (AMP vehicle), sc (<i>n</i> = 8). Changes in locomotor activity were recorded for a total of 120 min. Data were expressed as changes in ambulation defined as the total number of photobeam breaks per 5 min interval. At the end of this behavioral study, each animal was euthanized, then decapitated, and the plasma and brain tissues were collected for the evaluation of exposure levels of <b>16a</b>. <i>Data Analysis.</i> Behavioral data were analyzed using a one-way ANOVA with main effects of treatment and time. <i>Post hoc</i> analyses were performed using a Dunnett’s <i>t-</i>test with all treatment groups compared to the VAMP group using JMP  8.0 (SAS Institute, Cary, NC) statistical software. Data were graphed using SigmaPlot for Windows Version 11.0 (Saugua, MA). A probability of <i>p</i> ≤ 0.05 was taken as the level of statistical significance. Percent Effect and Reversal calculations for the 3AMP, 10AMP, 30AMP, 56.6AMP, and 100AMP treatment groups were performed with the following formula relative to the VAMP treatment group: (1) Total number of photobeam breaks in the time interval from <i>t</i> = 60 to <i>t</i> = 120 was calculated for each rat in each treatment group; (2) Mean total number of photobeam breaks in the time interval from <i>t</i> = 60 to <i>t</i> = 120 was calculated for the VAMP group; (3) Percent effect = ratio of the total number of photobeam breaks for each rat in each treatment group divided by the mean total number of photobeam breaks in the time interval from <i>t</i> = 60 to <i>t</i> = 120 of the VAMP group multiplied by 100; (4) Percent reversal = 100-the percent effect for each rat in each treatment group; (5) finally the mean ± SE percent reversal for each treatment group was calculated from the individual percent reversal values. Percent effect and change calculations for the VAMP and 100 V treatment groups relative to the VV treatment group were also performed with the following formula: (1) Total number of photobeam breaks in the time interval from t = 60 to <i>t</i> = 120 was calculated for each rat in each treatment group; (2) Mean total number of photobeam breaks in the time interval from <i>t</i> = 60 to <i>t</i> = 120 was calculated for the VV group; (3) Percent Effect = Ratio of the total number of photobeam breaks for each rat in each treatment group divided by the mean total number of photobeam breaks in the time interval from <i>t</i> = 60 to <i>t</i> = 120 of the VV group multiplied by 100; (4) percent change = the percent effect for each rat in each treatment group −100; (5) finally the Mean ± SE percent change for each treatment group was calculated from the individual percent change values. <i>LC-MS/MS Sample Preparation and Analysis Methodology</i>. Brain samples were homogenized in 3 mL of 70:30 isopropanol/water and then centrifuged at 3500 rpm for 5 min. Resulting brain sample supernatant and plasma samples were transferred into a 96-well plate containing plasma blanks, plasma double blank, a standard curve of the test article, and quality control samples for subsequent LC-MS/MS analysis. Each sample was diluted with acetonitrile containing 50 nM carbamazepine (internal standard), centrifuged at 3500 rpm, and the resulting supernatant was transferred to a new 96-well plate. After an equal volume of water was added to each sample (to provide 50:50 acetonitrile/water solution), the plate was analyzed via ESI on a triple-quadrupole mass spectrometer (AB Sciex API-4000) coupled with an autosampling liquid chromatography system (Shimadzu LC-10AD pumps, Leap Technologies CTC PAL autosampler). Analyte (test article) was separated by gradient elution using a C18 3.0 × 50 mm, 3 μm column (Fortis Technologies) thermostatted at 40 °C. HPLC mobile phase A was 0.1% formic acid in water (pH unadjusted), mobile phase B was 0.1% formic acid in acetonitrile (pH unadjusted), and the gradient used was 30–90% mobile phase B with 0.2 min hold at 30% B, linear increase to 90% B over 0.8 min, hold at 90% B for 0.6 min, and a return to 30% B over 0.1 min followed by a re-equilibration (0.5 min) to provide a 2.0 min total run time per sample. HPLC flow rate was 0.5 mL/min, source temperature was 500 °C, and mass spectral analyses were performed using the following MRM transitions: 353.5 → 259.2 and 353.5 → 123.2 <i>m</i>/<i>z</i>. ESI was achieved by a Turbo-Ionspray source in positive ionization mode (5.0 kV spray voltage). The raw plasma and brain concentration data obtained by LC-MS/MS were analyzed by Analyst software (AB Sciex, version 1.5.1), which used the ratio of peak area responses of drug relative to internal standard to construct a standard curve with a dynamic range covering the concentrations found in the samples. Free plasma and brain concentrations were calculated by multiplication of the total concentration values by <i>f</i><sub>u</sub> plasma and <i>f</i><sub>u</sub> brain, respectively, based on data from in vitro rat plasma protein and rat brain homogenate binding experiments.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Rotarod</h4><div class="NLM_p last">The effects of <b>16a</b> on motor performance were evaluated using an automated rotarod setup with a rotarod (7.0 cm in diameter) rotating at a constant speed of 20 rotations/min (MedAssociates, Inc., St Albans, CA). Male Harlan Sprague–Dawley rats (Harlan Laboratories, Indianapolis, IN) weighing 250–300 g were used. Animals were given two training trials of 120 s on the rotarod with a 10 min interval between trials, followed by baseline assessment of performance with a 120 s trial, any animals that did not reach a performance criteria of 85 s were excluded from the study. Animals were next pretreated for 30 min with vehicle (20% HP-β-CD) or a dose of 16a (n = 6 each group) and then tested on the rotarod using a 120 s trial. The amount of time in s that each animal remained on the rotarod was recorded; animals not falling off of the rotarod were given a maximal score of 120 s. Data were expressed as the mean latency to fall off the rotarod in seconds for each treatment group. <i>Data Analysis</i>. Behavioral data were analyzed using a one-way ANOVA with main effects of treatment. Post hoc analyses were performed using a Dunnett’s <i>t</i> test with all treatment groups compared to the vehicle group using JMP  8.0 (SAS Institute, Cary, NC) statistical software. Data were graphed using SigmaPlot for Windows Version 11.0 (Saugua, MA). A probability of <i>p</i> ≤ 0.05 was taken as the level of statistical significance.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Modified Irwin Neurological Test Battery</h4><div class="NLM_p last">Male Harlan Sprague–Dawley rats (Harlan Laboratories, Indianapolis, IN) weighing 250–300 g were used. Animals were evaluated in the modified Irwin neurological test battery at t = 0 to provide a baseline measurement across each functional end point. Animals were next administered either vehicle (20% HP-β-CD) or a 100 mg/kg p.o. dose of <b>16a</b> (<i>n</i> = 6 each group) and then assessed after a 30 min, 1 h, and 4 h pretreatment interval in the modified Irwin neurological test battery. Changes in the different functional end points of the Irwin test battery were given a score of 0, 1 or 2; with 0 = no effect, 1 = moderate effect, and 2 = robust full effect. All data were collected blinded to treatment for each animal. Following functional end points were scored. Autonomic nervous system functions: ptosis, exophthalmos, miosis, mydriasis, corneal reflex, pinna reflex, piloerection, respiratory rate, writhing, tail erection, lacrimation, salivation, vasodilation, skin color, irritability and rectal temperature; Somatomotor nervous system functions: motor activity, ataxia, arch/roll, tremors, leg weakness, rigid stance, spraddle, placing loss, grasping loss, righting loss, catalepsy, tail pinch reaction, escape loss and physical appearance. <i>Data Analysis</i>. Mean change values for each functional end point in the Irwin test battery of each treatment group were calculated using Microsoft Excel. Behavioral data were then analyzed using a one-way ANOVA with main effect of treatment. Post hoc analyses were performed using a Dunnett’s <i>t</i> test with all treatment groups compared to the vehicle group using JMP  8.0 (SAS Institute, Cary, NC) statistical software. Data were graphed using SigmaPlot for Windows Version 11.0 (Saugua, MA). A probability of <i>p</i> ≤ 0.05 was taken as the level of statistical significance.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71"><a href="/doi/suppl/10.1021/jm400650w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18380" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18380" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The different LCMS methods used for the characterization of intermediate and final compounds. Mean scores of <b>16a</b> effects on autonomic and somatomotor nervous system functions in rats. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400650w/suppl_file/jm400650w_si_001.pdf">jm400650w_si_001.pdf (205.2 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400650w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Manuel Bartolomé-Nebreda</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#056f676477716a696a456c71762b6f6b6f2b666a68"><span class="__cf_email__" data-cfemail="c5afa7a4b7b1aaa9aa85acb1b6ebafabafeba6aaa8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susana Conde-Ceide</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisca Delgado</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Iturrino</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joaquín Pastor</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miguel Ángel Pena</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrés A. Trabanco</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Tresadern</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carola M. Wassvik</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaun R. Stauffer</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satyawan Jadhav</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiran Gogi</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paige N. Vinson</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meredith J. Noetzel</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily Days</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">C. David Weaver</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig W. Lindsley</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colleen M. Niswender</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carrie K. Jones</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">P. Jeffrey Conn</span> - <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederik Rombouts</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hilde Lavreysen</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregor J. Macdonald</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Mackie</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Steckler</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal
Chemistry, ¶CREATe Analytical Sciences, and ‡CREATe Molecular Informatics, Janssen Research and Development, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Department
of Pharmacology and ∥Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Vanderbilt
Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">#Department of Chemistry and △Vanderbilt Institute of Chemical
Biology, Vanderbilt University, Nashville, Tennessee 37232, United States</span>; 
    <span class="hlFld-Affiliation affiliation">○Neuroscience Medicinal Chemistry, ●Neuroscience Biology, and ▲CREATe Discovery
ADME/Tox, Janssen Research and Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d5585e5392-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01304" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01304" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) research was supported by grants from Janssen Pharmaceutical Companies of Johnson & Johnson and in part by the NIH (NS031373, MH062646). The authors would like to thank Dr. Lieve Heylen and Dr. Tom Jacobs for their help with data management and interpretation, Dr. Han Min Tong for her assistance in the preparation of this manuscript, and the members of the purification and analysis group and the biology and ADME/Tox teams from Janssen R&D for their experimental contribution.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i73" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i73"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i74" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i74"> Abbreviations Used</h2><tr><td class="NLM_term">AMP</td><td class="NLM_def"><p class="first last"><i>d</i>-amphetamine hemisulfate</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">b/p</td><td class="NLM_def"><p class="first last">brain to plasma ratio</p></td></tr><tr><td class="NLM_term">chromanone</td><td class="NLM_def"><p class="first last">2,3-dihydro-4<i>H</i>-1-benzopyran-4-one</p></td></tr><tr><td class="NLM_term">CL<sub>p</sub></td><td class="NLM_def"><p class="first last">plasma clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">peak plasma concentration</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">concentration response curve</p></td></tr><tr><td class="NLM_term">D<sub>2</sub></td><td class="NLM_def"><p class="first last">dopamine 2</p></td></tr><tr><td class="NLM_term">DAD</td><td class="NLM_def"><p class="first last">diode array detector</p></td></tr><tr><td class="NLM_term">dihydrobenzothiazolone</td><td class="NLM_def"><p class="first last">5,6-dihydro-7(4<i>H</i>)-benzothiazolone</p></td></tr><tr><td class="NLM_term">dihydrothiazolopyridone</td><td class="NLM_def"><p class="first last">6,7-dihydro-thiazolo[5,4-<i>c</i>]pyridin-4(5<i>H</i>)-one</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetic</p></td></tr><tr><td class="NLM_term"><i>E</i><sub>hep</sub></td><td class="NLM_def"><p class="first last">hepatic extraction ratio</p></td></tr><tr><td class="NLM_term">EPS</td><td class="NLM_def"><p class="first last">extrapyramidal symptoms</p></td></tr><tr><td class="NLM_term">ESCI</td><td class="NLM_def"><p class="first last">electrospray combined with atmospheric pressure chemical ionization</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u</sub></td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">GABAergic</td><td class="NLM_def"><p class="first last">γ-aminobutiric acidergic</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HP-β-CD</td><td class="NLM_def"><p class="first last">2-hydroxylpropyl-β-cyclodextrin</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LC-HRMS</td><td class="NLM_def"><p class="first last">liquid chromatography combined with high resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography combined with mass spectrometry</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">Mp</td><td class="NLM_def"><p class="first last">melting point</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">mGlu</td><td class="NLM_def"><p class="first last">metabotropic glutamate</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance (NMR)</p></td></tr><tr><td class="NLM_term">mGlu<sub>5</sub></td><td class="NLM_def"><p class="first last">metabotropic glutamate 5</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">ppm</td><td class="NLM_def"><p class="first last">parts per million</p></td></tr><tr><td class="NLM_term">p.o.</td><td class="NLM_def"><p class="first last">oral</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">RP-HPLC</td><td class="NLM_def"><p class="first last">reversed-phase high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure activity relationship</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">structure properties relationship</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub>, <i>t</i><sub>R</sub></td><td class="NLM_def"><p class="first last">retention time; time to reach peak concentration</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">VCNDD</td><td class="NLM_def"><p class="first last">Vanderbilt Center for Neuroscience Drug Discovery</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Tandon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasrallah, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshavan, M. S.</span><span> </span><span class="NLM_article-title">Schizophrenia, “Just the Facts” 4. Clinical Features and Conceptualization</span> <span class="citation_source-journal">Schizophr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1016%2Fj.schres.2009.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=19328655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ps12mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=1-23&author=R.+Tandonauthor=H.+A.+Nasrallahauthor=M.+S.+Keshavan&title=Schizophrenia%2C+%E2%80%9CJust+the+Facts%E2%80%9D+4.+Clinical+Features+and+Conceptualization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia, "just the facts" 4. Clinical features and conceptualization</span></div><div class="casAuthors">Tandon Rajiv; Nasrallah Henry A; Keshavan Matcheri S</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-23</span>
        ISSN:<span class="NLM_cas:issn">0920-9964</span>.
    </div><div class="casAbstract">Although dementia praecox or schizophrenia has been considered a unique disease entity for the past century, its definitions and boundaries have continued to vary over this period.  At any given time, the changing concept of schizophrenia has been influenced by available diagnostic tools and treatments, related conditions from which it most needs to be distinguished, extant knowledge and scientific paradigms.  There is significant heterogeneity in the etiopathology, symptomatology, and course of schizophrenia.  It is characterized by an admixture of positive, negative, cognitive, mood, and motor symptoms whose severity varies across patients and through the course of the illness.  Positive symptoms usually first begin in adolescence or early adulthood, but are often preceded by varying degrees of negative and cognitive symptomatology.  Schizophrenia tends to be a chronic and relapsing disorder with generally incomplete remissions, variable degrees of functional impairment and social disability, frequent comorbid substance abuse, and decreased longevity.  Although schizophrenia may not represent a single disease with a unitary etiology or pathogenetic process, alternative approaches have thus far been unsuccessful in better defining this syndrome or its component entities.  The symptomatologic, course, and etio-pathological heterogeneity can usefully be addressed by a dimensional approach to psychopathology, a clinical staging approach to illness course, and by elucidating endophenotypes and markers of illness progression, respectively.  This will allow an approach to the deconstruction of schizophrenia into its multiple component parts and strategies to reconfigure these components in a more meaningful manner.  Possible implications for DSM-V and ICD-11 definitions of schizophrenia are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvnCea0e_JZZotVjB3IRIyfW6udTcc2eb4lRuYZ4owGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ps12mtw%253D%253D&md5=8ed68c03937fb30924537e7cbe9f624e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2009.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2009.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DTandon%26aufirst%3DR.%26aulast%3DNasrallah%26aufirst%3DH.%2BA.%26aulast%3DKeshavan%26aufirst%3DM.%2BS.%26atitle%3DSchizophrenia%252C%2520%25E2%2580%259CJust%2520the%2520Facts%25E2%2580%259D%25204.%2520Clinical%2520Features%2520and%2520Conceptualization%26jtitle%3DSchizophr.%2520Res.%26date%3D2009%26volume%3D110%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Activation of Metabotropic Glutamate Receptors as a Novel Approach for the Treatment of Schizophrenia</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=148-155&author=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+K.+Jones&title=Activation+of+Metabotropic+Glutamate+Receptors+as+a+Novel+Approach+for+the+Treatment+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DActivation%2520of%2520Metabotropic%2520Glutamate%2520Receptors%2520as%2520a%2520Novel%2520Approach%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D148%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolome, J. M.</span><span> </span><span class="NLM_article-title">A Decade of Progress in the Discovery and Development of ‘Atypical’ Antipsychotics</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1016%2FS0079-6468%2810%2949002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=20855038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=37-80&author=G.+J.+Macdonaldauthor=J.+M.+Bartolome&title=A+Decade+of+Progress+in+the+Discovery+and+Development+of+%E2%80%98Atypical%E2%80%99+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of progress in the discovery and development of 'Atypical' antipsychotics</span></div><div class="casAuthors">MacDonald, Gregor J.; Bartolome, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-80</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The currently marketed antipsychotic drugs, recently launched and late-stage clin. compds., and progress in the discovery of 'atypical' agents are shown.  Other dopaminergic mechanisms suggestive of an 'atypical-like' profile, and non-dopamine mechanisms suggestive of an 'atypical-like' profile are also briefly reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbxQYFJzTE6bVg90H21EOLACvtfcHk0lifCOLAfYASHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlSqtA%253D%253D&md5=a9f1a0d39a1c548a778a4a63da4fafd0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2810%2949002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252810%252949002-5%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DBartolome%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Decade%2520of%2520Progress%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520%25E2%2580%2598Atypical%25E2%2580%2599%2520Antipsychotics%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D49%26spage%3D37%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Olney, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, N. B.</span><span> </span><span class="NLM_article-title">NMDA Antagonists as Neurotherapeutic Drugs, Psychotogens, Neurotoxins, and Research Tools for Studying Schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1001%2Farchpsyc.1995.03950240016004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=7492260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADyaK28XotF2rtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1995&pages=998-1007&author=J.+W.+Olneyauthor=N.+B.+Farber&title=NMDA+Antagonists+as+Neurotherapeutic+Drugs%2C+Psychotogens%2C+Neurotoxins%2C+and+Research+Tools+for+Studying+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor dysfunction and schizophrenia</span></div><div class="casAuthors">Olney, John W.; Farber, Nuri B.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">998-1007</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">A review, with 120 refs., which advances a unified hypothesis pertaining to combined dysfunction of dopamine and N-methyl-D-aspartate glutamate receptors that highlights N-methyl-D-aspartate receptor hypofunction as a key mechanism that can help explain major clin. and pathophysiol. aspects of schizophrenia.  The following fundamental features of schizophrenia are accommodated by this hypothesis: (1) the occurrence of structural brain changes during early development that have the potential for producing subsequent clin. manifestations of schizophrenia, (2) a quiescent period in infancy and adolescence before clin. manifestations are expressed, (3) onset in early adulthood of psychotic symptoms, (4) involvement of dopamine (D2) receptors in some cases but not others that would explain why some but not all patients are responsive to typical neuroleptic therapy, and (5) ongoing neurodegenerative changes and cognitive deterioration in some patients.  We propose that since N-methyl-D-aspartate receptor hypofunction can cause psychosis in humans and corticolimbic neurodegenerative changes in the rat brain, and since these changes are prevented by certain antipsychotic drugs, including atypical neuroleptic agents (clozapine, olanzapine, fluperlapine), a better understanding of the N-methyl-D-aspartate receptor hypofunction mechanism and ways of preventing its neurodegenerative consequences in the rat brain may lead to improved pharmacotherapy in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8_jBCscao6LVg90H21EOLACvtfcHk0lifCOLAfYASHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XotF2rtA%253D%253D&md5=ce668d3a1c911f6a0eab2488b0a14ad5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1995.03950240016004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1995.03950240016004%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DNMDA%2520Antagonists%2520as%2520Neurotherapeutic%2520Drugs%252C%2520Psychotogens%252C%2520Neurotoxins%252C%2520and%2520Research%2520Tools%2520for%2520Studying%2520Schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1995%26volume%3D52%26spage%3D998%26epage%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Nakanishi, S.</span><span> </span><span class="NLM_article-title">Molecular Diversity of Glutamate Receptors and Implications for Brain Functions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=597-603&author=S.+Nakanishi&title=Molecular+Diversity+of+Glutamate+Receptors+and+Implications+for+Brain+Functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DS.%26atitle%3DMolecular%2520Diversity%2520of%2520Glutamate%2520Receptors%2520and%2520Implications%2520for%2520Brain%2520Functions%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D597%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Shigemoto, R.; Mizuno, N.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptors – Immunocytochemical and In Situ Hybridization Analysis</span>. In  <span class="citation_source-book">Handbook of Chemical Neuroanatomy</span>; <span class="NLM_contrib-group">Ottersen, O. P.; Storm-Mathisen, J.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=63-98&author=R.+Shigemoto&author=N.+Mizunoauthor=O.+P.+Ottersen&author=J.+Storm-Mathisen&title=Handbook+of+Chemical+Neuroanatomy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DShigemoto%26aufirst%3DR.%26atitle%3DMetabotropic%2520Glutamate%2520Receptors%2520%25E2%2580%2593%2520Immunocytochemical%2520and%2520In%2520Situ%2520Hybridization%2520Analysis%26btitle%3DHandbook%2520of%2520Chemical%2520Neuroanatomy%26aulast%3DOttersen%26aufirst%3DO.%2BP.%26pub%3DElsevier%26date%3D2000%26spage%3D63%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cauli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambolez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinat, E.</span><span> </span><span class="NLM_article-title">Classification of Fusiform Neocortical Interneurons Based on Unsupervised Clustering</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">6144</span><span class="NLM_x">–</span> <span class="NLM_lpage">6149</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6144-6149&author=B.+Cauliauthor=J.+T.+Porterauthor=K.+Tsuzukiauthor=B.+Lambolezauthor=J.+Rossierauthor=B.+Quenetauthor=E.+Audinat&title=Classification+of+Fusiform+Neocortical+Interneurons+Based+on+Unsupervised+Clustering"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCauli%26aufirst%3DB.%26aulast%3DPorter%26aufirst%3DJ.%2BT.%26aulast%3DTsuzuki%26aufirst%3DK.%26aulast%3DLambolez%26aufirst%3DB.%26aulast%3DRossier%26aufirst%3DJ.%26aulast%3DQuenet%26aufirst%3DB.%26aulast%3DAudinat%26aufirst%3DE.%26atitle%3DClassification%2520of%2520Fusiform%2520Neocortical%2520Interneurons%2520Based%2520on%2520Unsupervised%2520Clustering%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D6144%26epage%3D6149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Perroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homburger, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousset, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagni, L.</span><span> </span><span class="NLM_article-title">Direct Interaction Enables Cross-talk between Ionotropic and Group I Metabotropic Glutamate Receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">6799</span><span class="NLM_x">–</span> <span class="NLM_lpage">6805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=6799-6805&author=J.+Perroyauthor=F.+Raynaudauthor=V.+Homburgerauthor=M.-C.+Roussetauthor=L.+Telleyauthor=J.+Bockaertauthor=L.+Fagni&title=Direct+Interaction+Enables+Cross-talk+between+Ionotropic+and+Group+I+Metabotropic+Glutamate+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerroy%26aufirst%3DJ.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DHomburger%26aufirst%3DV.%26aulast%3DRousset%26aufirst%3DM.-C.%26aulast%3DTelley%26aufirst%3DL.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DFagni%26aufirst%3DL.%26atitle%3DDirect%2520Interaction%2520Enables%2520Cross-talk%2520between%2520Ionotropic%2520and%2520Group%2520I%2520Metabotropic%2520Glutamate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D6799%26epage%3D6805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Stauffer, S. R.</span><span> </span><span class="NLM_article-title">Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5)</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn2000519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFCmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=450-470&author=S.+R.+Stauffer&title=Progress+toward+Positive+Allosteric+Modulators+of+the+Metabotropic+Glutamate+Receptor+Subtype+5+%28mGluR5%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5)</span></div><div class="casAuthors">Stauffer, Shaun R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">450-470</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Review describes recent trends in the development of small mol. mGlu5 pos. allosteric modulators (PAMs).  A large body of pharmacol., genetic, electrophysiol., and in vivo behavioral evidence has accumulated over the past decade which continues to support the hypothesis and rationale for the activation of the metabotropic glutamate receptor subtype 5 (mGlu5) as a viable and promising target for the development of novel antipsychotics.  Until recently, functionally efficacious and potent mGlu5 PAMs have been somewhat structurally limited in scope and slow to emerge.  This Review will discuss efforts since late 2008 which have provided novel mGlu5 PAM chemotypes, offering ligands with a diverse range of pharmacol., physicochem., and DMPK properties that were previously unavailable.  In addn., significant biol. studies of importance in the past few years using the well established PAMs known as DFB, CPPHA, CDPPB, and ADX-47273 will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHnCTYtdTjz7Vg90H21EOLACvtfcHk0lib9HUekI3wPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFCmsbY%253D&md5=496ce47a9c3efefdd078844493b8011e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn2000519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000519%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26atitle%3DProgress%2520toward%2520Positive%2520Allosteric%2520Modulators%2520of%2520the%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520%2528mGluR5%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D450%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemiare, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span> </span><span class="NLM_article-title">Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 from a Series of <i>N</i>-(1,3-Diphenyl-1<i>H</i>-pyrazol-5-yl)benzamides That Potentiate Receptor Function In Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5825</span><span class="NLM_x">–</span> <span class="NLM_lpage">5828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049400d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5825-5828&author=C.+W.+Lindsleyauthor=D.+D.+Wisnoskiauthor=W.+H.+Leisterauthor=J.+A.+O%E2%80%99Brienauthor=W.+Lemiareauthor=D.+L.+Williamsauthor=M.+Burnoauthor=C.+Surauthor=G.+G.+Kinneyauthor=D.+J.+Pettiboneauthor=P.+R.+Millerauthor=S.+Smithauthor=M.+E.+Dugganauthor=G.+D.+Hartmanauthor=P.+J.+Connauthor=J.+R.+Huff&title=Discovery+of+Positive+Allosteric+Modulators+for+the+Metabotropic+Glutamate+Receptor+Subtype+5+from+a+Series+of+N-%281%2C3-Diphenyl-1H-pyrazol-5-yl%29benzamides+That+Potentiate+Receptor+Function+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm049400d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049400d%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemiare%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DP.%2BR.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520Positive%2520Allosteric%2520Modulators%2520for%2520the%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520from%2520a%2520Series%2520of%2520N-%25281%252C3-Diphenyl-1H-pyrazol-5-yl%2529benzamides%2520That%2520Potentiate%2520Receptor%2520Function%2520In%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5825%26epage%3D5828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. W.,  Jr.</span><span> </span><span class="NLM_article-title">A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has In Vivo Activity and Antipsychotic-like Effects in Rat Behavioral Models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1124%2Fjpet.104.079244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=15608073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=199-206&author=G.+G.+Kinneyauthor=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=M.+Burnoauthor=D.+J.+Bickelauthor=M.+K.+Clementsauthor=D.+D.+Wisnoskiauthor=C.+W.+Lindsleyauthor=P.+R.+Tillerauthor=S.+Smithauthor=M.+A.+Jacobsonauthor=C.+Surauthor=M.+E.+Dugganauthor=D.+J.+Pettiboneauthor=D.+W.+Williams&title=A+Novel+Selective+Positive+Allosteric+Modulator+of+Metabotropic+Glutamate+Receptor+Subtype+5+Has+In+Vivo+Activity+and+Antipsychotic-like+Effects+in+Rat+Behavioral+Models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models</span></div><div class="casAuthors">Kinney, Gene G.; O'Brien, Julie A.; Lemaire, Wei; Burno, Maryann; Bickel, Denise J.; Clements, Michelle K.; Chen, Tsing-Bau; Wisnoski, David D.; Lindsley, Craig W.; Tiller, Philip R.; Smith, Sheri; Jacobson, Marlene A.; Sur, Cyrille; Duggan, Mark E.; Pettibone, Douglas J.; Conn, P. Jeffrey; Williams, David L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We found that 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) is a potent and selective pos. allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5).  In Chinese hamster ovary cells expressing human mGluR5, CDPPB potentiated threshold responses to glutamate in fluorometric Ca2+ assays more than 7-fold with an EC50 value of approx. 27 nM.  At 1 μM, CDPPB shifted mGluR5 agonist concn. response curves to glutamate, quisqualate, and (R,S)-3,5-dihydroxyphenylglycine 3- to 9-fold to the left.  At higher concns., CDPPB exhibited agonist-like activity on cells expressing mGluR5.  No other activity was obsd. on any other mGluR or cell type at concns. up to 10 μM.  CDPPB had no effect on [3H]quisqualate binding to mGluR5 but did compete for binding of [3H]methoxyPEPy, an analog of the selective mGluR5 neg. allosteric modulator MPEP.  CDPPB was found to be brain penetrant and reversed amphetamine-induced locomotor activity and amphetamine-induced deficits in prepulse inhibition in rats, two models sensitive to antipsychotic drug treatment.  These results demonstrate that pos. allosteric modulation of mGluR5 produces behavioral effects, suggesting that such modulation serves as a viable approach to increasing mGluR5 activity in vivo.  These effects are consistent with the hypothesis that allosteric potentiation of mGluR5 may provide a novel approach for development of antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5MND_DZkDL7Vg90H21EOLACvtfcHk0ljxCyngJjCG5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLg%253D&md5=371bb91ca8ac48cdf8b38c95634385da</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.079244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.079244%26sid%3Dliteratum%253Aachs%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DTiller%26aufirst%3DP.%2BR.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BW.%26atitle%3DA%2520Novel%2520Selective%2520Positive%2520Allosteric%2520Modulator%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520Has%2520In%2520Vivo%2520Activity%2520and%2520Antipsychotic-like%2520Effects%2520in%2520Rat%2520Behavioral%2520Models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popiolek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wantuch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khawaja, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouranova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruthi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulcicchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pausch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span> </span><span class="NLM_article-title">ADX47273 [<i>S</i>-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-like and Procognitive Activities</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1124%2Fjpet.108.136580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=18753411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=827-839&author=F.+Liuauthor=S.+Grauerauthor=C.+Kelleyauthor=R.+Navarraauthor=R.+Grafauthor=G.+Zhangauthor=P.+J.+Atkinsonauthor=M.+Popiolekauthor=C.+Wantuchauthor=X.+Khawajaauthor=D.+Smithauthor=M.+Olsenauthor=E.+Kouranovaauthor=M.+Laiauthor=F.+Pruthiauthor=C.+Pulcicchioauthor=M.+Dayauthor=A.+Gilbertauthor=M.+H.+Pauschauthor=N.+J.+Brandonauthor=C.+E.+Beyerauthor=T.+A.+Comeryauthor=S.+Logueauthor=S.+Rosenzweig-Lipsonauthor=K.+L.+Marquis&title=ADX47273+%5BS-%284-Fluoro-phenyl%29-%7B3-%5B3-%284-fluoro-phenyl%29-%5B1%2C2%2C4%5Doxadiazol-5-yl%5D-piperidin-1-yl%7D-methanone%5D%3A+A+Novel+Metabotropic+Glutamate+Receptor+5-Selective+Positive+Allosteric+Modulator+with+Preclinical+Antipsychotic-like+and+Procognitive+Activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities</span></div><div class="casAuthors">Liu, Feng; Grauer, Steve; Kelley, Cody; Navarra, Rachel; Graf, Radka; Zhang, Guoming; Atkinson, Peter J.; Popiolek, Michael; Wantuch, Caitlin; Khawaja, Xavier; Smith, Deborah; Olsen, Michael; Kouranova, Evguenia; Lai, Margaret; Pruthi, Farhana; Pulicicchio, Claudine; Day, Mark; Gilbert, Adam; Pausch, Mark H.; Brandon, Nicholas J.; Beyer, Chad E.; Comery, Tom A.; Logue, Sheree; Rosenzweig-Lipson, Sharon; Marquis, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">827-839</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pos. allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 (mGlu5) enhance N-methyl-D-aspartate receptor function and may represent a novel approach for the treatment of schizophrenia.  ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-methanone], a recently identified potent and selective mGlu5 PAM, increased (9-fold) the response to threshold concn. of glutamate (50 nM) in fluorometric Ca2+ assays (EC50 = 170 nM) in human embryonic kidney 293 cells expressing rat mGlu5.  In the same system, ADX47273 dose-dependently shifted mGlu5 receptor glutamate response curve to the left (9-fold at 1 μM) and competed for binding of [3H]2-methyl-6-(phenylethynyl)pyridine (Ki = 4.3 μM), but not [3H]quisqualate.  In vivo, ADX47273 increased extracellular signal-regulated kinase and cAMP-responsive element-binding protein phosphorylation in hippocampus and prefrontal cortex, both of which are crit. for glutamate-mediated signal transduction mechanisms.  In models sensitive to antipsychotic drug treatment, ADX47273 reduced rat-conditioned avoidance responding [minimal ED (MED) = 30 mg/kg i.p.] and decreased mouse apomorphine-induced climbing (MED = 100 mg/kg i.p.), with little effect on stereotype or catalepsy.  Furthermore, ADX47273 blocked phencyclidine, apomorphine, and amphetamine-induced locomotor activities (MED = 100 mg/kg i.p.) in mice and decreased extracellular levels of dopamine in the nucleus accumbens, but not in the striatum, in rats.  In cognition models, ADX47273 increased novel object recognition (MED = 1 mg/kg i.p.) and reduced impulsivity in the five-choice serial reaction time test (MED = 10 mg/kg i.p.) in rats.  Taken together, these effects are consistent with the hypothesis that allosteric potentiation of mGlu5 may provide a novel approach for development of antipsychotic and procognitive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYX198d-NhtLVg90H21EOLACvtfcHk0ljxCyngJjCG5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLjN&md5=c76b2ab8c1d71dc75f52f582999326ac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136580%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DKelley%26aufirst%3DC.%26aulast%3DNavarra%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DAtkinson%26aufirst%3DP.%2BJ.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DWantuch%26aufirst%3DC.%26aulast%3DKhawaja%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DOlsen%26aufirst%3DM.%26aulast%3DKouranova%26aufirst%3DE.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DPruthi%26aufirst%3DF.%26aulast%3DPulcicchio%26aufirst%3DC.%26aulast%3DDay%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DA.%26aulast%3DPausch%26aufirst%3DM.%2BH.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DLogue%26aufirst%3DS.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26atitle%3DADX47273%2520%255BS-%25284-Fluoro-phenyl%2529-%257B3-%255B3-%25284-fluoro-phenyl%2529-%255B1%252C2%252C4%255Doxadiazol-5-yl%255D-piperidin-1-yl%257D-methanone%255D%253A%2520A%2520Novel%2520Metabotropic%2520Glutamate%2520Receptor%25205-Selective%2520Positive%2520Allosteric%2520Modulator%2520with%2520Preclinical%2520Antipsychotic-like%2520and%2520Procognitive%2520Activities%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D827%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grier, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Days, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">1105</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1124%2Fmol.110.067207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=20923853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=1105-1123&author=A.+L.+Rodriguezauthor=M.+D.+Grierauthor=C.+K.+Jonesauthor=E.+J.+Hermanauthor=A.+S.+Kaneauthor=R.+L.+Smithauthor=R.+Williamsauthor=Y.+Zhouauthor=J.+E.+Marloauthor=E.+L.+Daysauthor=T.+N.+Blattauthor=S.+Jadhavauthor=U.+Menonauthor=P.+N.+Vinsonauthor=J.+M.+Rookauthor=S.+R.+Staufferauthor=C.+M.+Niswenderauthor=C.+W.+Lindsleyauthor=C.+D.+Weaverauthor=P.+J.+Conn&title=Discovery+of+Novel+Allosteric+Modulators+of+Metabotropic+Glutamate+Receptor+Subtype+5+Reveals+Chemical+and+Functional+Diversity+and+In+Vivo+Activity+in+Rat+Behavioral+Models+of+Anxiolytic+and+Antipsychotic+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity</span></div><div class="casAuthors">Rodriguez, Alice L.; Grier, Mark D.; Jones, Carrie K.; Herman, Elizabeth J.; Kane, Alexander S.; Smith, Randy L.; Williams, Richard; Zhou, Ya; Marlo, Joy E.; Days, Emily L.; Blatt, Tasha N.; Jadhav, Satyawan; Menon, Usha N.; Vinson, Paige N.; Rook, Jerri M.; Stauffer, Shaun R.; Niswender, Colleen M.; Lindsley, Craig W.; Weaver, C. David; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1105-1123</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Modulators of metabotropic glutamate receptor subtype 5 (mGluR5) may provide novel treatments for multiple central nervous system (CNS) disorders, including anxiety and schizophrenia.  Although compds. have been developed to better understand the physiol. roles of mGluR5 and potential usefulness for the treatment of these disorders, there are limitations in the tools available, including poor selectivity, low potency, and limited soly.  To address these issues, we developed an innovative assay that allows simultaneous screening for mGluR5 agonists, antagonists, and potentiators.  We identified multiple scaffolds that possess diverse modes of activity at mGluR5, including both pos. and neg. allosteric modulators (PAMs and NAMs, resp.).  3-Fluoro-5-(3-(pyridine-2-yl)-1,2,4-oxadiazol-5-yl)benzonitrile (VU0285683) was developed as a novel selective mGluR5 NAM with high affinity for the 2-methyl-6-(phenylethynyl)-pyridine (MPEP) binding site.  VU0285683 had anxiolytic-like activity in two rodent models for anxiety but did not potentiate phencyclidine-induced hyperlocomotor activity.  (4-Hydroxypiperidin-1-yl)(4-phenylethynyl)phenyl)methanone (VU0092273) was identified as a novel mGluR5 PAM that also binds to the MPEP site.  VU0092273 was chem. optimized to an orally active analog, N-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide hydrochloride (VU0360172), which is selective for mGluR5.  This novel mGluR5 PAM produced a dose-dependent reversal of amphetamine-induced hyperlocomotion, a rodent model predictive of antipsychotic activity.  Discovery of structurally and functionally diverse allosteric modulators of mGluR5 that demonstrate in vivo efficacy in rodent models of anxiety and antipsychotic activity provide further support for the tremendous diversity of chem. scaffolds and modes of efficacy of mGluR5 ligands.  In addn., these studies provide strong support for the hypothesis that multiple structurally distinct mGluR5 modulators have robust activity in animal models that predict efficacy in the treatment of CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDfM6YTd9zTrVg90H21EOLACvtfcHk0limKE1OfTPFqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7bM&md5=2e243a2ef257c4552e948df39db00086</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.067207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.067207%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DGrier%26aufirst%3DM.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DHerman%26aufirst%3DE.%2BJ.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DSmith%26aufirst%3DR.%2BL.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMarlo%26aufirst%3DJ.%2BE.%26aulast%3DDays%26aufirst%3DE.%2BL.%26aulast%3DBlatt%26aufirst%3DT.%2BN.%26aulast%3DJadhav%26aufirst%3DS.%26aulast%3DMenon%26aufirst%3DU.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520Novel%2520Allosteric%2520Modulators%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520Reveals%2520Chemical%2520and%2520Functional%2520Diversity%2520and%2520In%2520Vivo%2520Activity%2520in%2520Rat%2520Behavioral%2520Models%2520of%2520Anxiolytic%2520and%2520Antipsychotic%2520Activity%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D1105%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gastambide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ÓNeill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M. D.</span><span> </span><span class="NLM_article-title">Selective Remediation of Reversal Learning Deficits in the Neurodevelopmental MAM Model of Schizophrenia by a Novel mGlu<sub>5</sub> Positive Allosteric Modulator</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=1057-1066&author=F.+Gastambideauthor=M.+C.+Cotelauthor=G.+Gilmourauthor=M.+J.+%C3%93Neillauthor=T.+W.+Robbinsauthor=M.+D.+Tricklebank&title=Selective+Remediation+of+Reversal+Learning+Deficits+in+the+Neurodevelopmental+MAM+Model+of+Schizophrenia+by+a+Novel+mGlu5+Positive+Allosteric+Modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGastambide%26aufirst%3DF.%26aulast%3DCotel%26aufirst%3DM.%2BC.%26aulast%3DGilmour%26aufirst%3DG.%26aulast%3D%25C3%2593Neill%26aufirst%3DM.%2BJ.%26aulast%3DRobbins%26aufirst%3DT.%2BW.%26aulast%3DTricklebank%26aufirst%3DM.%2BD.%26atitle%3DSelective%2520Remediation%2520of%2520Reversal%2520Learning%2520Deficits%2520in%2520the%2520Neurodevelopmental%2520MAM%2520Model%2520of%2520Schizophrenia%2520by%2520a%2520Novel%2520mGlu5%2520Positive%2520Allosteric%2520Modulator%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D1057%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gastambide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M. D.</span><span> </span><span class="NLM_article-title">The mGlu<sub>5</sub> Positive Allosteric Modulator LSN2463359 Differentially Modulates Motor, Instrumental and Cognitive Effects of NMDA Receptor Antagonists in the Rat</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=240-247&author=F.+Gastambideauthor=G.+Gilmourauthor=T.+W.+Robbinsauthor=M.+D.+Tricklebank&title=The+mGlu5+Positive+Allosteric+Modulator+LSN2463359+Differentially+Modulates+Motor%2C+Instrumental+and+Cognitive+Effects+of+NMDA+Receptor+Antagonists+in+the+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGastambide%26aufirst%3DF.%26aulast%3DGilmour%26aufirst%3DG.%26aulast%3DRobbins%26aufirst%3DT.%2BW.%26aulast%3DTricklebank%26aufirst%3DM.%2BD.%26atitle%3DThe%2520mGlu5%2520Positive%2520Allosteric%2520Modulator%2520LSN2463359%2520Differentially%2520Modulates%2520Motor%252C%2520Instrumental%2520and%2520Cognitive%2520Effects%2520of%2520NMDA%2520Receptor%2520Antagonists%2520in%2520the%2520Rat%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D240%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Gilmour, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broad, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wafford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fivush, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gastambide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanks, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taboada, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgard, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M. D.</span><span> </span><span class="NLM_article-title">In Vitro Characterisation of the Novel Positive Allosteric Modulators of the mGlu<sub>5</sub> Receptor, LSN2463359 and LSN2814617, and Their Effects on Sleep architecture and Operant Responding in the Rat</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=224-239&author=G.+Gilmourauthor=L.+M.+Broadauthor=K.+A.+Waffordauthor=T.+Brittonauthor=E.+M.+Colvinauthor=A.+Fivushauthor=F.+Gastambideauthor=B.+Getmanauthor=B.+A.+Heinzauthor=A.+P.+McCarthyauthor=L.+Prietoauthor=E.+Shanksauthor=J.+W.+Smithauthor=L.+Taboadaauthor=D.+M.+Edgardauthor=M.+D.+Tricklebank&title=In+Vitro+Characterisation+of+the+Novel+Positive+Allosteric+Modulators+of+the+mGlu5+Receptor%2C+LSN2463359+and+LSN2814617%2C+and+Their+Effects+on+Sleep+architecture+and+Operant+Responding+in+the+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilmour%26aufirst%3DG.%26aulast%3DBroad%26aufirst%3DL.%2BM.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DBritton%26aufirst%3DT.%26aulast%3DColvin%26aufirst%3DE.%2BM.%26aulast%3DFivush%26aufirst%3DA.%26aulast%3DGastambide%26aufirst%3DF.%26aulast%3DGetman%26aufirst%3DB.%26aulast%3DHeinz%26aufirst%3DB.%2BA.%26aulast%3DMcCarthy%26aufirst%3DA.%2BP.%26aulast%3DPrieto%26aufirst%3DL.%26aulast%3DShanks%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DJ.%2BW.%26aulast%3DTaboada%26aufirst%3DL.%26aulast%3DEdgard%26aufirst%3DD.%2BM.%26aulast%3DTricklebank%26aufirst%3DM.%2BD.%26atitle%3DIn%2520Vitro%2520Characterisation%2520of%2520the%2520Novel%2520Positive%2520Allosteric%2520Modulators%2520of%2520the%2520mGlu5%2520Receptor%252C%2520LSN2463359%2520and%2520LSN2814617%252C%2520and%2520Their%2520Effects%2520on%2520Sleep%2520architecture%2520and%2520Operant%2520Responding%2520in%2520the%2520Rat%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D224%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hammond, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsdley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Chemical Class of mGlu<sub>5</sub> Allosteric Ligands with Distinct Modes of Pharmacology</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100051m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCns7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=702-716&author=A.+S.+Hammondauthor=A.+L.+Rodriguezauthor=S.+D.+Townsendauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=C.+W.+Linsdleyauthor=P.+J.+Conn&title=Discovery+of+a+Novel+Chemical+Class+of+mGlu5+Allosteric+Ligands+with+Distinct+Modes+of+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Chemical Class of mGlu5 Allosteric Ligands with Distinct Modes of Pharmacology</span></div><div class="casAuthors">Hammond, Alexis S.; Rodriguez, Alice L.; Townsend, Steven D.; Niswender, Colleen M.; Gregory, Karen J.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">702-716</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously discovered a pos. allosteric modulator (PAM) of the metabotropic glutamate receptor subtype 5 (mGlu5) termed 4 N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) that elicits receptor activation through a novel allosteric site on mGlu5, distinct from the classical mGlu5 neg. allosteric modulator (NAM) MPEP allosteric site.  However, a shallow structure-activity relationship (SAR), poor physiochem. properties, and weak PAM activity at rat mGlu5 limited the utility of CPPHA to explore allosteric activation of mGlu5 at a non-MPEP site.  Thus, we performed a functional high-throughput screen (HTS) and identified a novel mGlu5 PAM benzamide scaffold, exemplified by VU0001850 (EC50 = 1.3 μM, 106% Glumax) and VU0040237 (EC50 = 350 nM, 84% Glu Max).  An iterative parallel synthesis approach delivered 22 analogs, optimized mGlu5 PAM activity to afford VU0357121 (EC50 = 33 nM, 92% Glumax), and also revealed the first non-MPEP site neutral allosteric ligand (VU0365396).  Like CPPHA, PAMs within this class do not appear to bind at the MPEP allosteric site based on radioligand binding studies.  Moreover, mutagenesis studies indicate that VU0357121 and related analogs bind to a yet uncharacterized allosteric site on mGlu5, distinct from CPPHA, yet share a functional interaction with the MPEP site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD8WTnrb1QNrVg90H21EOLACvtfcHk0lh8SpqTatI0bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCns7bL&md5=29902bd947cafaee04307ccaf24856fe</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn100051m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100051m%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DTownsend%26aufirst%3DS.%2BD.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLinsdley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Chemical%2520Class%2520of%2520mGlu5%2520Allosteric%2520Ligands%2520with%2520Distinct%2520Modes%2520of%2520Pharmacology%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D702%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-Aryl Piperazines as Selective mGluR5 Potentiators with Improved In Vivo Utility</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100181a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=433-438&author=Y.+Zhouauthor=J.+Mankaauthor=A.+L.+Rodriguezauthor=C.+D.+Weaverauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=S.+R.+Stauffer&title=Discovery+of+N-Aryl+Piperazines+as+Selective+mGluR5+Potentiators+with+Improved+In+Vivo+Utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fml100181a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100181a%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DManka%26aufirst%3DJ.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26atitle%3DDiscovery%2520of%2520N-Aryl%2520Piperazines%2520as%2520Selective%2520mGluR5%2520Potentiators%2520with%2520Improved%2520In%2520Vivo%2520Utility%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D433%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadient, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeller, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhajlani, V.</span><span> </span><span class="NLM_article-title">Preclinical Profile of a Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">659</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1016%2Fj.ejphar.2011.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=21335002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=659&publication_year=2011&pages=146-154&author=N.+Spearauthor=R.+A.+Gadientauthor=D.+E.+Wilkinsauthor=M.+L.+Doauthor=J.+S.+Smithauthor=K.+L.+Zellerauthor=P.+Schroederauthor=M.+Zhangauthor=J.+Aroraauthor=V.+Chhajlani&title=Preclinical+Profile+of+a+Novel+Metabotropic+Glutamate+Receptor+5+Positive+Allosteric+Modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator</span></div><div class="casAuthors">Spear, Nathan; Gadient, Reto A.; Wilkins, Deidre E.; Do, My Linh; Smith, Jeffrey S.; Zeller, Kim L.; Schroeder, Patricia; Zhang, Minli; Arora, Jalaj; Chhajlani, Vijay</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">659</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">146-154</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent reports have indicated that patients with schizophrenia have a profound hypo-functionality of glutamatergic signaling pathways.  Pos. allosteric modulation of mGlu5 receptor has been postulated to augment NMDA function and thereby alleviate the glutamatergic hypo-function obsd. in schizophrenic patients.  Here we report the in vitro and in vivo characterization of CPPZ (1-(4-(2-chloro-4-fluorophenyl)piperazin-1-yl)-2-(pyridin-4-ylmethoxy)ethanone), a structurally novel pos. allosteric modulator selective for mGlu5 receptor.  In HEK293 cells stably over-expressing human mGlu5 receptor, CPPZ potentiates the intracellular calcium response elicited by a suboptimal concn. of the endogenous agonist glutamate.  CPPZ does not have any intrinsic agonist activity and behaves functionally as a pos. allosteric modulator.  This is further supported by binding data, which demonstrate that CPPZ is able to displace the neg. allosteric modulator MPEP but does not compete with the orthosteric ligand quisqualic acid.  Instead, CPPZ enhances the binding of the orthosteric ligand.  In native prepns., CPPZ potentiates calcium flux in rat cortical neurons stimulated with the group I agonist dihydroxyphenylglycine (DHPG).  In addn., CPPZ modulates long-term potentiation in rat hippocampal slices, a process known to be NMDA dependent.  In vivo, CPPZ reverses hyper locomotion triggered by the NMDA open channel blocker MK801 in CD1 mice.  CPPZ was also able to reduce rat conditioned avoidance responding to elec. shock.  Both in vitro and in vivo data demonstrate that this novel compd. acts as an mGlu5 receptor pos. allosteric modulator, which modulates NMDA dependent responses and suggests that the enhancement of mGlu5 receptor activity may prove useful in the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphXRIE2GAZWbVg90H21EOLACvtfcHk0lh8SpqTatI0bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFGntL8%253D&md5=19caa87a3fb91d4d714a29398a00e8db</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DGadient%26aufirst%3DR.%2BA.%26aulast%3DWilkins%26aufirst%3DD.%2BE.%26aulast%3DDo%26aufirst%3DM.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BS.%26aulast%3DZeller%26aufirst%3DK.%2BL.%26aulast%3DSchroeder%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DArora%26aufirst%3DJ.%26aulast%3DChhajlani%26aufirst%3DV.%26atitle%3DPreclinical%2520Profile%2520of%2520a%2520Novel%2520Metabotropic%2520Glutamate%2520Receptor%25205%2520Positive%2520Allosteric%2520Modulator%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D659%26spage%3D146%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><div class="note"><p class="first last">Chromanone derivatives <b>9</b>, <b>10</b>, <b>11</b> and <b>12</b> have recently also been described as mGlu<sub>5</sub> receptor PAMs by Varnes <i>et al</i>. confirming our findings.</p></div><span class="NLM_contrib-group">Varnes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoesch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sygowski, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadient, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span> </span><span class="NLM_article-title">Discovery of Novel Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 5 (mGlu<sub>5</sub>)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1402</span><span class="NLM_x">–</span> <span class="NLM_lpage">1406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1402-1406&author=J.+G.+Varnesauthor=A.+P.+Marcusauthor=R.+C.+Maugerauthor=S.+R.+Thronerauthor=V.+Hoeschauthor=M.+M.+Kingauthor=X.+Wangauthor=L.+A.+Sygowskiauthor=N.+Spearauthor=R.+Gadientauthor=D.+G.+Brownauthor=J.+B.+Campbell&title=Discovery+of+Novel+Positive+Allosteric+Modulators+of+the+Metabotropic+Glutamate+Receptor+5+%28mGlu5%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarnes%26aufirst%3DJ.%2BG.%26aulast%3DMarcus%26aufirst%3DA.%2BP.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DThroner%26aufirst%3DS.%2BR.%26aulast%3DHoesch%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSygowski%26aufirst%3DL.%2BA.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DGadient%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520Novel%2520Positive%2520Allosteric%2520Modulators%2520of%2520the%2520Metabotropic%2520Glutamate%2520Receptor%25205%2520%2528mGlu5%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1402%26epage%3D1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">Compounds were tested for agonist, PAM, or antagonist activity on mGlu receptors in fluorescent Ca<sup>2+</sup> assays using HEK293 cells expressing human mGlu<sub>1</sub>, mGlu<sub>2</sub>, mGlu<sub>3</sub>, mGlu<sub>7</sub>, or mGlu<sub>8</sub> receptors. Effects on the human mGlu<sub>4</sub> receptor were tested in Ca<sup>2+</sup> or [<sup>35</sup>S]-GTPγS functional assays (receptor either expressed in HEK293 or L929sA cells). Evaluation of effects on the rat mGlu<sub>6</sub> receptors expressed in CHO cells were assessed in [<sup>35</sup>S]-GTPγS functional assays.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand Efficiency: a Useful Metric for Lead Selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+a+Useful+Metric+for+Lead+Selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eYoQrNwTMBCh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520a%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">Data not shown.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Manka, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Days, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span> </span><span class="NLM_article-title">Optimization of an Ether Series of mGlu<sub>5</sub> Positive Allosteric Modulators: Molecular Determinants of MPEP-site Interaction Crossover</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6481</span><span class="NLM_x">–</span> <span class="NLM_lpage">6485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6481-6485&author=J.+T.+Mankaauthor=P.+N.+Vinsonauthor=K.+J.+Gregoryauthor=Y.+Zhouauthor=R.+Williamsauthor=K.+Gogiauthor=E.+Daysauthor=S.+Jadhavauthor=E.+J.+Hermanauthor=H.+Lavreysenauthor=C.+Mackieauthor=J.+M.+Bartolom%C3%A9author=G.+J.+Macdonaldauthor=T.+Stecklerauthor=J.+S.+Danielsauthor=C.+D.+Weaverauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=S.+R.+Stauffer&title=Optimization+of+an+Ether+Series+of+mGlu5+Positive+Allosteric+Modulators%3A+Molecular+Determinants+of+MPEP-site+Interaction+Crossover"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DGogi%26aufirst%3DK.%26aulast%3DDays%26aufirst%3DE.%26aulast%3DJadhav%26aufirst%3DS.%26aulast%3DHerman%26aufirst%3DE.%2BJ.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DSteckler%26aufirst%3DT.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26atitle%3DOptimization%2520of%2520an%2520Ether%2520Series%2520of%2520mGlu5%2520Positive%2520Allosteric%2520Modulators%253A%2520Molecular%2520Determinants%2520of%2520MPEP-site%2520Interaction%2520Crossover%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6481%26epage%3D6485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Macdonald, G. J.; Tresadern, G. J.; Trabanco-Suarez, A. A.; Pastor-Fernandez, J.</span> Preparation of Bicyclic Thiazoles as Allosteric Modulators of mGluR5 Receptors. WO 2011073347 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macdonald%2C+G.+J.%3B+Tresadern%2C+G.+J.%3B+Trabanco-Suarez%2C+A.+A.%3B+Pastor-Fernandez%2C+J.+Preparation+of+Bicyclic+Thiazoles+as+Allosteric+Modulators+of+mGluR5+Receptors.+WO+2011073347+A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Macdonald, G. J.; Trabanco-Suarez, A. A.; Conde-Ceide, S.; Tresadern, G. J.; Bartolome-Nebreda, J. M.; Pastor-Fernandez, J.</span> Preparation of Bicyclic Thiazoles as Allosteric Modulators of mGluR5 Receptors. WO 2011073339 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macdonald%2C+G.+J.%3B+Trabanco-Suarez%2C+A.+A.%3B+Conde-Ceide%2C+S.%3B+Tresadern%2C+G.+J.%3B+Bartolome-Nebreda%2C+J.+M.%3B+Pastor-Fernandez%2C+J.+Preparation+of+Bicyclic+Thiazoles+as+Allosteric+Modulators+of+mGluR5+Receptors.+WO+2011073339+A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Brandl, T.; Maier, U.; Hoffmann, M.; Scheuerer, S.; Joergensen, A. T.; Pautsch, A.; Breitfelder, S.; Grauert, M.; Hoenke, C.; Erb, K.; Pieper, M.; Pragst, I.</span><span> </span><span class="NLM_article-title">Preparation of Dihydrothiazoloquinazolines as PI-3 Kinase Inhibitors</span>. WO 2007115929 A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Brandl&author=U.+Maier&author=M.+Hoffmann&author=S.+Scheuerer&author=A.+T.+Joergensen&author=A.+Pautsch&author=S.+Breitfelder&author=M.+Grauert&author=C.+Hoenke&author=K.+Erb&author=M.+Pieper&author=I.+Pragst&title=Preparation+of+Dihydrothiazoloquinazolines+as+PI-3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandl%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Dihydrothiazoloquinazolines%2520as%2520PI-3%2520Kinase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Days, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=120-133&author=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=H.+P.+Choauthor=E.+Daysauthor=Y.+Zhouauthor=A.+L.+Rodriguezauthor=H.+Lavreysenauthor=S.+R.+Staufferauthor=C.+M.+Niswenderauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+W.+Lindsleyauthor=C.+D.+Weaverauthor=P.+J.+Conn&title=Functional+Impact+of+Allosteric+Agonist+Activity+of+Selective+Positive+Allosteric+Modulators+of+Metabotropic+Glutamate+Receptor+Subtype+5+in+Regulating+Central+Nervous+System+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DDays%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DFunctional%2520Impact%2520of%2520Allosteric%2520Agonist%2520Activity%2520of%2520Selective%2520Positive%2520Allosteric%2520Modulators%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520in%2520Regulating%2520Central%2520Nervous%2520System%2520Function%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D120%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">LeadProfilingScreen. Ricerca Biosciences. Screen performed on the following targets: A<sub>1</sub>, A<sub>2A</sub>, A<sub>3</sub>, α<sub>1A</sub>, α<sub>1B</sub>, α<sub>1D</sub>, α<sub>2A</sub>, β<sub>1</sub>, β<sub>2</sub>, AR, B<sub>1</sub>, B<sub>2</sub>, CaCH L-Type (benzothiazepine), CaCH L-Type (dihydropyridine), CaCH N-Type, CB<sub>1</sub>, D<sub>1</sub>, D<sub>2S</sub>, D<sub>3</sub>, D<sub>4.2</sub>, ET<sub>A</sub>, ET<sub>B</sub>, EGF, ER<sub>α</sub>, GABA<sub>A</sub> (flunitrazepam), GABA<sub>A</sub> (muscinol), GABA<sub>B1A</sub>, GR, kainate, NMDA (agonism), NMDA (glycine), NMDA (phencyclidine), H<sub>1</sub>, H<sub>2</sub>, H<sub>3</sub>, IL-1, CysLT<sub>1</sub>, MT<sub>1</sub>, M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, NPY<sub>1</sub>, NPY<sub>2</sub>, acetylcholine, acetylcholine α1 (bungarotoxin), OP<sub>1</sub>, OP<sub>2</sub>, OP<sub>3</sub>, phorbol ester, PAF, KCH<sub>ATP</sub>, hERG, EP<sub>4</sub>, P<sub>2X</sub>, P<sub>2Y</sub>, rolipram, 5HT<sub>1A</sub>, 5HT<sub>2B</sub>, 5HT<sub>3</sub>, σ<sub>1</sub>, NK<sub>1</sub>, thyroid hormone, DAT, GABA transporter, NET, SERT.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Investigating Metabotropic Glutamate Receptor 5 Allosteric Modulator Cooperativity, Affinity and Agonism: Enriching Structure-function Relationships</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=860-875&author=K.+J.+Gregoryauthor=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=S.+R.+Staufferauthor=A.+L.+Rodriguezauthor=K.+A.+Emmitteauthor=Y.+Zhouauthor=A.+C.+Chunauthor=A.+S.+Feltsauthor=B.+A.+Chauderauthor=C.+W.+Lindsleyauthor=C.+M.+Niswenderauthor=P.+J.+Conn&title=Investigating+Metabotropic+Glutamate+Receptor+5+Allosteric+Modulator+Cooperativity%2C+Affinity+and+Agonism%3A+Enriching+Structure-function+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DA.%2BC.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DInvestigating%2520Metabotropic%2520Glutamate%2520Receptor%25205%2520Allosteric%2520Modulator%2520Cooperativity%252C%2520Affinity%2520and%2520Agonism%253A%2520Enriching%2520Structure-function%2520Relationships%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D860%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">Based upon rat brain homogenate binding fraction unbound (18%) and total brain levels ([brain]<sub>90min</sub> = 17.5 ± 13.4 μM). Estimated average terminal unbound brain concentrations of <b>16a</b> after the 3, 10, 30, and 56.6 p.o. doses were 14 ± 11, 15 ± 13, 551 ± 449, and 908 ± 1029 nM respectively.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Carter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunnett, S. B.</span><span> </span><span class="NLM_article-title">Motor Coordination and Balance in Rodents</span> <span class="citation_source-journal">Curr. Protocols Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">8.12.1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8.12.14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=8.12.1-8.12.14&author=R.+J.+Carterauthor=J.+Mortonauthor=S.+B.+Dunnett&title=Motor+Coordination+and+Balance+in+Rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DR.%2BJ.%26aulast%3DMorton%26aufirst%3DJ.%26aulast%3DDunnett%26aufirst%3DS.%2BB.%26atitle%3DMotor%2520Coordination%2520and%2520Balance%2520in%2520Rodents%26jtitle%3DCurr.%2520Protocols%2520Neurosci.%26date%3D2001%26spage%3D8.12.1%26epage%3D8.12.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">Measures included scoring for ptosis, exophthalmos, miosis, mydriasis, corneal reflex, pinna reflex, piloerection, respiratory rate, writhing, tail erection, lacrimation, salivation, vasodilation, skin color, irritability, rectal temperature, motor activity, ataxia, arch/roll, tremors, leg weakness, rigid stance, spraddle, placing loss, grasping loss, righting loss, catalepsy, tail pinch reaction, escape loss and physical appearance.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':[],'ref21':['cit21'],'ref22':[],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':[],'ref29':['cit29'],'ref30':[],'ref31':['cit31'],'ref32':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Karen J. Gregory, Thomas M. Bridges, Rocco G. Gogliotti, Shaun R. Stauffer, Meredith J. Noetzel, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, <span class="NLM_string-name hlFld-ContribAuthor">Colleen M. Niswender</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro to in Vivo Translation of Allosteric Modulator Concentration-Effect Relationships: Implications for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2019,</strong> <em>2 </em>
                                    (6)
                                     , 442-452. <a href="https://doi.org/10.1021/acsptsci.9b00062" title="DOI URL">https://doi.org/10.1021/acsptsci.9b00062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.9b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.9b00062%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DIn%252BVitro%252Bto%252Bin%252BVivo%252BTranslation%252Bof%252BAllosteric%252BModulator%252BConcentration-Effect%252BRelationships%25253A%252BImplications%252Bfor%252BDrug%252BDiscovery%26aulast%3DGregory%26aufirst%3DKaren%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07082019%26date%3D27112019%26date%3D15112019%26volume%3D2%26issue%3D6%26spage%3D442%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Claudia Llinas del Torrent, Nil Casajuana-Martin, Leonardo Pardo, Gary Tresadern, <span class="NLM_string-name hlFld-ContribAuthor">Laura Pérez-Benito</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms Underlying Allosteric Molecular Switches of Metabotropic Glutamate Receptor 5. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (5)
                                     , 2456-2466. <a href="https://doi.org/10.1021/acs.jcim.8b00924" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00924%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DMechanisms%252BUnderlying%252BAllosteric%252BMolecular%252BSwitches%252Bof%252BMetabotropic%252BGlutamate%252BReceptor%252B5%26aulast%3DLlinas%2Bdel%2BTorrent%26aufirst%3DClaudia%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D12122018%26date%3D12032019%26date%3D27022019%26volume%3D59%26issue%3D5%26spage%3D2456%26epage%3D2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Andres A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">John P.  Overington</span>, <span class="hlFld-ContribAuthor ">Herman W. T.  van Vlijmen</span>, and <span class="hlFld-ContribAuthor ">Gerard J. P.  van Westen</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (12)
                                     , 2976-2985. <a href="https://doi.org/10.1021/acs.jcim.7b00338" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00338%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIdentification%252Bof%252BAllosteric%252BModulators%252Bof%252BMetabotropic%252BGlutamate%252B7%252BReceptor%252BUsing%252BProteochemometric%252BModeling%26aulast%3DTresadern%26aufirst%3DGary%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06062017%26date%3D12122017%26date%3D26122017%26date%3D26112017%26volume%3D57%26issue%3D12%26spage%3D2976%26epage%3D2985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susana  Conde-Ceide</span>, <span class="hlFld-ContribAuthor ">Carlos M.  Martínez-Viturro</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>, <span class="hlFld-ContribAuthor ">Pedro M.  Garcia-Barrantes</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">Paige N.  Vinson</span>, <span class="hlFld-ContribAuthor ">Jerri M.  Rook</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">Anton  Megens</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Wilhelmus H.  Drinkenburg</span>, <span class="hlFld-ContribAuthor ">Abdellah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Thomas  Steckler</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Shaun R.  Stauffer</span>, <span class="hlFld-ContribAuthor ">José Manuel  Bartolomé-Nebreda</span>, and <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (6)
                                     , 716-720. <a href="https://doi.org/10.1021/acsmedchemlett.5b00181" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00181%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BVU0409551%25252FJNJ-46778212%25253A%252BAn%252BmGlu5%252BPositive%252BAllosteric%252BModulator%252BClinical%252BCandidate%252BTargeting%252BSchizophrenia%26aulast%3DConde-Ceide%26aufirst%3DSusana%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D04052015%26date%3D20052015%26date%3D22052015%26date%3D11062015%26date%3D20052015%26volume%3D6%26issue%3D6%26spage%3D716%26epage%3D720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Turlington</span>, <span class="hlFld-ContribAuthor ">Chrysa  Malosh</span>, <span class="hlFld-ContribAuthor ">Jon  Jacobs</span>, <span class="hlFld-ContribAuthor ">Jason T.  Manka</span>, <span class="hlFld-ContribAuthor ">Meredith J.  Noetzel</span>, <span class="hlFld-ContribAuthor ">Paige N.  Vinson</span>, <span class="hlFld-ContribAuthor ">Satyawan  Jadhav</span>, <span class="hlFld-ContribAuthor ">Elizabeth J.  Herman</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">José M.  Bartolomé-Nebreda</span>, <span class="hlFld-ContribAuthor ">Susana  Conde-Ceide</span>, <span class="hlFld-ContribAuthor ">M. Luz  Martín-Martín</span>, <span class="hlFld-ContribAuthor ">Han Min  Tong</span>, <span class="hlFld-ContribAuthor ">Silvia  López</span>, <span class="hlFld-ContribAuthor ">Gregor J.  MacDonald</span>, <span class="hlFld-ContribAuthor ">Thomas  Steckler</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">C. David  Weaver</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, and <span class="hlFld-ContribAuthor ">Shaun R.  Stauffer</span>  . </span><span class="cited-content_cbyCitation_article-title">Tetrahydronaphthyridine and Dihydronaphthyridinone Ethers As Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 5 (mGlu5). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (13)
                                     , 5620-5637. <a href="https://doi.org/10.1021/jm500259z" title="DOI URL">https://doi.org/10.1021/jm500259z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500259z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500259z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTetrahydronaphthyridine%252Band%252BDihydronaphthyridinone%252BEthers%252BAs%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BMetabotropic%252BGlutamate%252BReceptor%252B5%252B%252528mGlu5%252529%26aulast%3DTurlington%26aufirst%3DMark%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18022014%26date%3D25062014%26date%3D10072014%26date%3D10062014%26volume%3D57%26issue%3D13%26spage%3D5620%26epage%3D5637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Turlington</span>, <span class="hlFld-ContribAuthor ">Meredith J.  Noetzel</span>, <span class="hlFld-ContribAuthor ">Aspen  Chun</span>, <span class="hlFld-ContribAuthor ">Ya  Zhou</span>, <span class="hlFld-ContribAuthor ">Rocco D.  Gogliotti</span>, <span class="hlFld-ContribAuthor ">Elizabeth D.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">Paige N.  Vinson</span>, <span class="hlFld-ContribAuthor ">Jerri M.  Rook</span>, <span class="hlFld-ContribAuthor ">Kiran K.  Gogi</span>, <span class="hlFld-ContribAuthor ">Zixiu  Xiang</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">Carrie  Jones</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Jens  Meiler</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, and <span class="hlFld-ContribAuthor ">Shaun R.  Stauffer</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploration of Allosteric Agonism Structure–Activity Relationships within an Acetylene Series of Metabotropic Glutamate Receptor 5 (mGlu5) Positive Allosteric Modulators (PAMs): Discovery of 5-((3-Fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7976-7996. <a href="https://doi.org/10.1021/jm401028t" title="DOI URL">https://doi.org/10.1021/jm401028t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401028t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401028t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252BAllosteric%252BAgonism%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bwithin%252Ban%252BAcetylene%252BSeries%252Bof%252BMetabotropic%252BGlutamate%252BReceptor%252B5%252B%252528mGlu5%252529%252BPositive%252BAllosteric%252BModulators%252B%252528PAMs%252529%25253A%252BDiscovery%252Bof%252B5-%252528%2525283-Fluorophenyl%252529ethynyl%252529-N-%2525283-methyloxetan-3-yl%252529picolinamide%252B%252528ML254%252529%26aulast%3DTurlington%26aufirst%3DMark%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08072013%26date%3D09102013%26date%3D24102013%26date%3D19092013%26volume%3D56%26issue%3D20%26spage%3D7976%26epage%3D7996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunhao  Yuan</span>, <span class="hlFld-ContribAuthor ">Huimin  Yang</span>, <span class="hlFld-ContribAuthor ">Qi  Gong</span>, <span class="hlFld-ContribAuthor ">Shan  Luo</span>, <span class="hlFld-ContribAuthor ">Jing  Gu</span>, <span class="hlFld-ContribAuthor ">Yanqing  Ge</span>, <span class="hlFld-ContribAuthor ">Hongchao  Guo</span>, <span class="hlFld-ContribAuthor ">Lei  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Brønsted Base‐Catalyzed Tandem [2+4] Annulation/Tautomerization/Aromatization Reaction of α‐Alkylidene Succinimides with 5‐Alkenyl Thiazolones. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (13)
                                     , 3336-3347. <a href="https://doi.org/10.1002/adsc.202100425" title="DOI URL">https://doi.org/10.1002/adsc.202100425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100425%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DBr%2525C3%2525B8nsted%252BBase%2525E2%252580%252590Catalyzed%252BTandem%252B%25255B2%25252B4%25255D%252BAnnulation%25252FTautomerization%25252FAromatization%252BReaction%252Bof%252B%2525CE%2525B1%2525E2%252580%252590Alkylidene%252BSuccinimides%252Bwith%252B5%2525E2%252580%252590Alkenyl%252BThiazolones%26aulast%3DYuan%26aufirst%3DChunhao%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D13%26spage%3D3336%26epage%3D3347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rabdan M.  Tikhov</span>, <span class="hlFld-ContribAuthor ">Nikolai Yu.  Kuznetsov</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of piperidine-2,4-dione-type azaheterocycles and their application in modern drug development and natural product synthesis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (15)
                                     , 2793-2812. <a href="https://doi.org/10.1039/D0OB00287A" title="DOI URL">https://doi.org/10.1039/D0OB00287A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00287A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00287A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DConstruction%252Bof%252Bpiperidine-2%25252C4-dione-type%252Bazaheterocycles%252Band%252Btheir%252Bapplication%252Bin%252Bmodern%252Bdrug%252Bdevelopment%252Band%252Bnatural%252Bproduct%252Bsynthesis%26aulast%3DTikhov%26aufirst%3DRabdan%2BM.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D15%26spage%3D2793%26epage%3D2812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiong  Wu</span>, <span class="hlFld-ContribAuthor ">Ruiying  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Shi</span>, <span class="hlFld-ContribAuthor ">Wenchao  Li</span>, <span class="hlFld-ContribAuthor ">Meng  Li</span>, <span class="hlFld-ContribAuthor ">Peng  Chen</span>, <span class="hlFld-ContribAuthor ">Bowen  Pan</span>, <span class="hlFld-ContribAuthor ">Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Caifeng  Li</span>, <span class="hlFld-ContribAuthor ">Jianbing  Wang</span>, <span class="hlFld-ContribAuthor ">Guibo  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Sun</span>, <span class="hlFld-ContribAuthor ">Hongzheng  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111729. <a href="https://doi.org/10.1016/j.ejmech.2019.111729" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111729%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpanaxatriol%252Bderivatives%252Bagainst%252Bmyocardial%252Bischemia%25252Freperfusion%252Binjury%252Bin%252Bthe%252Brat%26aulast%3DWu%26aufirst%3DQiong%26date%3D2020%26volume%3D185%26spage%3D111729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoltán  Orgován</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (19)
                                     , 1768-1781. <a href="https://doi.org/10.2174/1568026619666190808150039" title="DOI URL">https://doi.org/10.2174/1568026619666190808150039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190808150039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190808150039%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BApproaches%252Bfor%252BAllosteric%252BMetabotropic%252BGlutamate%252BReceptor%252B%252528mGluR%252529%252BModulators%26aulast%3DOrgov%25C3%25A1n%26aufirst%3DZolt%25C3%25A1n%26date%3D2019%26volume%3D19%26issue%3D19%26spage%3D1768%26epage%3D1781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam C.  Mar</span>, <span class="hlFld-ContribAuthor ">Simon R. O.  Nilsson</span>, <span class="hlFld-ContribAuthor ">Begoña  Gamallo-Lana</span>, <span class="hlFld-ContribAuthor ">Ming  Lei</span>, <span class="hlFld-ContribAuthor ">Theda  Dourado</span>, <span class="hlFld-ContribAuthor ">Johan  Alsiö</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Saksida</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Bussey</span>, <span class="hlFld-ContribAuthor ">Trevor W.  Robbins</span>. </span><span class="cited-content_cbyCitation_article-title">MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2017,</strong> <em>234 </em>
                                    (19)
                                     , 2837-2857. <a href="https://doi.org/10.1007/s00213-017-4679-5" title="DOI URL">https://doi.org/10.1007/s00213-017-4679-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-017-4679-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-017-4679-5%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DMAM-E17%252Brat%252Bmodel%252Bimpairments%252Bon%252Ba%252Bnovel%252Bcontinuous%252Bperformance%252Btask%25253A%252Beffects%252Bof%252Bpotential%252Bcognitive%252Benhancing%252Bdrugs%26aulast%3DMar%26aufirst%3DAdam%2BC.%26date%3D2017%26date%3D2017%26volume%3D234%26issue%3D19%26spage%3D2837%26epage%3D2857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Frederik J.R.  Rombouts</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, <span class="hlFld-ContribAuthor ">Andres A.  Trabanco</span>. </span><span class="cited-content_cbyCitation_article-title">Industrial medicinal chemistry insights: neuroscience hit generation at Janssen. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2017,</strong> <em>22 </em>
                                    (10)
                                     , 1478-1488. <a href="https://doi.org/10.1016/j.drudis.2017.05.013" title="DOI URL">https://doi.org/10.1016/j.drudis.2017.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2017.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2017.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DIndustrial%252Bmedicinal%252Bchemistry%252Binsights%25253A%252Bneuroscience%252Bhit%252Bgeneration%252Bat%252BJanssen%26aulast%3DTresadern%26aufirst%3DGary%26date%3D2017%26volume%3D22%26issue%3D10%26spage%3D1478%26epage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susana  Conde-Ceide</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>, <span class="hlFld-ContribAuthor ">Sergio A.  Alonso de Diego</span>, <span class="hlFld-ContribAuthor ">Silvia  López</span>, <span class="hlFld-ContribAuthor ">María Luz  Martín-Martín</span>, <span class="hlFld-ContribAuthor ">Carlos M.  Martínez-Viturro</span>, <span class="hlFld-ContribAuthor ">Miguel-Angel  Pena</span>, <span class="hlFld-ContribAuthor ">Han Min  Tong</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Thomas  Steckler</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Shaun R.  Stauffer</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">José Manuel  Bartolomé-Nebreda</span>. </span><span class="cited-content_cbyCitation_article-title">Preliminary investigation of 6,7-dihydropyrazolo[1,5- a ]pyrazin-4-one derivatives as a novel series of mGlu 5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 429-434. <a href="https://doi.org/10.1016/j.bmcl.2015.11.098" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.098%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPreliminary%252Binvestigation%252Bof%252B6%25252C7-dihydropyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrazin-4-one%252Bderivatives%252Bas%252Ba%252Bnovel%252Bseries%252Bof%252BmGlu%252B5%252Breceptor%252Bpositive%252Ballosteric%252Bmodulators%252Bwith%252Befficacy%252Bin%252Bpreclinical%252Bmodels%252Bof%252Bschizophrenia%26aulast%3DConde-Ceide%26aufirst%3DSusana%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D429%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya  Zhou</span>, <span class="hlFld-ContribAuthor ">Chrysa  Malosh</span>, <span class="hlFld-ContribAuthor ">Susana  Conde-Ceide</span>, <span class="hlFld-ContribAuthor ">Carlos Manuel  Martínez-Viturro</span>, <span class="hlFld-ContribAuthor ">Jesus  Alcázar</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Thomas  Steckler</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Shaun R.  Stauffer</span>, <span class="hlFld-ContribAuthor ">José Manuel  Bartolomé-Nebreda</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3515-3519. <a href="https://doi.org/10.1016/j.bmcl.2015.06.096" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.096%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFurther%252Boptimization%252Bof%252Bthe%252BmGlu5%252BPAM%252Bclinical%252Bcandidate%252BVU0409551%25252FJNJ-46778212%25253A%252BProgress%252Band%252Bchallenges%252Btowards%252Ba%252Bback-up%252Bcompound%26aulast%3DZhou%26aufirst%3DYa%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3515%26epage%3D3519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María Luz  Martín-Martín</span>, <span class="hlFld-ContribAuthor ">José Manuel  Bartolomé-Nebreda</span>, <span class="hlFld-ContribAuthor ">Susana  Conde-Ceide</span>, <span class="hlFld-ContribAuthor ">Sergio A.  Alonso de Diego</span>, <span class="hlFld-ContribAuthor ">Silvia  López</span>, <span class="hlFld-ContribAuthor ">Carlos M.  Martínez-Viturro</span>, <span class="hlFld-ContribAuthor ">Han Min  Tong</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Thomas  Steckler</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Meredith J.  Noetzel</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Shaun R.  Stauffer</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (6)
                                     , 1310-1317. <a href="https://doi.org/10.1016/j.bmcl.2015.01.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.01.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.01.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.01.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BSAR%252Bof%252Bnovel%252Bseries%252Bof%252Bimidazopyrimidinones%252Band%252Bdihydroimidazopyrimidinones%252Bas%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Bmetabotropic%252Bglutamate%252Breceptor%252B5%252B%252528mGlu5%252529%26aulast%3DMart%25C3%25ADn-Mart%25C3%25ADn%26aufirst%3DMar%25C3%25ADa%2BLuz%26date%3D2015%26volume%3D25%26issue%3D6%26spage%3D1310%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Turlington</span>, <span class="hlFld-ContribAuthor ">Meredith J.  Noetzel</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Paige N.  Vinson</span>, <span class="hlFld-ContribAuthor ">Thomas  Steckler</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">José M.  Bartolomé-Nebreda</span>, <span class="hlFld-ContribAuthor ">Susana  Conde-Ceide</span>, <span class="hlFld-ContribAuthor ">Han Min  Tong</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">J. Scott  Daniels</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Shaun R.  Stauffer</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SAR of a novel series of metabotropic glutamate receptor 5 positive allosteric modulators with high ligand efficiency. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (15)
                                     , 3641-3646. <a href="https://doi.org/10.1016/j.bmcl.2014.04.087" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.087%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BSAR%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bmetabotropic%252Bglutamate%252Breceptor%252B5%252Bpositive%252Ballosteric%252Bmodulators%252Bwith%252Bhigh%252Bligand%252Befficiency%26aulast%3DTurlington%26aufirst%3DMark%26date%3D2014%26volume%3D24%26issue%3D15%26spage%3D3641%26epage%3D3646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Theresa  Williams</span>, <span class="hlFld-ContribAuthor ">Marlene A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Mikhail  Kalinichev</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Rocher</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 143-182. <a href="https://doi.org/10.1007/7355_2014_57" title="DOI URL">https://doi.org/10.1007/7355_2014_57</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_57%26sid%3Dliteratum%253Aachs%26atitle%3DActivation%252Bof%252Bthe%252BmGlu5%252BReceptor%252Bfor%252Bthe%252BTreatment%252Bof%252BSchizophrenia%252Band%252BCognitive-Deficit-Associated%252BDisorders%26aulast%3DWilliams%26aufirst%3DTheresa%26date%3D2014%26date%3D2014%26spage%3D143%26epage%3D182%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. mGlu<sub>5</sub> receptor PAMs with reported efficacy in preclinical models of schizophrenia and cognition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Parallel simultaneous evolution from HTS hit <b>9</b> to optimized series <b>15</b> and <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Isoamyl nitrite, CuBr<sub>2</sub>, CH<sub>3</sub>CN, 80 °C, 1 h, 75%; (b) phenyl acetylene, [1,1′-<i>bis</i>(diphenylphospino)ferrocene]dichloro-palladium(II), CuI, Et<sub>3</sub>N, 1,4-dioxane, reflux, 2 h, 52%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) NBS, CCl<sub>4</sub>, 10–15 °C, 2 h; (ii) thiourea, NaHCO<sub>3</sub>, EtOH, 80 °C, 2.5 h; (iii) HCl, 1,4-dioxane, rt, 30 min, 100%; (b) isoamyl nitrite, CuBr<sub>2</sub>, CH<sub>3</sub>CN, rt, 1.5 h, 55%; (c) phenyl acetylene, [1,1′-bis(diphenylphosphino)ferrocene]dichloro-palladium(II), CuI, Et<sub>3</sub>N, 1,4-dioxane, reflux, 30%; (d) <b>14b</b>, MeI or <b>14c</b>, MeOCH<sub>2</sub>CH<sub>2</sub>Br, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C, 16 h, 19% for <b>14b</b> and 20% for <b>14c</b>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ethyl malonyl chloride, Et<sub>3</sub>N or DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 22–70%; (b) NaOEt, EtOH, 85 °C, 16 h, 55–91%; (c) <b>24a</b>-<b>c</b>, CH<sub>3</sub>CO<sub>2</sub>H, H<sub>2</sub>O, 90 °C, 16 h, 53–73%; or <b>24d,e</b>, CH<sub>3</sub>CN, H<sub>2</sub>O, 90 °C, 2 h; (d) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min, 73–76%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnOH, NaH, THF, 120 °C, 15 min, microwave, 54%; (b) MeI, NaH, THF, 120 °C, 15 min, microwave, 54%; (c) (i) thiourea, NaHCO<sub>3</sub>, EtOH, 80 °C, 1 h; (ii) isoamyl nitrite, CuBr<sub>2</sub>, CH<sub>3</sub>CN, rt, 45 min, 16%; (d) BnOH, NaH, THF, 120 °C, 15 min, microwave, 63%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CO, [1,1′-bis(diphenylphospino)ferrocene]dichloro-palladium(II), MeOH, Et<sub>3</sub>N, 50 °C, 16 h, 21%; (b) MeI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 60 h, 42%; (c) NaBH<sub>4</sub>, MeOH, 0 °C, 30 min, 99%; (d) PhOH, di-<i>tert</i>-butyl azodicarboxylate, PPh<sub>3</sub>, THF, 120 °C, 20 min, microwave, 20%.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaBH<sub>4</sub>, MeOH, 0 °C, 30 min, 40%; (b) PhOH, di-<i>tert</i>-butyl azodicarboxylate, PPh<sub>3</sub>, THF, 120 °C, 20 min, microwave, 64%; (c) <b>32</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h, 13–49%.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>25a</b>–<b>c</b>, NaHCO<sub>3</sub>, EtOH, 70 °C, 15 min, 10–25% or <b>25d</b>,<b>e</b>, NaHCO<sub>3</sub>, DMF, 100 °C, 30 min, 10–23%.</p></p></figure><figure data-id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ethyl thiooxamate, NaHCO<sub>3</sub>, EtOH, 80 °C, 2 h, 15%; (b) (i) NaBH<sub>4</sub>, MeOH, 0 °C, 2 h; (ii) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 27%; (c) Ar-OH, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 24 h, 8–20%.</p></p></figure><figure data-id="sch9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>16m</b>-<b>o</b>,<b>q</b>, <b>33</b>, CuI, K<sub>2</sub>CO<sub>3</sub>, <i>N</i>,<i>N</i>′-dimethylethylenediamine, toluene, 120 °C, 16 h, 15–64% or <b>16p</b>, 2-bromo-4-fluoropyridine, CuI, K<sub>3</sub>PO<sub>4</sub>, <i>N</i>,<i>N</i>′-dimethylethylenediamine, toluene, 140 °C, 16 h, 64%.</p></p></figure><figure data-id="fig3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glutamate CRC in the presence of increasing concentrations of <b>16a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Profile summary of <b>16a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Dose-dependent effect of <b>16a</b> on the reversal of amphetamine-induced hyperlocomotion in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/medium/jm-2013-00650w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of <b>16a</b> on rotarod performance in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm400650w/production/images/large/jm-2013-00650w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400650w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i75">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Tandon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasrallah, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshavan, M. S.</span><span> </span><span class="NLM_article-title">Schizophrenia, “Just the Facts” 4. Clinical Features and Conceptualization</span> <span class="citation_source-journal">Schizophr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1016%2Fj.schres.2009.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=19328655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ps12mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=1-23&author=R.+Tandonauthor=H.+A.+Nasrallahauthor=M.+S.+Keshavan&title=Schizophrenia%2C+%E2%80%9CJust+the+Facts%E2%80%9D+4.+Clinical+Features+and+Conceptualization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia, "just the facts" 4. Clinical features and conceptualization</span></div><div class="casAuthors">Tandon Rajiv; Nasrallah Henry A; Keshavan Matcheri S</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-23</span>
        ISSN:<span class="NLM_cas:issn">0920-9964</span>.
    </div><div class="casAbstract">Although dementia praecox or schizophrenia has been considered a unique disease entity for the past century, its definitions and boundaries have continued to vary over this period.  At any given time, the changing concept of schizophrenia has been influenced by available diagnostic tools and treatments, related conditions from which it most needs to be distinguished, extant knowledge and scientific paradigms.  There is significant heterogeneity in the etiopathology, symptomatology, and course of schizophrenia.  It is characterized by an admixture of positive, negative, cognitive, mood, and motor symptoms whose severity varies across patients and through the course of the illness.  Positive symptoms usually first begin in adolescence or early adulthood, but are often preceded by varying degrees of negative and cognitive symptomatology.  Schizophrenia tends to be a chronic and relapsing disorder with generally incomplete remissions, variable degrees of functional impairment and social disability, frequent comorbid substance abuse, and decreased longevity.  Although schizophrenia may not represent a single disease with a unitary etiology or pathogenetic process, alternative approaches have thus far been unsuccessful in better defining this syndrome or its component entities.  The symptomatologic, course, and etio-pathological heterogeneity can usefully be addressed by a dimensional approach to psychopathology, a clinical staging approach to illness course, and by elucidating endophenotypes and markers of illness progression, respectively.  This will allow an approach to the deconstruction of schizophrenia into its multiple component parts and strategies to reconfigure these components in a more meaningful manner.  Possible implications for DSM-V and ICD-11 definitions of schizophrenia are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvnCea0e_JZZotVjB3IRIyfW6udTcc2ebgVLoRaRra3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ps12mtw%253D%253D&md5=8ed68c03937fb30924537e7cbe9f624e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2009.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2009.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DTandon%26aufirst%3DR.%26aulast%3DNasrallah%26aufirst%3DH.%2BA.%26aulast%3DKeshavan%26aufirst%3DM.%2BS.%26atitle%3DSchizophrenia%252C%2520%25E2%2580%259CJust%2520the%2520Facts%25E2%2580%259D%25204.%2520Clinical%2520Features%2520and%2520Conceptualization%26jtitle%3DSchizophr.%2520Res.%26date%3D2009%26volume%3D110%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Activation of Metabotropic Glutamate Receptors as a Novel Approach for the Treatment of Schizophrenia</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=148-155&author=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+K.+Jones&title=Activation+of+Metabotropic+Glutamate+Receptors+as+a+Novel+Approach+for+the+Treatment+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DActivation%2520of%2520Metabotropic%2520Glutamate%2520Receptors%2520as%2520a%2520Novel%2520Approach%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D148%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolome, J. M.</span><span> </span><span class="NLM_article-title">A Decade of Progress in the Discovery and Development of ‘Atypical’ Antipsychotics</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1016%2FS0079-6468%2810%2949002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=20855038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=37-80&author=G.+J.+Macdonaldauthor=J.+M.+Bartolome&title=A+Decade+of+Progress+in+the+Discovery+and+Development+of+%E2%80%98Atypical%E2%80%99+Antipsychotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of progress in the discovery and development of 'Atypical' antipsychotics</span></div><div class="casAuthors">MacDonald, Gregor J.; Bartolome, Jose Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-80</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The currently marketed antipsychotic drugs, recently launched and late-stage clin. compds., and progress in the discovery of 'atypical' agents are shown.  Other dopaminergic mechanisms suggestive of an 'atypical-like' profile, and non-dopamine mechanisms suggestive of an 'atypical-like' profile are also briefly reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbxQYFJzTE6bVg90H21EOLACvtfcHk0liE1luiLiZNWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlSqtA%253D%253D&md5=a9f1a0d39a1c548a778a4a63da4fafd0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2810%2949002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252810%252949002-5%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DBartolome%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Decade%2520of%2520Progress%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520%25E2%2580%2598Atypical%25E2%2580%2599%2520Antipsychotics%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D49%26spage%3D37%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Olney, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, N. B.</span><span> </span><span class="NLM_article-title">NMDA Antagonists as Neurotherapeutic Drugs, Psychotogens, Neurotoxins, and Research Tools for Studying Schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1001%2Farchpsyc.1995.03950240016004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=7492260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADyaK28XotF2rtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1995&pages=998-1007&author=J.+W.+Olneyauthor=N.+B.+Farber&title=NMDA+Antagonists+as+Neurotherapeutic+Drugs%2C+Psychotogens%2C+Neurotoxins%2C+and+Research+Tools+for+Studying+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor dysfunction and schizophrenia</span></div><div class="casAuthors">Olney, John W.; Farber, Nuri B.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">998-1007</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">A review, with 120 refs., which advances a unified hypothesis pertaining to combined dysfunction of dopamine and N-methyl-D-aspartate glutamate receptors that highlights N-methyl-D-aspartate receptor hypofunction as a key mechanism that can help explain major clin. and pathophysiol. aspects of schizophrenia.  The following fundamental features of schizophrenia are accommodated by this hypothesis: (1) the occurrence of structural brain changes during early development that have the potential for producing subsequent clin. manifestations of schizophrenia, (2) a quiescent period in infancy and adolescence before clin. manifestations are expressed, (3) onset in early adulthood of psychotic symptoms, (4) involvement of dopamine (D2) receptors in some cases but not others that would explain why some but not all patients are responsive to typical neuroleptic therapy, and (5) ongoing neurodegenerative changes and cognitive deterioration in some patients.  We propose that since N-methyl-D-aspartate receptor hypofunction can cause psychosis in humans and corticolimbic neurodegenerative changes in the rat brain, and since these changes are prevented by certain antipsychotic drugs, including atypical neuroleptic agents (clozapine, olanzapine, fluperlapine), a better understanding of the N-methyl-D-aspartate receptor hypofunction mechanism and ways of preventing its neurodegenerative consequences in the rat brain may lead to improved pharmacotherapy in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8_jBCscao6LVg90H21EOLACvtfcHk0lj4emkNX6Xf-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XotF2rtA%253D%253D&md5=ce668d3a1c911f6a0eab2488b0a14ad5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1995.03950240016004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1995.03950240016004%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DNMDA%2520Antagonists%2520as%2520Neurotherapeutic%2520Drugs%252C%2520Psychotogens%252C%2520Neurotoxins%252C%2520and%2520Research%2520Tools%2520for%2520Studying%2520Schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1995%26volume%3D52%26spage%3D998%26epage%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Nakanishi, S.</span><span> </span><span class="NLM_article-title">Molecular Diversity of Glutamate Receptors and Implications for Brain Functions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=597-603&author=S.+Nakanishi&title=Molecular+Diversity+of+Glutamate+Receptors+and+Implications+for+Brain+Functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DS.%26atitle%3DMolecular%2520Diversity%2520of%2520Glutamate%2520Receptors%2520and%2520Implications%2520for%2520Brain%2520Functions%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D597%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Shigemoto, R.; Mizuno, N.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptors – Immunocytochemical and In Situ Hybridization Analysis</span>. In  <span class="citation_source-book">Handbook of Chemical Neuroanatomy</span>; <span class="NLM_contrib-group">Ottersen, O. P.; Storm-Mathisen, J.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=63-98&author=R.+Shigemoto&author=N.+Mizunoauthor=O.+P.+Ottersen&author=J.+Storm-Mathisen&title=Handbook+of+Chemical+Neuroanatomy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DShigemoto%26aufirst%3DR.%26atitle%3DMetabotropic%2520Glutamate%2520Receptors%2520%25E2%2580%2593%2520Immunocytochemical%2520and%2520In%2520Situ%2520Hybridization%2520Analysis%26btitle%3DHandbook%2520of%2520Chemical%2520Neuroanatomy%26aulast%3DOttersen%26aufirst%3DO.%2BP.%26pub%3DElsevier%26date%3D2000%26spage%3D63%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cauli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambolez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinat, E.</span><span> </span><span class="NLM_article-title">Classification of Fusiform Neocortical Interneurons Based on Unsupervised Clustering</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">6144</span><span class="NLM_x">–</span> <span class="NLM_lpage">6149</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6144-6149&author=B.+Cauliauthor=J.+T.+Porterauthor=K.+Tsuzukiauthor=B.+Lambolezauthor=J.+Rossierauthor=B.+Quenetauthor=E.+Audinat&title=Classification+of+Fusiform+Neocortical+Interneurons+Based+on+Unsupervised+Clustering"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCauli%26aufirst%3DB.%26aulast%3DPorter%26aufirst%3DJ.%2BT.%26aulast%3DTsuzuki%26aufirst%3DK.%26aulast%3DLambolez%26aufirst%3DB.%26aulast%3DRossier%26aufirst%3DJ.%26aulast%3DQuenet%26aufirst%3DB.%26aulast%3DAudinat%26aufirst%3DE.%26atitle%3DClassification%2520of%2520Fusiform%2520Neocortical%2520Interneurons%2520Based%2520on%2520Unsupervised%2520Clustering%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D6144%26epage%3D6149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Perroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homburger, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousset, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagni, L.</span><span> </span><span class="NLM_article-title">Direct Interaction Enables Cross-talk between Ionotropic and Group I Metabotropic Glutamate Receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">6799</span><span class="NLM_x">–</span> <span class="NLM_lpage">6805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=6799-6805&author=J.+Perroyauthor=F.+Raynaudauthor=V.+Homburgerauthor=M.-C.+Roussetauthor=L.+Telleyauthor=J.+Bockaertauthor=L.+Fagni&title=Direct+Interaction+Enables+Cross-talk+between+Ionotropic+and+Group+I+Metabotropic+Glutamate+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerroy%26aufirst%3DJ.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DHomburger%26aufirst%3DV.%26aulast%3DRousset%26aufirst%3DM.-C.%26aulast%3DTelley%26aufirst%3DL.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DFagni%26aufirst%3DL.%26atitle%3DDirect%2520Interaction%2520Enables%2520Cross-talk%2520between%2520Ionotropic%2520and%2520Group%2520I%2520Metabotropic%2520Glutamate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D6799%26epage%3D6805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Stauffer, S. R.</span><span> </span><span class="NLM_article-title">Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5)</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn2000519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFCmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=450-470&author=S.+R.+Stauffer&title=Progress+toward+Positive+Allosteric+Modulators+of+the+Metabotropic+Glutamate+Receptor+Subtype+5+%28mGluR5%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5)</span></div><div class="casAuthors">Stauffer, Shaun R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">450-470</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Review describes recent trends in the development of small mol. mGlu5 pos. allosteric modulators (PAMs).  A large body of pharmacol., genetic, electrophysiol., and in vivo behavioral evidence has accumulated over the past decade which continues to support the hypothesis and rationale for the activation of the metabotropic glutamate receptor subtype 5 (mGlu5) as a viable and promising target for the development of novel antipsychotics.  Until recently, functionally efficacious and potent mGlu5 PAMs have been somewhat structurally limited in scope and slow to emerge.  This Review will discuss efforts since late 2008 which have provided novel mGlu5 PAM chemotypes, offering ligands with a diverse range of pharmacol., physicochem., and DMPK properties that were previously unavailable.  In addn., significant biol. studies of importance in the past few years using the well established PAMs known as DFB, CPPHA, CDPPB, and ADX-47273 will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHnCTYtdTjz7Vg90H21EOLACvtfcHk0lhJ80hniA-Ttg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFCmsbY%253D&md5=496ce47a9c3efefdd078844493b8011e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn2000519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000519%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26atitle%3DProgress%2520toward%2520Positive%2520Allosteric%2520Modulators%2520of%2520the%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520%2528mGluR5%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D450%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemiare, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span> </span><span class="NLM_article-title">Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 from a Series of <i>N</i>-(1,3-Diphenyl-1<i>H</i>-pyrazol-5-yl)benzamides That Potentiate Receptor Function In Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5825</span><span class="NLM_x">–</span> <span class="NLM_lpage">5828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049400d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5825-5828&author=C.+W.+Lindsleyauthor=D.+D.+Wisnoskiauthor=W.+H.+Leisterauthor=J.+A.+O%E2%80%99Brienauthor=W.+Lemiareauthor=D.+L.+Williamsauthor=M.+Burnoauthor=C.+Surauthor=G.+G.+Kinneyauthor=D.+J.+Pettiboneauthor=P.+R.+Millerauthor=S.+Smithauthor=M.+E.+Dugganauthor=G.+D.+Hartmanauthor=P.+J.+Connauthor=J.+R.+Huff&title=Discovery+of+Positive+Allosteric+Modulators+for+the+Metabotropic+Glutamate+Receptor+Subtype+5+from+a+Series+of+N-%281%2C3-Diphenyl-1H-pyrazol-5-yl%29benzamides+That+Potentiate+Receptor+Function+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm049400d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049400d%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemiare%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DP.%2BR.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520Positive%2520Allosteric%2520Modulators%2520for%2520the%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520from%2520a%2520Series%2520of%2520N-%25281%252C3-Diphenyl-1H-pyrazol-5-yl%2529benzamides%2520That%2520Potentiate%2520Receptor%2520Function%2520In%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5825%26epage%3D5828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. W.,  Jr.</span><span> </span><span class="NLM_article-title">A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has In Vivo Activity and Antipsychotic-like Effects in Rat Behavioral Models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1124%2Fjpet.104.079244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=15608073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=199-206&author=G.+G.+Kinneyauthor=J.+A.+O%E2%80%99Brienauthor=W.+Lemaireauthor=M.+Burnoauthor=D.+J.+Bickelauthor=M.+K.+Clementsauthor=D.+D.+Wisnoskiauthor=C.+W.+Lindsleyauthor=P.+R.+Tillerauthor=S.+Smithauthor=M.+A.+Jacobsonauthor=C.+Surauthor=M.+E.+Dugganauthor=D.+J.+Pettiboneauthor=D.+W.+Williams&title=A+Novel+Selective+Positive+Allosteric+Modulator+of+Metabotropic+Glutamate+Receptor+Subtype+5+Has+In+Vivo+Activity+and+Antipsychotic-like+Effects+in+Rat+Behavioral+Models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models</span></div><div class="casAuthors">Kinney, Gene G.; O'Brien, Julie A.; Lemaire, Wei; Burno, Maryann; Bickel, Denise J.; Clements, Michelle K.; Chen, Tsing-Bau; Wisnoski, David D.; Lindsley, Craig W.; Tiller, Philip R.; Smith, Sheri; Jacobson, Marlene A.; Sur, Cyrille; Duggan, Mark E.; Pettibone, Douglas J.; Conn, P. Jeffrey; Williams, David L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We found that 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) is a potent and selective pos. allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5).  In Chinese hamster ovary cells expressing human mGluR5, CDPPB potentiated threshold responses to glutamate in fluorometric Ca2+ assays more than 7-fold with an EC50 value of approx. 27 nM.  At 1 μM, CDPPB shifted mGluR5 agonist concn. response curves to glutamate, quisqualate, and (R,S)-3,5-dihydroxyphenylglycine 3- to 9-fold to the left.  At higher concns., CDPPB exhibited agonist-like activity on cells expressing mGluR5.  No other activity was obsd. on any other mGluR or cell type at concns. up to 10 μM.  CDPPB had no effect on [3H]quisqualate binding to mGluR5 but did compete for binding of [3H]methoxyPEPy, an analog of the selective mGluR5 neg. allosteric modulator MPEP.  CDPPB was found to be brain penetrant and reversed amphetamine-induced locomotor activity and amphetamine-induced deficits in prepulse inhibition in rats, two models sensitive to antipsychotic drug treatment.  These results demonstrate that pos. allosteric modulation of mGluR5 produces behavioral effects, suggesting that such modulation serves as a viable approach to increasing mGluR5 activity in vivo.  These effects are consistent with the hypothesis that allosteric potentiation of mGluR5 may provide a novel approach for development of antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5MND_DZkDL7Vg90H21EOLACvtfcHk0lgADjybyO14nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSnsLg%253D&md5=371bb91ca8ac48cdf8b38c95634385da</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.079244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.079244%26sid%3Dliteratum%253Aachs%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DTiller%26aufirst%3DP.%2BR.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BW.%26atitle%3DA%2520Novel%2520Selective%2520Positive%2520Allosteric%2520Modulator%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520Has%2520In%2520Vivo%2520Activity%2520and%2520Antipsychotic-like%2520Effects%2520in%2520Rat%2520Behavioral%2520Models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popiolek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wantuch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khawaja, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouranova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruthi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulcicchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pausch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span> </span><span class="NLM_article-title">ADX47273 [<i>S</i>-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-like and Procognitive Activities</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1124%2Fjpet.108.136580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=18753411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=827-839&author=F.+Liuauthor=S.+Grauerauthor=C.+Kelleyauthor=R.+Navarraauthor=R.+Grafauthor=G.+Zhangauthor=P.+J.+Atkinsonauthor=M.+Popiolekauthor=C.+Wantuchauthor=X.+Khawajaauthor=D.+Smithauthor=M.+Olsenauthor=E.+Kouranovaauthor=M.+Laiauthor=F.+Pruthiauthor=C.+Pulcicchioauthor=M.+Dayauthor=A.+Gilbertauthor=M.+H.+Pauschauthor=N.+J.+Brandonauthor=C.+E.+Beyerauthor=T.+A.+Comeryauthor=S.+Logueauthor=S.+Rosenzweig-Lipsonauthor=K.+L.+Marquis&title=ADX47273+%5BS-%284-Fluoro-phenyl%29-%7B3-%5B3-%284-fluoro-phenyl%29-%5B1%2C2%2C4%5Doxadiazol-5-yl%5D-piperidin-1-yl%7D-methanone%5D%3A+A+Novel+Metabotropic+Glutamate+Receptor+5-Selective+Positive+Allosteric+Modulator+with+Preclinical+Antipsychotic-like+and+Procognitive+Activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities</span></div><div class="casAuthors">Liu, Feng; Grauer, Steve; Kelley, Cody; Navarra, Rachel; Graf, Radka; Zhang, Guoming; Atkinson, Peter J.; Popiolek, Michael; Wantuch, Caitlin; Khawaja, Xavier; Smith, Deborah; Olsen, Michael; Kouranova, Evguenia; Lai, Margaret; Pruthi, Farhana; Pulicicchio, Claudine; Day, Mark; Gilbert, Adam; Pausch, Mark H.; Brandon, Nicholas J.; Beyer, Chad E.; Comery, Tom A.; Logue, Sheree; Rosenzweig-Lipson, Sharon; Marquis, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">827-839</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pos. allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 (mGlu5) enhance N-methyl-D-aspartate receptor function and may represent a novel approach for the treatment of schizophrenia.  ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-methanone], a recently identified potent and selective mGlu5 PAM, increased (9-fold) the response to threshold concn. of glutamate (50 nM) in fluorometric Ca2+ assays (EC50 = 170 nM) in human embryonic kidney 293 cells expressing rat mGlu5.  In the same system, ADX47273 dose-dependently shifted mGlu5 receptor glutamate response curve to the left (9-fold at 1 μM) and competed for binding of [3H]2-methyl-6-(phenylethynyl)pyridine (Ki = 4.3 μM), but not [3H]quisqualate.  In vivo, ADX47273 increased extracellular signal-regulated kinase and cAMP-responsive element-binding protein phosphorylation in hippocampus and prefrontal cortex, both of which are crit. for glutamate-mediated signal transduction mechanisms.  In models sensitive to antipsychotic drug treatment, ADX47273 reduced rat-conditioned avoidance responding [minimal ED (MED) = 30 mg/kg i.p.] and decreased mouse apomorphine-induced climbing (MED = 100 mg/kg i.p.), with little effect on stereotype or catalepsy.  Furthermore, ADX47273 blocked phencyclidine, apomorphine, and amphetamine-induced locomotor activities (MED = 100 mg/kg i.p.) in mice and decreased extracellular levels of dopamine in the nucleus accumbens, but not in the striatum, in rats.  In cognition models, ADX47273 increased novel object recognition (MED = 1 mg/kg i.p.) and reduced impulsivity in the five-choice serial reaction time test (MED = 10 mg/kg i.p.) in rats.  Taken together, these effects are consistent with the hypothesis that allosteric potentiation of mGlu5 may provide a novel approach for development of antipsychotic and procognitive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYX198d-NhtLVg90H21EOLACvtfcHk0lgADjybyO14nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLjN&md5=c76b2ab8c1d71dc75f52f582999326ac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136580%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DKelley%26aufirst%3DC.%26aulast%3DNavarra%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DAtkinson%26aufirst%3DP.%2BJ.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DWantuch%26aufirst%3DC.%26aulast%3DKhawaja%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DOlsen%26aufirst%3DM.%26aulast%3DKouranova%26aufirst%3DE.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DPruthi%26aufirst%3DF.%26aulast%3DPulcicchio%26aufirst%3DC.%26aulast%3DDay%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DA.%26aulast%3DPausch%26aufirst%3DM.%2BH.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DLogue%26aufirst%3DS.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26atitle%3DADX47273%2520%255BS-%25284-Fluoro-phenyl%2529-%257B3-%255B3-%25284-fluoro-phenyl%2529-%255B1%252C2%252C4%255Doxadiazol-5-yl%255D-piperidin-1-yl%257D-methanone%255D%253A%2520A%2520Novel%2520Metabotropic%2520Glutamate%2520Receptor%25205-Selective%2520Positive%2520Allosteric%2520Modulator%2520with%2520Preclinical%2520Antipsychotic-like%2520and%2520Procognitive%2520Activities%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D827%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grier, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Days, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">1105</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1124%2Fmol.110.067207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=20923853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=1105-1123&author=A.+L.+Rodriguezauthor=M.+D.+Grierauthor=C.+K.+Jonesauthor=E.+J.+Hermanauthor=A.+S.+Kaneauthor=R.+L.+Smithauthor=R.+Williamsauthor=Y.+Zhouauthor=J.+E.+Marloauthor=E.+L.+Daysauthor=T.+N.+Blattauthor=S.+Jadhavauthor=U.+Menonauthor=P.+N.+Vinsonauthor=J.+M.+Rookauthor=S.+R.+Staufferauthor=C.+M.+Niswenderauthor=C.+W.+Lindsleyauthor=C.+D.+Weaverauthor=P.+J.+Conn&title=Discovery+of+Novel+Allosteric+Modulators+of+Metabotropic+Glutamate+Receptor+Subtype+5+Reveals+Chemical+and+Functional+Diversity+and+In+Vivo+Activity+in+Rat+Behavioral+Models+of+Anxiolytic+and+Antipsychotic+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity</span></div><div class="casAuthors">Rodriguez, Alice L.; Grier, Mark D.; Jones, Carrie K.; Herman, Elizabeth J.; Kane, Alexander S.; Smith, Randy L.; Williams, Richard; Zhou, Ya; Marlo, Joy E.; Days, Emily L.; Blatt, Tasha N.; Jadhav, Satyawan; Menon, Usha N.; Vinson, Paige N.; Rook, Jerri M.; Stauffer, Shaun R.; Niswender, Colleen M.; Lindsley, Craig W.; Weaver, C. David; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1105-1123</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Modulators of metabotropic glutamate receptor subtype 5 (mGluR5) may provide novel treatments for multiple central nervous system (CNS) disorders, including anxiety and schizophrenia.  Although compds. have been developed to better understand the physiol. roles of mGluR5 and potential usefulness for the treatment of these disorders, there are limitations in the tools available, including poor selectivity, low potency, and limited soly.  To address these issues, we developed an innovative assay that allows simultaneous screening for mGluR5 agonists, antagonists, and potentiators.  We identified multiple scaffolds that possess diverse modes of activity at mGluR5, including both pos. and neg. allosteric modulators (PAMs and NAMs, resp.).  3-Fluoro-5-(3-(pyridine-2-yl)-1,2,4-oxadiazol-5-yl)benzonitrile (VU0285683) was developed as a novel selective mGluR5 NAM with high affinity for the 2-methyl-6-(phenylethynyl)-pyridine (MPEP) binding site.  VU0285683 had anxiolytic-like activity in two rodent models for anxiety but did not potentiate phencyclidine-induced hyperlocomotor activity.  (4-Hydroxypiperidin-1-yl)(4-phenylethynyl)phenyl)methanone (VU0092273) was identified as a novel mGluR5 PAM that also binds to the MPEP site.  VU0092273 was chem. optimized to an orally active analog, N-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide hydrochloride (VU0360172), which is selective for mGluR5.  This novel mGluR5 PAM produced a dose-dependent reversal of amphetamine-induced hyperlocomotion, a rodent model predictive of antipsychotic activity.  Discovery of structurally and functionally diverse allosteric modulators of mGluR5 that demonstrate in vivo efficacy in rodent models of anxiety and antipsychotic activity provide further support for the tremendous diversity of chem. scaffolds and modes of efficacy of mGluR5 ligands.  In addn., these studies provide strong support for the hypothesis that multiple structurally distinct mGluR5 modulators have robust activity in animal models that predict efficacy in the treatment of CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDfM6YTd9zTrVg90H21EOLACvtfcHk0lgDyxqJ54EHjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7bM&md5=2e243a2ef257c4552e948df39db00086</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.067207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.067207%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DGrier%26aufirst%3DM.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DHerman%26aufirst%3DE.%2BJ.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DSmith%26aufirst%3DR.%2BL.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMarlo%26aufirst%3DJ.%2BE.%26aulast%3DDays%26aufirst%3DE.%2BL.%26aulast%3DBlatt%26aufirst%3DT.%2BN.%26aulast%3DJadhav%26aufirst%3DS.%26aulast%3DMenon%26aufirst%3DU.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520Novel%2520Allosteric%2520Modulators%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520Reveals%2520Chemical%2520and%2520Functional%2520Diversity%2520and%2520In%2520Vivo%2520Activity%2520in%2520Rat%2520Behavioral%2520Models%2520of%2520Anxiolytic%2520and%2520Antipsychotic%2520Activity%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D1105%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gastambide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ÓNeill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M. D.</span><span> </span><span class="NLM_article-title">Selective Remediation of Reversal Learning Deficits in the Neurodevelopmental MAM Model of Schizophrenia by a Novel mGlu<sub>5</sub> Positive Allosteric Modulator</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=1057-1066&author=F.+Gastambideauthor=M.+C.+Cotelauthor=G.+Gilmourauthor=M.+J.+%C3%93Neillauthor=T.+W.+Robbinsauthor=M.+D.+Tricklebank&title=Selective+Remediation+of+Reversal+Learning+Deficits+in+the+Neurodevelopmental+MAM+Model+of+Schizophrenia+by+a+Novel+mGlu5+Positive+Allosteric+Modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGastambide%26aufirst%3DF.%26aulast%3DCotel%26aufirst%3DM.%2BC.%26aulast%3DGilmour%26aufirst%3DG.%26aulast%3D%25C3%2593Neill%26aufirst%3DM.%2BJ.%26aulast%3DRobbins%26aufirst%3DT.%2BW.%26aulast%3DTricklebank%26aufirst%3DM.%2BD.%26atitle%3DSelective%2520Remediation%2520of%2520Reversal%2520Learning%2520Deficits%2520in%2520the%2520Neurodevelopmental%2520MAM%2520Model%2520of%2520Schizophrenia%2520by%2520a%2520Novel%2520mGlu5%2520Positive%2520Allosteric%2520Modulator%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D1057%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gastambide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M. D.</span><span> </span><span class="NLM_article-title">The mGlu<sub>5</sub> Positive Allosteric Modulator LSN2463359 Differentially Modulates Motor, Instrumental and Cognitive Effects of NMDA Receptor Antagonists in the Rat</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=240-247&author=F.+Gastambideauthor=G.+Gilmourauthor=T.+W.+Robbinsauthor=M.+D.+Tricklebank&title=The+mGlu5+Positive+Allosteric+Modulator+LSN2463359+Differentially+Modulates+Motor%2C+Instrumental+and+Cognitive+Effects+of+NMDA+Receptor+Antagonists+in+the+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGastambide%26aufirst%3DF.%26aulast%3DGilmour%26aufirst%3DG.%26aulast%3DRobbins%26aufirst%3DT.%2BW.%26aulast%3DTricklebank%26aufirst%3DM.%2BD.%26atitle%3DThe%2520mGlu5%2520Positive%2520Allosteric%2520Modulator%2520LSN2463359%2520Differentially%2520Modulates%2520Motor%252C%2520Instrumental%2520and%2520Cognitive%2520Effects%2520of%2520NMDA%2520Receptor%2520Antagonists%2520in%2520the%2520Rat%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D240%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Gilmour, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broad, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wafford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fivush, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gastambide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanks, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taboada, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgard, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M. D.</span><span> </span><span class="NLM_article-title">In Vitro Characterisation of the Novel Positive Allosteric Modulators of the mGlu<sub>5</sub> Receptor, LSN2463359 and LSN2814617, and Their Effects on Sleep architecture and Operant Responding in the Rat</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=224-239&author=G.+Gilmourauthor=L.+M.+Broadauthor=K.+A.+Waffordauthor=T.+Brittonauthor=E.+M.+Colvinauthor=A.+Fivushauthor=F.+Gastambideauthor=B.+Getmanauthor=B.+A.+Heinzauthor=A.+P.+McCarthyauthor=L.+Prietoauthor=E.+Shanksauthor=J.+W.+Smithauthor=L.+Taboadaauthor=D.+M.+Edgardauthor=M.+D.+Tricklebank&title=In+Vitro+Characterisation+of+the+Novel+Positive+Allosteric+Modulators+of+the+mGlu5+Receptor%2C+LSN2463359+and+LSN2814617%2C+and+Their+Effects+on+Sleep+architecture+and+Operant+Responding+in+the+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilmour%26aufirst%3DG.%26aulast%3DBroad%26aufirst%3DL.%2BM.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DBritton%26aufirst%3DT.%26aulast%3DColvin%26aufirst%3DE.%2BM.%26aulast%3DFivush%26aufirst%3DA.%26aulast%3DGastambide%26aufirst%3DF.%26aulast%3DGetman%26aufirst%3DB.%26aulast%3DHeinz%26aufirst%3DB.%2BA.%26aulast%3DMcCarthy%26aufirst%3DA.%2BP.%26aulast%3DPrieto%26aufirst%3DL.%26aulast%3DShanks%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DJ.%2BW.%26aulast%3DTaboada%26aufirst%3DL.%26aulast%3DEdgard%26aufirst%3DD.%2BM.%26aulast%3DTricklebank%26aufirst%3DM.%2BD.%26atitle%3DIn%2520Vitro%2520Characterisation%2520of%2520the%2520Novel%2520Positive%2520Allosteric%2520Modulators%2520of%2520the%2520mGlu5%2520Receptor%252C%2520LSN2463359%2520and%2520LSN2814617%252C%2520and%2520Their%2520Effects%2520on%2520Sleep%2520architecture%2520and%2520Operant%2520Responding%2520in%2520the%2520Rat%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D224%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hammond, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsdley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Chemical Class of mGlu<sub>5</sub> Allosteric Ligands with Distinct Modes of Pharmacology</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100051m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCns7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=702-716&author=A.+S.+Hammondauthor=A.+L.+Rodriguezauthor=S.+D.+Townsendauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=C.+W.+Linsdleyauthor=P.+J.+Conn&title=Discovery+of+a+Novel+Chemical+Class+of+mGlu5+Allosteric+Ligands+with+Distinct+Modes+of+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Chemical Class of mGlu5 Allosteric Ligands with Distinct Modes of Pharmacology</span></div><div class="casAuthors">Hammond, Alexis S.; Rodriguez, Alice L.; Townsend, Steven D.; Niswender, Colleen M.; Gregory, Karen J.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">702-716</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously discovered a pos. allosteric modulator (PAM) of the metabotropic glutamate receptor subtype 5 (mGlu5) termed 4 N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) that elicits receptor activation through a novel allosteric site on mGlu5, distinct from the classical mGlu5 neg. allosteric modulator (NAM) MPEP allosteric site.  However, a shallow structure-activity relationship (SAR), poor physiochem. properties, and weak PAM activity at rat mGlu5 limited the utility of CPPHA to explore allosteric activation of mGlu5 at a non-MPEP site.  Thus, we performed a functional high-throughput screen (HTS) and identified a novel mGlu5 PAM benzamide scaffold, exemplified by VU0001850 (EC50 = 1.3 μM, 106% Glumax) and VU0040237 (EC50 = 350 nM, 84% Glu Max).  An iterative parallel synthesis approach delivered 22 analogs, optimized mGlu5 PAM activity to afford VU0357121 (EC50 = 33 nM, 92% Glumax), and also revealed the first non-MPEP site neutral allosteric ligand (VU0365396).  Like CPPHA, PAMs within this class do not appear to bind at the MPEP allosteric site based on radioligand binding studies.  Moreover, mutagenesis studies indicate that VU0357121 and related analogs bind to a yet uncharacterized allosteric site on mGlu5, distinct from CPPHA, yet share a functional interaction with the MPEP site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD8WTnrb1QNrVg90H21EOLACvtfcHk0lgi8pWO8YoX2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCns7bL&md5=29902bd947cafaee04307ccaf24856fe</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn100051m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100051m%26sid%3Dliteratum%253Aachs%26aulast%3DHammond%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DTownsend%26aufirst%3DS.%2BD.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLinsdley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Chemical%2520Class%2520of%2520mGlu5%2520Allosteric%2520Ligands%2520with%2520Distinct%2520Modes%2520of%2520Pharmacology%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D702%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-Aryl Piperazines as Selective mGluR5 Potentiators with Improved In Vivo Utility</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100181a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=433-438&author=Y.+Zhouauthor=J.+Mankaauthor=A.+L.+Rodriguezauthor=C.+D.+Weaverauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=S.+R.+Stauffer&title=Discovery+of+N-Aryl+Piperazines+as+Selective+mGluR5+Potentiators+with+Improved+In+Vivo+Utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fml100181a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100181a%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DManka%26aufirst%3DJ.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26atitle%3DDiscovery%2520of%2520N-Aryl%2520Piperazines%2520as%2520Selective%2520mGluR5%2520Potentiators%2520with%2520Improved%2520In%2520Vivo%2520Utility%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D433%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadient, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeller, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhajlani, V.</span><span> </span><span class="NLM_article-title">Preclinical Profile of a Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">659</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1016%2Fj.ejphar.2011.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=21335002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=659&publication_year=2011&pages=146-154&author=N.+Spearauthor=R.+A.+Gadientauthor=D.+E.+Wilkinsauthor=M.+L.+Doauthor=J.+S.+Smithauthor=K.+L.+Zellerauthor=P.+Schroederauthor=M.+Zhangauthor=J.+Aroraauthor=V.+Chhajlani&title=Preclinical+Profile+of+a+Novel+Metabotropic+Glutamate+Receptor+5+Positive+Allosteric+Modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator</span></div><div class="casAuthors">Spear, Nathan; Gadient, Reto A.; Wilkins, Deidre E.; Do, My Linh; Smith, Jeffrey S.; Zeller, Kim L.; Schroeder, Patricia; Zhang, Minli; Arora, Jalaj; Chhajlani, Vijay</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">659</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">146-154</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent reports have indicated that patients with schizophrenia have a profound hypo-functionality of glutamatergic signaling pathways.  Pos. allosteric modulation of mGlu5 receptor has been postulated to augment NMDA function and thereby alleviate the glutamatergic hypo-function obsd. in schizophrenic patients.  Here we report the in vitro and in vivo characterization of CPPZ (1-(4-(2-chloro-4-fluorophenyl)piperazin-1-yl)-2-(pyridin-4-ylmethoxy)ethanone), a structurally novel pos. allosteric modulator selective for mGlu5 receptor.  In HEK293 cells stably over-expressing human mGlu5 receptor, CPPZ potentiates the intracellular calcium response elicited by a suboptimal concn. of the endogenous agonist glutamate.  CPPZ does not have any intrinsic agonist activity and behaves functionally as a pos. allosteric modulator.  This is further supported by binding data, which demonstrate that CPPZ is able to displace the neg. allosteric modulator MPEP but does not compete with the orthosteric ligand quisqualic acid.  Instead, CPPZ enhances the binding of the orthosteric ligand.  In native prepns., CPPZ potentiates calcium flux in rat cortical neurons stimulated with the group I agonist dihydroxyphenylglycine (DHPG).  In addn., CPPZ modulates long-term potentiation in rat hippocampal slices, a process known to be NMDA dependent.  In vivo, CPPZ reverses hyper locomotion triggered by the NMDA open channel blocker MK801 in CD1 mice.  CPPZ was also able to reduce rat conditioned avoidance responding to elec. shock.  Both in vitro and in vivo data demonstrate that this novel compd. acts as an mGlu5 receptor pos. allosteric modulator, which modulates NMDA dependent responses and suggests that the enhancement of mGlu5 receptor activity may prove useful in the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphXRIE2GAZWbVg90H21EOLACvtfcHk0lgRSFHFui8Cow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFGntL8%253D&md5=19caa87a3fb91d4d714a29398a00e8db</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DGadient%26aufirst%3DR.%2BA.%26aulast%3DWilkins%26aufirst%3DD.%2BE.%26aulast%3DDo%26aufirst%3DM.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BS.%26aulast%3DZeller%26aufirst%3DK.%2BL.%26aulast%3DSchroeder%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DArora%26aufirst%3DJ.%26aulast%3DChhajlani%26aufirst%3DV.%26atitle%3DPreclinical%2520Profile%2520of%2520a%2520Novel%2520Metabotropic%2520Glutamate%2520Receptor%25205%2520Positive%2520Allosteric%2520Modulator%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D659%26spage%3D146%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><div class="note"><p class="first last">Chromanone derivatives <b>9</b>, <b>10</b>, <b>11</b> and <b>12</b> have recently also been described as mGlu<sub>5</sub> receptor PAMs by Varnes <i>et al</i>. confirming our findings.</p></div><span class="NLM_contrib-group">Varnes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoesch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sygowski, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadient, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span> </span><span class="NLM_article-title">Discovery of Novel Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 5 (mGlu<sub>5</sub>)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1402</span><span class="NLM_x">–</span> <span class="NLM_lpage">1406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1402-1406&author=J.+G.+Varnesauthor=A.+P.+Marcusauthor=R.+C.+Maugerauthor=S.+R.+Thronerauthor=V.+Hoeschauthor=M.+M.+Kingauthor=X.+Wangauthor=L.+A.+Sygowskiauthor=N.+Spearauthor=R.+Gadientauthor=D.+G.+Brownauthor=J.+B.+Campbell&title=Discovery+of+Novel+Positive+Allosteric+Modulators+of+the+Metabotropic+Glutamate+Receptor+5+%28mGlu5%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarnes%26aufirst%3DJ.%2BG.%26aulast%3DMarcus%26aufirst%3DA.%2BP.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DThroner%26aufirst%3DS.%2BR.%26aulast%3DHoesch%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSygowski%26aufirst%3DL.%2BA.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DGadient%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520Novel%2520Positive%2520Allosteric%2520Modulators%2520of%2520the%2520Metabotropic%2520Glutamate%2520Receptor%25205%2520%2528mGlu5%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1402%26epage%3D1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">Compounds were tested for agonist, PAM, or antagonist activity on mGlu receptors in fluorescent Ca<sup>2+</sup> assays using HEK293 cells expressing human mGlu<sub>1</sub>, mGlu<sub>2</sub>, mGlu<sub>3</sub>, mGlu<sub>7</sub>, or mGlu<sub>8</sub> receptors. Effects on the human mGlu<sub>4</sub> receptor were tested in Ca<sup>2+</sup> or [<sup>35</sup>S]-GTPγS functional assays (receptor either expressed in HEK293 or L929sA cells). Evaluation of effects on the rat mGlu<sub>6</sub> receptors expressed in CHO cells were assessed in [<sup>35</sup>S]-GTPγS functional assays.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand Efficiency: a Useful Metric for Lead Selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400650w&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400650w&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400650w&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+a+Useful+Metric+for+Lead+Selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eb-BWzgYuCambntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520a%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">Data not shown.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Manka, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Days, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span> </span><span class="NLM_article-title">Optimization of an Ether Series of mGlu<sub>5</sub> Positive Allosteric Modulators: Molecular Determinants of MPEP-site Interaction Crossover</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6481</span><span class="NLM_x">–</span> <span class="NLM_lpage">6485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6481-6485&author=J.+T.+Mankaauthor=P.+N.+Vinsonauthor=K.+J.+Gregoryauthor=Y.+Zhouauthor=R.+Williamsauthor=K.+Gogiauthor=E.+Daysauthor=S.+Jadhavauthor=E.+J.+Hermanauthor=H.+Lavreysenauthor=C.+Mackieauthor=J.+M.+Bartolom%C3%A9author=G.+J.+Macdonaldauthor=T.+Stecklerauthor=J.+S.+Danielsauthor=C.+D.+Weaverauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=S.+R.+Stauffer&title=Optimization+of+an+Ether+Series+of+mGlu5+Positive+Allosteric+Modulators%3A+Molecular+Determinants+of+MPEP-site+Interaction+Crossover"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DGogi%26aufirst%3DK.%26aulast%3DDays%26aufirst%3DE.%26aulast%3DJadhav%26aufirst%3DS.%26aulast%3DHerman%26aufirst%3DE.%2BJ.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DSteckler%26aufirst%3DT.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26atitle%3DOptimization%2520of%2520an%2520Ether%2520Series%2520of%2520mGlu5%2520Positive%2520Allosteric%2520Modulators%253A%2520Molecular%2520Determinants%2520of%2520MPEP-site%2520Interaction%2520Crossover%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6481%26epage%3D6485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Macdonald, G. J.; Tresadern, G. J.; Trabanco-Suarez, A. A.; Pastor-Fernandez, J.</span> Preparation of Bicyclic Thiazoles as Allosteric Modulators of mGluR5 Receptors. WO 2011073347 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macdonald%2C+G.+J.%3B+Tresadern%2C+G.+J.%3B+Trabanco-Suarez%2C+A.+A.%3B+Pastor-Fernandez%2C+J.+Preparation+of+Bicyclic+Thiazoles+as+Allosteric+Modulators+of+mGluR5+Receptors.+WO+2011073347+A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Macdonald, G. J.; Trabanco-Suarez, A. A.; Conde-Ceide, S.; Tresadern, G. J.; Bartolome-Nebreda, J. M.; Pastor-Fernandez, J.</span> Preparation of Bicyclic Thiazoles as Allosteric Modulators of mGluR5 Receptors. WO 2011073339 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macdonald%2C+G.+J.%3B+Trabanco-Suarez%2C+A.+A.%3B+Conde-Ceide%2C+S.%3B+Tresadern%2C+G.+J.%3B+Bartolome-Nebreda%2C+J.+M.%3B+Pastor-Fernandez%2C+J.+Preparation+of+Bicyclic+Thiazoles+as+Allosteric+Modulators+of+mGluR5+Receptors.+WO+2011073339+A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Brandl, T.; Maier, U.; Hoffmann, M.; Scheuerer, S.; Joergensen, A. T.; Pautsch, A.; Breitfelder, S.; Grauert, M.; Hoenke, C.; Erb, K.; Pieper, M.; Pragst, I.</span><span> </span><span class="NLM_article-title">Preparation of Dihydrothiazoloquinazolines as PI-3 Kinase Inhibitors</span>. WO 2007115929 A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Brandl&author=U.+Maier&author=M.+Hoffmann&author=S.+Scheuerer&author=A.+T.+Joergensen&author=A.+Pautsch&author=S.+Breitfelder&author=M.+Grauert&author=C.+Hoenke&author=K.+Erb&author=M.+Pieper&author=I.+Pragst&title=Preparation+of+Dihydrothiazoloquinazolines+as+PI-3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandl%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Dihydrothiazoloquinazolines%2520as%2520PI-3%2520Kinase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Days, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=120-133&author=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=H.+P.+Choauthor=E.+Daysauthor=Y.+Zhouauthor=A.+L.+Rodriguezauthor=H.+Lavreysenauthor=S.+R.+Staufferauthor=C.+M.+Niswenderauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+W.+Lindsleyauthor=C.+D.+Weaverauthor=P.+J.+Conn&title=Functional+Impact+of+Allosteric+Agonist+Activity+of+Selective+Positive+Allosteric+Modulators+of+Metabotropic+Glutamate+Receptor+Subtype+5+in+Regulating+Central+Nervous+System+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DDays%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DFunctional%2520Impact%2520of%2520Allosteric%2520Agonist%2520Activity%2520of%2520Selective%2520Positive%2520Allosteric%2520Modulators%2520of%2520Metabotropic%2520Glutamate%2520Receptor%2520Subtype%25205%2520in%2520Regulating%2520Central%2520Nervous%2520System%2520Function%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D120%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">LeadProfilingScreen. Ricerca Biosciences. Screen performed on the following targets: A<sub>1</sub>, A<sub>2A</sub>, A<sub>3</sub>, α<sub>1A</sub>, α<sub>1B</sub>, α<sub>1D</sub>, α<sub>2A</sub>, β<sub>1</sub>, β<sub>2</sub>, AR, B<sub>1</sub>, B<sub>2</sub>, CaCH L-Type (benzothiazepine), CaCH L-Type (dihydropyridine), CaCH N-Type, CB<sub>1</sub>, D<sub>1</sub>, D<sub>2S</sub>, D<sub>3</sub>, D<sub>4.2</sub>, ET<sub>A</sub>, ET<sub>B</sub>, EGF, ER<sub>α</sub>, GABA<sub>A</sub> (flunitrazepam), GABA<sub>A</sub> (muscinol), GABA<sub>B1A</sub>, GR, kainate, NMDA (agonism), NMDA (glycine), NMDA (phencyclidine), H<sub>1</sub>, H<sub>2</sub>, H<sub>3</sub>, IL-1, CysLT<sub>1</sub>, MT<sub>1</sub>, M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, NPY<sub>1</sub>, NPY<sub>2</sub>, acetylcholine, acetylcholine α1 (bungarotoxin), OP<sub>1</sub>, OP<sub>2</sub>, OP<sub>3</sub>, phorbol ester, PAF, KCH<sub>ATP</sub>, hERG, EP<sub>4</sub>, P<sub>2X</sub>, P<sub>2Y</sub>, rolipram, 5HT<sub>1A</sub>, 5HT<sub>2B</sub>, 5HT<sub>3</sub>, σ<sub>1</sub>, NK<sub>1</sub>, thyroid hormone, DAT, GABA transporter, NET, SERT.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Investigating Metabotropic Glutamate Receptor 5 Allosteric Modulator Cooperativity, Affinity and Agonism: Enriching Structure-function Relationships</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=860-875&author=K.+J.+Gregoryauthor=M.+J.+Noetzelauthor=J.+M.+Rookauthor=P.+N.+Vinsonauthor=S.+R.+Staufferauthor=A.+L.+Rodriguezauthor=K.+A.+Emmitteauthor=Y.+Zhouauthor=A.+C.+Chunauthor=A.+S.+Feltsauthor=B.+A.+Chauderauthor=C.+W.+Lindsleyauthor=C.+M.+Niswenderauthor=P.+J.+Conn&title=Investigating+Metabotropic+Glutamate+Receptor+5+Allosteric+Modulator+Cooperativity%2C+Affinity+and+Agonism%3A+Enriching+Structure-function+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DA.%2BC.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DInvestigating%2520Metabotropic%2520Glutamate%2520Receptor%25205%2520Allosteric%2520Modulator%2520Cooperativity%252C%2520Affinity%2520and%2520Agonism%253A%2520Enriching%2520Structure-function%2520Relationships%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D860%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">Based upon rat brain homogenate binding fraction unbound (18%) and total brain levels ([brain]<sub>90min</sub> = 17.5 ± 13.4 μM). Estimated average terminal unbound brain concentrations of <b>16a</b> after the 3, 10, 30, and 56.6 p.o. doses were 14 ± 11, 15 ± 13, 551 ± 449, and 908 ± 1029 nM respectively.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Carter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunnett, S. B.</span><span> </span><span class="NLM_article-title">Motor Coordination and Balance in Rodents</span> <span class="citation_source-journal">Curr. Protocols Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">8.12.1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8.12.14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=8.12.1-8.12.14&author=R.+J.+Carterauthor=J.+Mortonauthor=S.+B.+Dunnett&title=Motor+Coordination+and+Balance+in+Rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DR.%2BJ.%26aulast%3DMorton%26aufirst%3DJ.%26aulast%3DDunnett%26aufirst%3DS.%2BB.%26atitle%3DMotor%2520Coordination%2520and%2520Balance%2520in%2520Rodents%26jtitle%3DCurr.%2520Protocols%2520Neurosci.%26date%3D2001%26spage%3D8.12.1%26epage%3D8.12.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">Measures included scoring for ptosis, exophthalmos, miosis, mydriasis, corneal reflex, pinna reflex, piloerection, respiratory rate, writhing, tail erection, lacrimation, salivation, vasodilation, skin color, irritability, rectal temperature, motor activity, ataxia, arch/roll, tremors, leg weakness, rigid stance, spraddle, placing loss, grasping loss, righting loss, catalepsy, tail pinch reaction, escape loss and physical appearance.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i71"><a href="/doi/suppl/10.1021/jm400650w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_83884"></div></div></div></div></div><hr /></hr><p class="last">The different LCMS methods used for the characterization of intermediate and final compounds. Mean scores of <b>16a</b> effects on autonomic and somatomotor nervous system functions in rats. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400650w/suppl_file/jm400650w_si_001.pdf">jm400650w_si_001.pdf (205.2 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400650w&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm400650w%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400650w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799410549ebd942","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
